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ABSTRACT
L-glutamate decarboxylase (GAD, EC.4.1.1.15), the enzyme responsible
for the synthesis of the inhibitory neurotransmitter 4-aminobutyric acid
(GABA) was partially purified from chick brain using a combination of
column chromatographic (ion exchange, hydroxyapatite and gel filtration)
and electrophoretic techniques. Preparative polyacrylamide gel
electrophoresis resulted in enzyme inactivation and was, therefore,
of limited use. Chick brain GAD proved to be unstable so attempts were
made to develop an efficient affinity chromatography procedure (using
the cofactor pyridoxal-5-phosphate (PLP) as the ligand) which would
enable purification to homogeneity with a minimum number of steps.
However, this technique depends on ready dissociation of PLP from the
enzyme. Evidence is presented to suggest that the association between
GAD and PLP is very tight and that dissociation does not occur easily.
Chick brain GAD has an of approximately 150 000 - 15 000,
calculated by gel filtration chromatography, and an apparent for its
substrate glutamate of 3.7 - 0.4 mM.
The localisation and regional variation of GABA metabolism in
chick brain, from day 1 to day 14 post hatch, was investigated.
activities of GAD and 4-aminobutyrate:2-oxoglutarate transaminase
(GABA-T, EC.2.6.1.19), the enzyme responsible for the degradation of
GABA, were determined in homogenates of tissue taken from six different
brain regions. This was complemented by histochemical localisation
of GABA-T in thin (20 urn) transversa sections of chick brain.
It had been intended to localise GABAergic neurons by immunocytochemical
£ •
techniques however, lack of a homogenous protein precluded conventional
methods of raising antibodies in rabbits. Balb/c mice were injected
with partially purified GAD and the spleen cells from an immune mouse
fused with myeloma cells from the same strain of mouse. The hybrid cells
produced were screened for anti-GAD activity. Two fusions were carried
out in an attempt to raise monoclonal antibodies to chick brain GAD.
From fusion 1, 3% of the wells seeded contained hybrids, and from
fusion 2, 20% of the wells seeded contained hybrids. Preliminary screening
experiments indicated that one of the hybrids formed from fusion 1 and
several of those formed from fusion 2 may have secreted anti-GAD antibodies.
GABA and the specific
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1.1 GABA - a major inhibitory neurotransmitter of the central
nervous system
The amino acid 4-amino-butyric acid (GABA) is one of the most
abundant amino acids in brain occurring at concentrations of between
1 and 10 jimol/g wet weight (Baxter 1976). GABA is distributed
throughout the central nervous system (CNS), having been detected
in almost every brain nucleus examined, and exhibits great topographical
variations in concentration (Fahn & CSte 1968; Van der Heyden et al
1979). Although the presence of high concentrations of GABA in
vertebrate CNS had been reported in 1950 (Roberts et_ al^ 1950; Undenfriend
1950; Roberts & Frankel 1950; Awapara et_ ^ 1950) and GABA had
been identified as the active substrate which caused the inhibitory
effects of crude brain extracts on the function of the crayfish
stretch receptor system (Bazemore £^t al 1957) , controversy as to the
physiological role of GABA in the CNS continued for a number of years.
GABA is now accepted as a major inhibitory neurotransmitter in
both vertebrate and invertebrate CNS. For reviews see Roberts (1974),
Krnjevic (1974), Roberts et_ _al^ (1976), Krogsgaard-Larsen et_ al_ (1979).
To summarise briefly there is both in vivo and ir^ vitro evidence for a
neurotransmitter role for GABA. Microiontophoretic application of
GABA to neurons resulted in hyperpolarisation and changes in membrane
conductance similar to those observed with the natural transmitter.
GABA release has been demonstrated in vivo after stimulation of
inhibitory neurons and in vitro using synaptosomes and tissue slices.
GABA release has also been shown to have a calcium dependency.
L-glutamate decarboxylase (GAD EC.4.1.1.15), the synthetic enzyme has,
been localised in the synaptosomal fraction of brain, has been
demonstrated immunocytochemically at nerve terminals and has been
shown to be concentrated in regions which have an inhibitory function
and where, subsequently, GABA has been shown to act as a neurotransmitter.
Finally a mechanism whereby GABA can be removed from the synaptic
cleft has been demonstrated. This is a sodium and an energy
dependent high affinity uptake system.
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1.2 Difficulties associated with studying GABAergic systems in the CNS
Several characteristics of the GABA system complicate studies both
of the role of GABA as a neurotransmitter and the regulation of GABA
metabolism. GABA is ubiquitously distributed throughout the CNS and,
unlike the monoamines and acetylcholine which are frequently restricted
to specific brain nuclei, GABA or GAD activity can be measured in almost
every brain nucleus examined (Fahn & Cote 1968; 1Tappaz et al 1976;
Massari et_ al 1976; Van der Heydon et. al 1979). Similarly receptor
binding sites for GABA can be found throughout the CNS (Placheta &
Karobath 1979; Olsen 1981).
An ill vivo approach to studying the GABAergic system has advantages
since tissue damage is kept to a minimum, the viability of the tissue
is assured by an intact blood supply and the results of a particular
experimental manipulation, e.g. the release of GABA evoked by
stimulation of a certain structure or nerve tract, may be supposed to
be a direct result of that physiological stimulation. However, in vivo
studies are hampered by the complexity of the tissue which means that
the experiments are technically difficult to carry out, for example,
microiontophoretic application of a neurotransmitter substance to a
group of cells without affecting any neighbouring cells. In addition
localised tissue damage will occur during stimulation of nerve cells
which may allow leakage.
Another complication which arises when studying amino acid
neurotransmitters is that they are involved in the intermediary
metabolism of the cell. In the case of GABA it has been estimated
(using rat brain slices) that the GABA shunt (see Section 1.6)
constitutes about 8% of the total carbon flux of the tricarboxylic
acid cycle (Balazs et al 1970) . Consequently there is a question
as to whether GABA released in response to a physiological stimulus
reflects a neurotransmitter role for the amino acid or a change in
cellular metabolism caused by the stimulus.
The circuitry of the GABA system can also make it difficult to
interpret or predict the specific functional result of a particular
pharmacological manipulation. GABAergic neurons are often of the
type which project over a short distance and are intrinsic to the
nucleus, i.e. interneurons. In addition GABAergic neurons may synapse
on each other (Vincent e_t al_ 19 78) consequently augmentation of
GABAergic transmission in one nucleus may indirectly cause inhibition
of GABAergic activity in an adjacent area (see Section 1.4).
I
Compartmentalisation of GABA metabolism also poses problems when
interpreting the results of in vivo experiments. GABA is synthesised
primarily in GABAergic neurons, in particular at the axon terminals,
(Fonnum & Walberg 1973) although there is somewhat controversial
evidence that glia may also contain a low level of GAD activity (see
Section 1.8). Removal of GABA from the synaptic cleft occurs by
uptake into both nerve terminals and glial cells (Iversen & Kelly 1975).
In addition, neuronal perikarya also have the capacity to take up GABA
(East et_ al 1980) and all three of these compartments contain 4-
aminobutyrate:2-oxoglutarate transaminase (GABA-T EC.2.6.1.19)
(Robinson & Wells 1973; Kuriyama 1976; Barber & Saito 1976).
Consequently, the administration of drugs which affect GABA
metabolism may affect all or only one of these compartments, not
necessarily the nerve terminal compartment. As a result whole brain
GABA concentrations may appear normal, or elevated, when the
neurotransmitter GABA pool is markedly depleted or vice versa.
Measurement of the whole brain GABA concentration is therefore of
little value since changes in the GABA concentration of only one
GABA pool or in only a few nuclei may be sufficient to markedly affect
behavioural or physiological functions but would be undetected as
a change in whole brain GABA.
As a consequence of the difficulties of studying the role of GABA
in the CNS in_ vivo many investigations involving uptake and release of
the amino acid have been made using tissue slice or synaptosomal
preparations. Although experiments in vitro eliminate many of the
technical problems associated with irt_ vivo experiments and allow
investigation of tissue from a specific region of the CNS, minimising
tissue damage during preparation and maintaining tissue viability
become major considerations. Results from in vitro experiments must,
in addition, be interpreted with care with respect to the possibility
that the mechanism observed in vitro may not be identical to the
in vivo situation.
Several of the problems of interpretation associated with in vivo
experiments also apply in vitro e.g. which tissue elements accumulate
radiolabelled amino acids? This is still applicable when using
synaptosomal preparations since even "pure" synaptosomal preparations
are contaminated with gliasomes (Henn et al 1976). In addition, it is
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not always altogether clear which pool radiolabelled amino acids enter,
or are released from, during in vitro uptake and release experiments
and whether this is the same pool as their endogenous counterparts.
1.3 GABA release
The demonstration of synaptic release of an electrophysiologically
active substance in response to neural stimulation is of considerable
importance for transmitter identification. Investigations involved in
trying to demonstrate, and to determine the mechanism of GABA release
in the CNS in response to a stimulus have encountered many of the problems
both technical and of interpretation mentioned in the previous section.
Calcium-dependent release of GABA has been demonstrated in vitro,
using tissue slices or synaptosomes which had been preloaded with [ "^hJ
GABA (Srinvasan et al 1969; De Belleroche & Bradford 1972; Levy et al
19 73; Redburn e£ a_l 1976; Cotman et_ al 1976) , and in vivo (Obata &
Takeda 1969; Roberts, P.J. 1974). Data obtained from these experiments were
consistent with stimulus or depolarisation-induced release of
neurotransmitter first proposed by Katz and Miledi (1967). In addition
2+
Ca -independent release of GABA, which is in all other respects
indistinguishable from the depolarisation-induced release process,
has also been demonstrated (Srinivasan et_ al 1969; Obata & Takeda 1979;
Fagg & Lane 1979).
Data from in vitro studies on the release of endogenous GABA from
tissue slices (electrically-induced depolarisation) and synaptosomes
(potassium-induced depolarisation) suggested that GABA released in a
2+
Ca -dependent manner originated from a different pool from that
2+
released in a Ca -independent manner (Valdes & Orrego 1978; Haycock
2+
et^ al 1978). It was suggested that Ca - dependent release of GABA
was from a bound (possibly vesicular) pool reflecting depolarisation-
2+
secretion coupling whereas Ca -independent release might liberate
GABA from a soluble pool by a membrane carrier system (facilitated by
a depolarisation-induced influx of sodium into the terminals) and may
reflect membrane transport processes. However, there is no evidence
to date for vesicular storage of GABA and available evidence suggests
a cytoplasmic rather than vesicular location for the neurotransmitter
(Mangan & Whittaker 1966; De Belleroche & Bradford 1973). In addition,
results from subcellular fractionation studies suggested that GAD,
the enzyme responsible for the synthesis of GABA, is a free cytoplasmic
constituent of synaptosomes (Fonnum 1968).
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Sandoval (1980(a)) put forward the proposal that depolarisation-
2+
induced release in Ca -free medium may be due to an increased efflux
2+
of Ca from intracellular stores (primarily mitochondrial) elicited
by the accumulation of sodium at nerve endings. This was based on
several observations including that of a sodium-dependent efflux of
calcium which has been demonstrated for mitochondria from excitable
tissues (Carafoli & Crompton 1978), including brain, (Silbergeld 1977)
but not for mitochondria from non-excitable tissues (Carafoli & Crompton
2+
1978); that treatments which elicit Ca loss from mitochondria stimulate
transmitter release from synaptosomes (Sandoval 1980(b)) and that
increased sodium concentrations stimulated the release of recently
accumulated [ "^hJ GABA (Sandoval 1980(a)).
In addition to depolarisation-induced release of GABA it has been
suggested that there might be continuous coupled synthesis-secretion
of GABA from the synaptosomes of inhibitory neurons which maintain
tonic inhibition of the post synaptic neurons. Since release is
dependent on GAD activity, inhibition of the enzyme activity would
reduce this tonic inhibition and lead to convulsions (Tapia et al 1975).
Additional observations that inhibition of GAD activity resulted in
immediate convulsions, (Tapia et al 1967; Tapia et al 1969; Wood &
Peesker 1973), that there is some correlation between the inhibition
of GAD in nerve endings and the occurrence of convulsions caused by
some drugs (Perez de la Mora et al 1973) and that in the presence of
2+ .
Ca GAD is bound to synaptosomal membranes (Fonnum 1968) supported
this theory. Immunocytochemical localisation of GAD (at both the
light and electron microscope level) has shown the enzyme associated
with the presynaptic membrane although in addition there was some
association with mitochondrial and synaptic Vesicle membranes
(McLaughlin e£ al 1975; Wood et a_l 1976). Further evidence that
2+
Ca ions promotes the association of GAD with membranes was obtained
2 +
from experiments in which the effect of Ca on binding of GAD to
liposomes was investigated (Covarrubias & Tapia 1978; 1980).
Although the mechanism by which GABA is released has not been
clarified, depolarisation induces the release of the neurotransmitter
2+
in a manner which is at least partially dependent on exogenous Ca
ions. In addition a second mechanism for GABA release has been postulated,
that of coupled synthesis and secretion of the neurotransmitter.
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1.4 Synaptic inhibition by GABA
GABAergic neurons can mediate both presynaptic and post synaptic
inhibition. Post synaptic inhibition was the first to be demonstrated
microiontophoretically (Curtis & Johnston 1974). GABA is released
presynaptically and binds rapidly and reversibly to post synaptic
membrane receptors (Enna et al 1975; Olsen et_ al 1979). This interaction
regulates the opening and closing of membrane CI ion channels and
results in increased membrane permeability to CI ions causing
hyperpolarisation of the post synaptic neuron which reduces the likelihood
of transmission of an excitatory impulse (Curtis & Johnston 1974;
McBurney & Barker 1978; Curtis 1979).
In addition there is evidence that GABA can mediate presynaptic
inhibition by causing a slow depolarisation of primary afferent fibres,
also possibly associated with increased permeability to CI ions,
(De Groat 1972; Fonnum 1978) by axo-axonal synapses. This causes a
reduction in the amplitude of the action potentials in afferent terminals
reducing their ability to release transmitter at the synapse.
Figure 1.1 is a schematic diagram showing four types of GABAergic
synapse. Figure 1.1a illustrates presynaptic inhibition, impulses in
primary afferent neurons (e.g. spinal and cranial nerves) are subject
to presynaptic modulation by impulses from other afferents or from
central structures before being transmitted to second order neurons.
Other GABAergic neurons are involved in postsynaptic inhibition-GABAergic
interneurons can form parts of local feedback inhibitory loops on
principal neurons (e.g. in the cerebellar cortex) by collateral
(Figure 1.1b) or recurrent (Figure 1.1c) inhibition. Both mechanisms
allow the first excitatory impulses to fully activate a principal
neuron whereas subsequent signals encounter a target cell which has
been made less excitable by the preceding impulses thus preventing
excessive excitation of neurons. Finally GABAergic neurons can directly
transmit inhibitory influences from one central structure to another
distant one (Figure l.ld) for example, the cerebellar Purkinje cells
which carry the total inhibitory output from the cerebellar cortex.
1
figure l.I acnematic diagram of four types of GABAergic




(d) Post synaptic inhibition by projection neurons
See text, Section 1 .li for more details.
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1.5 GABAergic systems and behaviour
GABA has become increasingly implicated in regulating the overall
level of neuronal excitability throughout the CNS consequently, any
interference with inhibitory synaptic transmission mediated by GABA
has potentially a profound effect on the whole animal. Impairment
of GABAergic transmission, whether at the level of GABA synthesis,
release at the synapse or interaction with postsynaptic receptors,
results in seizures (Tower 1976; Johnston 1978; Meldrum 1979).
Deficiencies in the GABAergic system have been implicated in a
number of neurological disorders including Huntington's chorea ,
(McGeer & McGeer 1976; Enna 1977); Parkinson's disease, (Lloyd &
Hornykiewicz 1973; Lloyd at aL 1975; Lloyd et_ al 1977); epilepsy
and schizophrenia (Tower 1976; Olsen £t_ _al 1980). Such deficiencies
include a decrease in the number of GABA receptors, changes in receptor
affinity for GABA, decreases in GABA level and changes in the level
of GAD activity.
The importance of GAD in brain is due to the fact that it catalyses
the rate limiting step in the synthesis of GABA. In addition, a number
of studies have demonstrated that the GABA level in its active
compartment is directly linked to presynaptic GAD activity (Iadarola &
Gale 1980). Administration of drugs which inhibit GAD activity either
specifically, for example, substrate analogues such as mercaptopropionic
acid, or non specifically using for example carbonyl reagents such as
hydrazides which react with pyridoxal-5-phosphate (PLP) result in the
onset of convulsions (Meldrum 1979; Horton 1980). The immediacy of the
effects of these drugs has suggested that GAD might be involved in a
coupled synthesis-secretion mechanism (Tapia at al 1975).
The implication that the level of GAD activity in addition to the
concentration of GABA in the neurotransmitter pool (rather than the
GABA concentration in the whole brain) is an important factor in
controlling neuronal excitability in the CNS indicates the importance




The predominant pathway for GABA biosynthesis in the CNS of both
vertebrates and invertebrates is the irreversible decarboxylation of
glutamate by GAD (Roberts et_ _al 1958) with PLP as an essential cofactor
(Roberts & Simonsen 1963).
The catabolism of GABA proceeds via two sequential reactions.
The first step is the transamination with 2-oxoglutarate catalysed
by GABA-T, which also requires PLP as a cofactor, to produce succinic
semialdehyde (SSA) and glutamate. SSA is then oxidised by succinic
semialdehyde dehydrogenase (SSADH EC.1.2.1.24) to yield succinate
which can enter the TCA cycle. The GABA metabolic pathway is referred
to as the GABA shunt since it provides an alternative metabolic pathway
which bypasses the oxidation of *-oxoglutarate to succinate (Roberts
£t_ al 1964; Baxter 1976; Cooper £it ^1 1978). Figure 1.2 shows
the GABA shunt and its relationship to cell intermediary metabolism.
1.7 Regulation of GAD activity
Although GAD is a key enzyme in the metabolism of GABA and has been
implicated in the control of neuronal excitability (Tapia e_t al 1975)
little is known about its regulation. It has been established that
PLP is a necessary cofactor for the enzyme (Roberts & Simonsen 1963)
however, the exact nature of the association between PLP and GAD is
not known. It is thought, by analogy with other amino acid decarboxylases,
that it forms a Schiff's base with a specific lysine residue on the
enzyme polypeptide (Fasella 1967; Strausbach & Fischer 1970).
A number of studies, commonly using crude preparations such as
cell cytosol, have been carried out to try to identify factors which
influence GAD activity and might therefore form the basis of a control
mechanism. It has been suggested that cofactor availability might,
either directly or indirectly, constitute a means of regulating GAD
activity (Baxter 1969; Tapia & Sandoval 1971; Bayon et al 1977(a) & (b);
Miller et al 1978). Such a regulatory mechanism would depend greatly
on the strength of the association between PLP and GAD, and this has
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Figure 1 .2 Schematic diagram sho-wing the GABA shunt and its
relationship to cell intermediary metabolism.
See text, Section 1.6 for further details.
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In vivo evidence is contradictory, with evidence interpreted as
suggesting that PLP may be loosely bound to the acbiVc site (Baxter 1969),
so that cofactor availability would directly control enzyme activity,
and also that PLP must be tightly bound to the enzyme since GAD activity
was unaffected by changes in the PLP concentration in the brain (Gey &
Georgi 1974). However, it is not surprising that such in vivo experiments
should yield contradictory results since whole brain PLP levels do not
necessarily reflect the levels in the neuronal GABA compartment.
One of the major considerations when carrying out such experiments is
that GABA exists in a number of compartments within the brain consequently
it is uncertain whether drugs administered in vivo have depleted PLP in
all the compartments containing GABA, in the neuronal GABA compartment
or only in the non-neuronal compartments (see Section 1.2).
Data from iri_ vitro studies using rat brain cytosol have been
interpreted as suggesting that GAD may have two types of PLP binding
sites, one which binds PLP very tightly, essentially irreversibly,
and allow a basal level of GABA synthesis unaffected by cofactor
concentration and another site which binds PLP loosely. In the
latter case, occupancy of the PLP binding site would be directly dependent
on the cofactor concentration and this would form the basis for a
control mechanism since increased occupation would lead to increased
enzyme activity. The data obtained did not predict whether the two
sites were present on the same molecule, on different subunits of the
same enzyme species or whether they were present on different enzyme
species.
Miller et_ al (1978) suggested that the association between GAD
and PLP was very tight in the absence of glutamate but that glutamate
could promote dissociation of PLP from the active site. This was
modified by Seligmann et_ al_ (1978) who proposed that, in the absence
of ATP, available PLP reactivated enzyme which had been inactivated
by glutamate-promoted dissociation, but that ATP blocked this
reactivation. More recently Martin e_t al^ (1980) carried out similar
experiments to those previously described (Miller e_t al_ 1978) replacing
rat brain cytosol with partially purified hog brain GAD. The results
were similar to those previously reported, however, inhibition of GAD
by ATP was reported to be PLP independent in contrast with previous
observations (Seligmann et^ al_ 1978). Factors which affect GAD activity
and their implications for control of GABA synthesis are discussed in
more detail in Section 7.
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1. 8 Non-neuronal GAD
For some time GAD in vertebrates was thought to exist exclusively
in the CNS, although trace amounts of GABA had previously been detected
in non-neural tissue (Roberts et_ al_ 1950) . Subsequently low levels of
GAD activity were detected in peripheral tissues such as kidney, heart,
liver and blood vessels (Haber et_ al 1970(a); Whelan et al 1969;
Kuriyama et^ al_ 1970; Wu 1977), in glia and gliomas (Haber et_ al_ 1970(b))
and in mitochondria from adult human and mouse brain (Haber e_t al 1970(c)).
Several differences in the properties of the enzyme activity detected
in these tissues, including stimulation rather than inhibition by
aminooxyacetic acid (A0AA) and stimulation by anions such as chloride
rather than inhibition, led to the concept of GAD II, a different
glutamate decarboxylase from that found in neurons.
However, the concept of a different GAD based on differences in
enzymological properties was refuted-by reports showing that it was
based on artefactual results (Miller & Martin 1973; Drummond & Phillips
1974; Kanazawa e_t al_ 1976; Wu et_ al_ 1978). In addition, Walsh and
Clark (1976) could not repeat the results of Haber et al (1970(c))
and failed to detect any GAD activity in mitochondria. Drummond and
Phillips (1974) reported that the GAD of mouse kidney appeared similar
to neuronal GAD, based on enzymological properties, and suggested
that the low levels of activity detected in peripheral tissues might
be associated with nerve endings in that tissue.
However, there is evidence that peripheral tissues do contain low
levels (5% or less of the activity of neuronal GAD, Wu 1980) of a
different form of GAD since there is no immunological cross reactivity
between mouse brain GAD and crude extracts from mouse peripheral tissues
(Wu e_t al^ 1978; Wu 1980) or purified bovine heart GAD (Wu 1977;
Wu 1980) and there are some slight differences in enzymological
properties. Analysis of the products of °4-decarboxylation by the heart
enzyme revealed, in addition to ( ] GABA, the presence of an
unidentified [ ^cj labelled substance which was not produced by the
neuronal enzyme.
There is evidence for a role for GABA in cerebrovascular function
(Fujiwara et_ al 1975; Edvinsson & Krause 1979). Krause et_ al (1980)
presented data indicating that GABA receptors and GAD and GABA-T
activities were associated with cerebral though not peripheral blood vessels.
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Subsequently low levels of GAD activity were detected in peripheral blood
vessels (Hamel e_t al_ 1981) . Further work revealed a number of
differences between neuronal and cerebrovascular GAD activity suggesting
that the latter may represent non-neuronal GAD. Consequently GABA
formation in cerebral blood vessels may be manipulated independently
from that in neuronal tissue (Hamel e£ al 1982).
1.9 Purification of GAD from CNS
The previous sections have shown the importance of GABA in the CNS
and of GAD the enzyme responsible for GABA synthesis. Moreover, that
there is a lack of definitive evidence for any particular mechanism by
which GAD activity may be regulated. In addition, GAD has been generally
accepted as a marker for GABAergic neurons (see Section 1.10) being
regarded as more reliable than GABA since there is a possibility that
the neurotransmitter may be metabolised or redistributedduring tissue
preparation. Consequently one of the aims of this project was to purify
chick brain GAD to homogeneity in order to raise antibodies which could
(5eeabb*u»+/o/i>)
be labelled (e.g. FITC^ and used for immunocytochemical localisation
of GABAergic neurons in chick brain, in particular those involved in
the visual system.
Neuronal GAD from several vertebrate species has been purified to
homogeneity (Wu et^ al_ 1973; Maitre e_t al_ 1978; Blindermann e_t al_ 1978(a) ;
Su et_ al 1979; Wu 1982). Table 1.1 shows some of the properties of
rat and human GAD which are the most characterised to date. Initially
attempts to purify this enzyme were unsuccessful due to its instability
(SK.<xk>l»rei/ia'ha«s)
however, a combination of PLP and AET^in all the buffers was found to
improve the stability of the enzyme.
Enzyme instability resulting in loss of enzyme activity has proved
to be a major problem in the purification of GAD since, for example,
location of fractions containing GAD can only be achieved by assaying
for enzyme activity. In addition, although GAD is present throughout
the brain, mainly as a component of the synaptoplasm, it is not
present in high concentrations. For example it has been estimated,
by radioimmunoassay (Blindermann et^ a_l 1979) that the overall concentration
of GAD in rat brain is 2.79 - 0.19 pmol/mg protein (specific activity
164 nmol GABA produced/mg protein/hour) (Blindermann et_ al_ 1978(b)).
Based on the molecular weight estimated for rat brain GAD (Maitre et al
1978) less than 0.04% of the total brain protein is GAD.
I 4
Table 1.1. Comparison of some properties of human and rat brain GAD






























Since there is no particularly concentrated source of GAD large
quantities of tissue are required to enable, purification to homogeneity
and to compensate for inactivation of the enzyme during purification.
However, only a tiny percentage of the protein present in the initial
tissue extract, e.g. supernatant, is GAD. Consequently, it is necessary
either to remove much of the unwanted protein prior to purification or
to process many small batches of tissue extract and pool the partially
purified protein preparations before carrying the procedure through to
homogeneity.
Successful purification of GAD has been achieved by two groups
using slightly different protocols. In both cases an initial protein
precipitation step was included. Ammonium sulphate fractionation was
used several times in the purification of GAD from mouse, catfish and
bovine brain (Wu e£ al 1973; Su et_ al_ 1979; Wu 1982) however, chick
brain GAD was inactivated by this procedure (see Section 5). A similar
observation was reported by Blindermann et_ al_ (1978(b)) who used a
heat precipitation step (50°C for 5 minutes at pH 5.4) to reduce the
protein content of the initial homogenates in the purification of
human and rat brain GAD (Blindermann e_t al 1978(a) ; Maitre e_£ al_ 1978) .
Although this step reduced the protein concentration by more than 80%,
only 25% of the original GAD activity was retained.
Apart from the initial protein precipitation step the protocol
used for the purification of rat and human brain GAD was similar to
that used for chick brain GAD incorporating ion exchange, hydroxyapatite
and gel filtration chromatography. The same methods were used in the
purification of mouse, catfish and bovine brain GAD, although ammonium
sulphate fractionation was included at several stages. In addition
preparative gel electrophoresis was also used in the purification of
catfish and bovine brain GAD (Su ejt al_ 1979; Wu 1982).
1.10 Affinity chromatography
Affinity chromatography is a technique which exploits a unique
biospecificity of a protein for a ligand covalently bound to an
insoluble support or matrix. An efficient affinity chromatography step
incorporated at an early stage of the purification procedure could
reduce the number of steps necessary to purify chick brain GAD, an
important consideration since the enzyme is unstable.
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PLP, an essential cofactor for GAD (Roberts & Simonsen 1963)
was chosen as a suitable ligand since there is a strong association
between GAD and PLP (Miller et^ al 197?). However, for maximal
binding of an enzyme to a column where the ligand is a cofactor,
it should be possible to aid the dissociation of the cofactor from
the enzyme in such a manner that the enzyme is not damaged so that
the solution which is applied to the column contains apoenzyme.
Although PLP binds tightly to GAD, Miller e_t al_ (1978) put forward
the proposal that in the presence of glutamate PLP dissociated
(reversibly) from the enzyme and suggested that this could be a means
of producing the apoenzyme.
Affinity chromatography using resin with a similar structure to
that used for chick brain GAD (N'-(oO-aminohexyl)-pyridoxamine phosphate-
Sepharose 4B) has been included in the purification of tyrosine amino¬
transferase (EC.2.6.1.5) (Miller et_ al_ 1972) and glutamate oxaloacetate
transaminase (EC.2.6.1.1) (Collier & Kohlaw 1971).
Affinity chromatography has not been often used in the purification
of GAD and in those instances where it was incorporated in the purification
protocol it did not prove as successful as might have been anticipated.
There have been three reports describing affinity chromatography of
mammalian GAD. In one instance <*-methy1 glutamate, a competitive
inhibitor of GAD, was used as the ligand (Yamaguchi & Matsumura 1977)
and in the other PLP was covalently attached to a Sepharose 4B matrix
through the aldehyde group (Possani et_ al_ 1977; Perez de la Mora et al
1981) .
Possani e_t al_ (1977) achieved binding which ranged from 16% to 47%
of the activity loaded (using a rat brain cytosolic fraction), however,
the enzyme could apparently only be partially eluted from the resin.
In the latter report the pellet obtained with 55% saturation of mouse
brain cytosol with ammonium sulphate was resuspended and applied to
the affinity column. Both the GAD which was eluted (1% of the activity
in the homogenate) and that which remained bound to the resin was used
to raise antibodies for immunocytochemistry.
However, SDS polyacry1amide gel electrophoresis revealed multiple
bands both from the "soluble" GAD preparation and the bound GAD preparation
similar to those obtained by Matsuda e£ al^ (1973), see also Section 5.
Both these preparations, when injected into rabbits did cause the
production of anti-GAD antibodies.
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Following the preliminary report (Possani ejt al 1977) it was
considered that large scale preparative affinity chromatography might
be successful if apoenzyme, rather than a solution containing both
holoenzyme and apoenzyme, was applied to column.
1.11 GAD as a marker for GABAergic neurons
There is good correlation between the regional distribution of high
GABA levels and that of GAD (Kuriyama et_ al_ 1966; Fonnum and Walberg 1973;
Fahn 1976). In addition, high levels of GAD activity have been shown
immunocytochemically only in those terminals thought to be GABAergic
(McLaughlin et_ aI 1974; McLaughlin e£ al_ 1975(a) ; Saito et^ al_ 1974(a) ;
Wood et_ al 1976) . Consequently GAD has been generally accepted as a
marker for GABAergic neurons. GAD as a neuronal marker has several
advantages over the neurotransmitter, GABA, in that it can be demonstrated
immunocytochemically and will not redistribute or be metabolised during
tissue preparation.
Following the purification of mouse GAD (Wu e_t al_ 1973) and the
production of antibodies to GAD (Matsuda e_t al 1973) a number of
immunocytochemical studies of the distribution of the enzyme in the
brains of several species have been reported (McLaughlin ejt al_ 1974;
McLaughlin et_ a_l 1975(a); McLaughlin et^ al_ 1975(b); Wood £t al_ 1976).
However, more recently human GAD which was judged to be pure by SDS
polyacrylamide gel electrophoresis and isoelectric focussing proved to be
able to catalyse a low level of decarboxylation of cysteine sulphinate
(Blindermann 1978(a)). This suggests several possibilities; that GAD
might be able to utilise cysteine sulphinate as a substrate under
certain conditions, that the enzyme responsible for both glutamate
decarboxylase and cysteine sulphinate decarboxylase activity might
be the same entity or that GAD and cysteine sulphinate decarboxylase
(EC.4.1.1.29) are so similar in structure that they copurified and
could not be distinguished even by the fairly rigorous methods employed.
Kinetic evidence did suggest that two different catalytic sites might
be involved in the decarboxylation of glutamate and cysteine sulphinate
(Blindermann et^ al_ 19 78(a)) .
The product of decarboxylation of cysteine sulphinate is hypotaurine,
the immediate prec urser of taurine which is a putative inhibitory
transmitter (Cooper ej^ al_ 1978). The same enzyme is thought to be
responsible for the decarboxylation of cysteic acid to yield taurine
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i(Hope 1955; Cuion-Rain et al 1975)*, Consequently, this finding has
important implications for the validity of identifying neurons as GABAergic
using immunological techniques.
Oertel et_ al_ (1980) tried to separate GAD and cysteine sulphinate
decarboxylase activities in order to raise antibodies to GAD alone for
immunocytochemical studies. However, it did not prove possible to
separate the two activities either biochemically or immunologically.
Wu (1982) using the protocol devised for the purification of mouse brain
GAD with the addition of a final preparative gel electrophoresis step,
separated two enzyme entities from bovine brain. One was responsible
for the decarboxylation of cysteine sulphinate and cysteic acid with
values for the two substrates of 0.22 mM and 0.18 mM respectively,
the other „decarboxylated glutamate, = 1.6 mM, but could also
decarboxylate cysteine sulphinate and cysteic acid with values of
5.2 mM and 5.4 mM respectively. It was found that although the two
enzymes copurified through several procedures they could be separated
by hydroxyapatite chromatography and were immunologically distinct.
It may be concluded therefore that GABA and taurine are the
products of two different enzymes. However, GAD, at least under certain
in vitro conditions, does have the capability of decarboxylating
cysteine sulphinate and cysteic acid. This finding would appear to
reconfirm the validity of immunocytochemical localisation of GABAergic
neurons. Unequivocal evidence for the identity or non identity of the
two enzyme entities^ and consequently different types of neurons,
could be established using monoclonal antibodies. The specificity of
monoclonal antibodies for one single determinant enables a distinction
between two entities which may not be possible using conventional
heterogeneous antisera which are polyclonal in nature (see Section 1).
1.12 Monoclonal antibodies
Until relatively recently the only method of obtaining antibodies
to a given substance was to immunise an animal (e.g. rabbit, goat, sheep,
horse) with a homogeneous preparation of the substance. When the animal
had reached a hyperimmune state a blood sample was removed since the
antibodies of interest would constitute a high percentage of the
immunoglobulin content of the serum. However, the antibody response to
a given substance is highly heterogeneous. When an animal is injected
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with an immunogen it responds by producing diverse antibodies against
different antigen molecules of, the immunogen and against different
determinants on a single antigen. In addition antibodies against other
unrelated antigens with which the animal has come into contact will
be present in the serum. It is virtually impossible to separate all
the various antibodies so conventional antisera contain mixtures of.
antibodies which vary with different animals.
The development of the monoclonal antibody technique (Kohler &
Milstein 1975; Kohler & Milstein 1976; Galfre et^ al_ 1977) has removed
the necessity of using a pure antigen to stimulate the production of
antibodies and has resulted in the ability to produce monospecific
antibodies to a specific determinant in a reproducible manner. The
technique involves fusing myeloma cells (myelomas are tumours of
antibody secreting cells that arise spontaneously in animals but can
also be induced) with naturally occurring lymphocytes from the same
species which proliferate in the spleen and other lymphoid organs as a
result of antigenic stimulation. Lymphocytes have a very short life
span and cannot be cultured in vitro, however, codominant expression
of immortality (conferred by the malignant phenotype of the myeloma
parent) and specific antibody production (a property of the lymphocytes)
is achieved in the hybridoma cells which are the result of the fusion.
After fus ion j, hybridoma cells are selected for by growth in HAT
(hypoxanthine, aminopterin, thymidine) selective medium (Littlefield 1964).
The presence of aminopterin in the medium blocks de_ novo synthesis
of nucleotides (see Figure 1.3). Aminopterin inhibits dihydrofolate
reductase preventing the formation of tetrahydrofolate and therefore
the transfer of methyl groups in the de novo synthesis of nucleotides.
To survive cells are, therefore, dependent on the second "salvage"
pathway of nucleotide synthesis which relies on active hypoxanthine
(guanine) phosphoribosyl transferase (H(G)PRTase EC2.4.2.8) and thymidine
kinase (TK EC.2.7.1.21) for incorporation of the hypoxanthine and
thymidine present in the medium. The parent tumour cell line is
selected for deficiency in H(G)PRT ase consequently only the hybridoma
cells (which have inherited an active salvage pathway from the parental
lymphocytes) survive this treatment.
lo
Figure 1 .3 Schematic diagram showing the effects of growth
in HAT selective medium on cell nucleotide metabolism.
A Purine nucleotide biosynthesis
B Fy^imidine nucleotide biosynthesis















































The parental tumour cell line is also selected for the inability to
secrete immunoglobulin (or preferably the inability to synthesise
immunoglobulin) since cell lines resulting from the fusion of two
immunoglobulin producing cells secrete new immunoglobulins as a result
of heterologous association of both parental heavy and light chains
(Kohler & Milstein 1975). This may be avoided by using a non-secreting
variant such as NS-1 (a Balb/c mouse cell line) which although it
synthesises light chain molecules does not secrete them. However, after
fusion it is possible that the myeloma light chain may be secreted as
part of a new hybrid immunoglobulin molecule (Kohler et_ cfL 1976) .
The steps involved in the production of monoclonal antibodies are
shown in Figure 1.4.
There are two major advantages of this technique. Firstly, it
enables the production of monospecific antibodies from non-purified
antigens. This is particularly useful if instability or low tissue
concentration of the antigen in question prevents purification to
homogeneity so that antibodies cannot be raised using conventional
techniques. Secondly, the monoclonal antibody produced by an
isolated clone is a well defined substance active against one single
determinant, rather than a heterogenous mixture of antibodies which
changes with each immunised animal and even with each bleeding of
the same animal. Once stable hybridomas are established, an unlimited
supply of antibodies of exactly the same chemical structure can be
produced from permanent tissue cultures. Alternatively large amounts
of the same monoclonal antibodies can be produced from tumours grown
in animals.
The first permanent cell lines secreting a predefined antibody
were against sheep red blood cells (Kohler & Milstein 1975), the hapten
2,4,5-trinitrophenyl (TNP) (Kohler & Milstein 1976), histocompatability
and other cell surface antigens (Galfre et_ al_ 1977; Williams et^ al
1977). Subsequently many other cell lines which secrete monoclonal
antibodies have been produced and it would appear that the procedure
is general, i.e. that any antibody which an animal can produce can also
be prepared as a monoclonal antibody through hybrid cell lines.
The degree of difficulty in obtaining a specific hybrid myeloma is
probably correlated with the immune response of the immunised animal
so that if the response is very weak it will be correspondingly difficult
to isolate a clone producing the desired antibody from amongst the
many hybrids secreting unwanted immunoglobulins.
Z 2
Figure 1 .1; Scheme showing a standard procedure used for the
production of monoclonal antibodies.
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1.13 Avian visual pathways
The previous sections have outlined several aspects of GABAergic
systems in general and have tried to illustrate the importance of the
amino acid in the CNS. It was of interest to apply some of the techniques
mentioned earlier in this section to investigate biochemically and
immunohistochemically the extent to which GABA was involved in a specific
pathway within the CNS, namely the visual system.
The avian visual system was chosen as a model to investigate the
role of GABA in the visual processes since it presents several advantages
as a neurobiological model. Despite the relatively small size of the
avian brain, the visual system is highly developed with prominent and
therefore easily accessible optic lobes. The retinal input is almost
completely crossed at the optic chiasma allowing experiments to be
performed on one side of the brain whilst using the other as a control.
In addition, the avian visual system has been extensively studied
morphologically, physiologically, biochemically and behaviourally.
In the avian visual system two pathways projecting from the retina
have been described, the tectofugal pathway and the thalamofugal pathway
(Karten 1969; Karten & Hodos 1970; Karten eit al_ 1973). The tectofugal
pathway extends from the retina to the superficial layers of the
the
contralateral optic tectum and thence to^nucleus rotundus in the
midbrain and finally to the ectostriatum in the forebrain. The
fche
thalamofugal pathway projects from^retina to the contralateral
dorsolateral thalamus and then to the Wulst in the forebrain
(see Figure 1.5).
The optic tectum, which is a highly organised, laminated structure,
is quantitatively the most important first relay in the avian visual
pathway connecting the retina with the thalamus, pretectum and lower
brain stem. This tectal relay system receives additional inputs from
the visual Wulst (hyperstriatum) nucleus spiriformis lateralis and the
contralateral tectum. There is a loop of reciprocal connections between
the tectum and the nucleus isthmi pars parvocellularis. The tectum
also projects to nucleus isthmo opticus which in turn sends efferent
fibres to the retina (Cuenod & Streit 1979). In addition many intrinsic
neurons and interneurons are present within the various tectal layers
(Karten 1969; Meier et_ al_ 1974; Hunt & Webster 1975; Hunt & Kunzle
1976(a); 1976(b); Streit & Reubi 1977) (see Figure 1.6).
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Abbreviations
Ch. Op. Chiasma opticum
E Ectostriatum
EP Zona periectostriatalis




IHA N-intercalatus hyperstriatum accessorium, int = lamina internus,
ext = lamina externus
N Neostriatum
OPT N. optic principalis thalami dorsalis
PA Paleostriatum augmentatum
PP Paleostriatum primitivum
Rt N. rotundus thalami
SGC Stratum griseum centrale
SGF Stratum griseum fibrosum centrale
TgO Tectus opticum
T^.Op Tractus opticus
Tr.Rt-€ Tractus rotundus ectostriatalis
TECTOFUGAL THALAMDFtJGAL
Figure 1 .3 Schematic summary of two major recognised
ascending visual projection pathways to the telencephalon,
the tectofugal pathway and the thalamofugal pathway, (from
Karten et al 1973) See text, Section 1.13 for further
details.
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Figure 1.6. Schematic representation of the input-output relationship
in avian optic tectum (Cu£nod and Streit 1979).
Layer nomenclature according to Cowan et_ al_ 1961 (roman numerals
with subdivision of layer II) and Ramon y Cajal (1891) (layers 1-13).
A, optic afferent fibres; B, Ipc afferent fibre; C, neuron projecting
to Ipc; D, large efferent neuron; E, horizontal intrinsic neuron;






























DLL} N.dorsolateralis anterior thalami, pars lateralis;
GL, N.geniculatus; ION, N.isthmo-opticus; Ipc, N.isthmi,
pars parvocellularis; SpL, N. spiriformis lateralis.
The optic tectum has been intensively studied biochemically to
elucidate the possible rotes of various neurotransmitters. There is
biochemical and electrophysiological evidence to suggest that the
inhibitory neurotransmitter GABA plays a prominent role in avian optic
tectum. Synaptosomes prepared from optic tectum had a high affinity
uptake mechanism for GABA (Henke et^ al^ 1976) whilst GAD has been shown
to be present in optic tectum, particularly within the superficial
layers (Henke & Fonnum 1976). Microiontophoretic application of GABA
resulted in the inhibition of a large number of neurons, again
particularly within superficial tectal regions, and that intertectal
inhibition could be abolished by the application of the GABA antagonist
bicuculline (Barth & Felix 1974). Light microscopic autoradiography
after injection of [ ^h] GABA into optic tectum revealed that four types
of neurons had been specifically labelled, two of them intrinsic and
two extrinsic. One type of GABAergic intrinsic neurons had their cell
bodies in sublayer lie (4) with short processes going radially into
layer II whilst the others ran horizontally within layer lid (5)
and lie (4) and had long dendrites and short axons (see Figure 1.6)•
The extrinsic GABAergic neurons projected from optic tectum into the
pretectum and ventral thalamus and also from the ventral part of the
optic tectum to the anterior portion of nucleus isthmi pars parvocellularis.
This connection between nucleus isthmi pars parvocellularis and optic
tectum is reciprocal (Hunt & Kunzle 1976(b)).
Although there is much information available regarding the optic
tectum, little is known about the role of neurotransmitters in other
structures of the avian visual system which have been shown to play
an important role in the visual processes (Hodos & Karten 1966;
Hodos 1969; Hodos & Karten 1970; Karten et al 1973). In addition,
much of the evidence regarding the identification of specific neurons
within and projecting from the optic tectum as GABAergic has been
obtained by light microscopic autoradiography following injection of [^h]
GABA (Henke & Fonnum 1976).
However, there are a number of factors which may reduce the
specificity of the technique and complicate the interpretation of the data.
These include difficulties in siting the injection correctly, diffusion
of the radiolabelled amino acid from the site of the injection and high
and/or low affinity uptake into non-neuronal elements such as glia and
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perikarya of non-GABAergic neurons. Immunohistochemical techniques using
antibodies to neuronal GAD, particularly a specific monoclonal antibody,
provide a means of determining whether a particular neuron is GABAergic.
One of the aims of the project was to use such immunohistochemical
techniques to trace GABAergic neurons within the avian visual system
in conjunction with biochemical techniques to determine the levels of
GABA metabolism in those structures involved in the visual process.
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SECTION 2: MATERIALS
One day old shaver chicks were obtained from the Poultry Research
Centre, Roslin, Midlothian. Wistar rats and Balb/c mice were obtained
from animal house stocks.
L-Ju-^c] glutamate (1.85-2.2 GBq/mmol) and[2,3-^H] GABA
(1.85-2.6 TBq/mmol) were purchased from Amersham International, pic.,
Buckinghamshire.
All constituents of tissue culture media were purchased from
Gibco, Paisley, Scotland.
Sheep immunoglobulin G against whole mouse serum was obtained
from the Scottish Antibody Production Unit, Law Hospital, Carluke.
Cholera toxin and phosphorylase b_ were a gift from Dr W Ward,
Department of Biochemistry, University of Edinburgh.
Toluene, Triton X100 and PPO were scintillation grade and
obtained from Koch Light Laboratories Ltd.
All other chemicals, buffer constituents and substrates were
obtained from BDH Chemicals Ltd. and were AnalaR grade, or from
Sigma, London, unless otherwise indicated in the text.
Tissue Tek II OCT embedding medium was obtained from Lab-Tek
Products, Division Miles Laboratories Inc. and DEPEX mounting
medium from Gurr, Searle Diagnostic, High Wycombe, Bucks.
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SECTION 3: GENERAL METHODS
3.1 Column chromatography
All the buffers which were used to equilibrate or elute chromatographic
columns used in the purification of GAD contained 0.1 mM PLP and 1 mM AET.
Standard buffer consists of 50 mM potassium phosphate containing
0.1 mM PLP and 1 mM AET, pH 7.4.
3.1.1 Gel filtration chromatography
All gel filtration chromatography was carried out at 4°C. The gels
used, Sephadex G200 and Sephadex G25, were swollen and the gel bed packed
in the column in the manner recommended by the manufacturers (see
"Sephadex, Gel Filtration in Theory and Practice", Pharmacia Fine
Chemicals).
3.1.1.1 Gel filtration using Sephadex G200
Calibration of the column
A column of Sephadex G200 (1.8 x 95 cm) was equilibrated in standard
buffer. The column was calibrated with a selection of proteins as shown
in Table 3.1. Figure 3.1 shows the elution profile obtained when a
solution of the proteins in blue dextran and fluorescein was applied to
the column and eluted with standard buffer at 10 ml/hour. Protein was
monitored by measuring absorbance at 280 nm. In this way the partition
coefficient, K^, could be related to the apparent M^ (see Figure 3.2).
ILp is given by:
*D = Ve - Vo
V
s
where = the elution volume for a particular protein
Vq = the elution volume for molecules completely excluded
from the gel
= the elution volume for molecules which readily diffuse
into the gel beads.
A semilogarithmic plot of versus log M^ (Figure 3.2) shows a
linear relationship over the range of M^_ used. The line of best fit
was calculated using the nonparametric method of Nimmo and Atkins (1979).
From this calibration the Sephadex G200 column could be used to
fractionate proteins of apparent M between 20 000 and 300 000.
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Table 3.1. standards for gel filtration chromatography
Protein Source M
—r— -
Trypsin inhibitor Soy Bean 21.5x10
Ovalbumin Egg 43xl03
Serum albumin (BSA) Bovine 68xl03
Dimeric serum albumin Bovine 136xl03
Immunoglobulin G (IgG) Bovine 147xl03
Catalase Bovine liver 232xl03
Reference
Wu and Sheraga (1962)
Weber and Osborn (1969)
Weber and Osborn (1969)
Weber and Osborn (1975)
Weber and Osborn (1975)
Darnall and Klotz (1975)
31
Figure 3»1 Elution profile obtained when the proteins listed
in Table 3.1 were used to calibrate a column of Sephadex G200
(1.8 x 95> cm). See section 3.1.1 .1 . Protein was monitored by

























Figure 3»2 A graph of versus log for the proteins (listed
in Table 3.1 ) used to calibrate the Sephadex G200 column. See
section 3»1-1*1 • The best straight line was calculated using the
nonparametric method of Nimmo and Atkins (1979)
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This column was routinely used during the purification of GAD
(see Section 5). In order to determine where GAD activity was eluted
in relation to the void volume, V , and the bed volume, V , and hence
o s
assign an apparent to the protein, on several occasions samples
containing GAD activity were mixed with blue dextran (0.2% w/v),
and fluorescein before application to the column. Elution with
standard buffer was at 10 ml/hour..
3.1.1.2 Desalting by gel filtration using Sephadex G25
Gel filtration using Sephadex G25 was selected as a fast and
efficient method of removing salts and other low molecular weight
compounds from protein solutions containing GAD activity. Since
separation of compounds of high and low molecular weight is very
good, large sample volumes of up to 30% of the total bed volume
can be used (Flodin 1961) . This is particularly useful when desalting
large volumes of supernatant prior to the purification of GAD.
Approximately 150 ml of a supernatant, prepared as described
in Section 5.1, was loaded onto a Sephadex G25 column (5.4 x 27 cm)
which had been previously equilibrated in standard buffer. Protein
was eluted with standard buffer. Usually two such columns were used
to prepare sufficient material to load onto the DEAE cellulose column
(see Section 5.1). Protein was monitored by measuring absorbance at
280 nm and the protein peak applied to the DEAE cellulose column.
A similar procedure was employed for desalting the pooled peak
fractions obtained from each DEAE cellulose column prior to chromatography
using hydroxyapatite (see Section 5.1). Standard buffer was replaced
with 5 mM potassium phosphate containing 0.1 mM PLP and 1 mM AET, pH 7.4.
Phosphate assays (see Section 3.6.3) which were performed on the
eluates from the Sephadex G25 columns, prior to chromatography on
hydroxyapatite, confirmed that the phosphate concentration was 5 mM.
It was confirmed that high and low molecular weight compounds
were completely separated under the conditions described above by
applying 150 ml of a mixture of blue dextrai?, 0.2% (w/v) , and fluorescein
on to a Sephadex G25 column, which was identical to those used for
desalting, and eluting using similar conditions.
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3.1.2 Ion exchange chromatography
3.1.2.1 DEAE cellulose
All ion exchange chromatography using DEAE cellulose was carried out
at 4°C using Whatman DE 52 DEAE cellulose. The DEAE cellulose was
degassed, equilibrated with standard buffer and packed in the column
using the methods recommended by the manufacturers in their information
leaflet 1L2. Experiments using DEAE cellulose are described in
Section 5.1.
3.1.2.2 Dowex AG 1 x 2
Conversion of Dowex AG 1 x 2 (100-200 mesh) to the acetate form
This is a two step process, firstly ion exchange as the chloride
is replaced by the hydroxide ion, followed by neutralisation of the
hydroxide using acetic acid.
The hydrated resin, generally about 250 ml of a thick slurry,
was poured into a wide column and washed with 20 volumes of 1M sodium
hydroxide. The effluent was tested for the presence of chloride ions
by adding a few drops of 1% (w/v) silver nitrate to a sample of the
effluent which had been acidified with concentrated nitric acid.
The absence of a white precipitate indicated that conversion was complete.
The resin was then washed with 4 volumes of double distilled water,
until the pH fell to less than pH 9, followed by 2 volumes of 1M acetic
acid until the pH approached pH 2. After rinsing with double distilled
water until the pH was greater than pH 5 the resin was ready for use.
Dowex AG 1 x 2, in the acetate form, was used to purify L -[u-^cj
glutamate (Section 4.1.1) and also in the assay for GAD activity to
separate the [ ^c] GABA produced from the residual [ ^c] glutamate
(Section 4.1.2).
The used resin was regenerated as follows. The resin was washed
with 3 volumes of 1M hydrochloric acid to remove the glutamate followed
by 3 volumes of double distilled water. Conversion of the resin to the
acetate form was carried out as described above.
3.1.3 Hydroxyapatite chromatography
Synthesis of the hydroxyapatite gel (Tiselius al 1956)
Equal volumes (1 1) 0.5M disodium hydrogen orthophosphate and
0.5M calcium chloride solutions were pumped (15 ml/minute) into a 3 1
beaker and mixed by stirring slowly (80 rpm) with a large stirrer bar.
When precipitation was complete the precipitate was allowed to settle
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completely before the supernatant, which was slightly cloudy, was removed.
The precipitate was washed four times with 1.5 1 double distilled water,
allowing complete settling each time.
After washing, the contents of the beaker were made up to 2 1 with
double distilled water and 50 ml of 40% (w/v) sodium hydroxide, which
had been freshly prepared, was added, stirring slowly. The contents of
the beaker were heated to boiling over a 45 minute period then boiled
gently for a further hour stirring continuously at 80 rpm. The gel was
allowed to settle for 5 minutes, the turbid supernatant removed and the
gel washed four times with 2 1 double distilled water, stirring for
5 minutes then allowing to settle for 5 minutes (no heating). After the
fourth wash the supernatant was removed and 2 1 0.01M sodium phosphate,
pH 6.8, was added to the gel and the mixture heated to boiling, stirring
gently. The gel was immediately removed from the heat and allowed to
settle for 5 minutes before the supernatant was removed. This was
repeated twice more, boiling for 15 minutes, then a further two times
adding 2 1 0.001M sodium phosphate, pH 6.8, and boiling for 15 minutes.
After it had been boiled for the fifth time the gel was ready for use.
The quantities used produced approximately 300 ml gel which will remain
effective for about 1 year when stored in 0.002M sodium phosphate,
pH 6.8, at 4°C.
Before it was used for column chromatography the hydroxyapatite gel
was washed into 0.002M potassium phosphate, pH 7.4 and mixed with
preswollen cellulose which had been equilibrated in the same buffer.
Slurries of the hydroxyapatite and of the cellulose were left to settle
for between 6 and 9 hours at 4°C before the settled gels were mixed
together in the ratio 1:1 (v/v). Whilst the column is being packed
the slurry yet to enter the column must be continuously mixed to
ensure an even distribution of the hydroxyapatite and cellulose.
The addition of cellulose allowed rapid elution (80 ml/hour) of the
columns.
Experiments using the hydroxyapatite column are described in
Section 5.1.
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3.2 Polyaerylamide gel electrophoresis
3.2.1 Non denaturing
Noil denaturing polyacrylamide gel electrophoresis (using both slab
and disc gels) was carried out using a single gel of uniform pore size
and a discontinuous buffer system similar to that described by Gordon
and Louis (1967). Using this system the sample is concentrated and the
proteins stack according to their charge as they enter the gel. Since
band sharpening occurs after all the constituents of the protein mixture
have entered the gel (i.e. after some degree of separation has occurred)
for good results the sample must be applied as a small volume of a
concentrated solution.
Samples, concentrated as described in Section 3.3, were mixed with
10% glycerol, containing bromophenol blue as the tracking dye, and loaded
onto 5% polyacrylamide disc or slab gels. The constituents of the gel
were 5% acrylamide (w/v) , 0.25% bis acrylamide (w/u) , 0.3% polyacry lamide,
0.05% Temed (v/v), 2 mM ammonium persulphate and 2 mM EDTA.
The gels were buffered with 0.37M Tris phosphate, pH 8.8. The electrode
buffer was 0.05M sodium borate containing 2 mM EDTA, pH 9.2.
For disc gels electrophoresis was carried out at room temperature,
3 mA/gel (constant current) until the tracking dye was 1 cm from the
bottom of the gel.
For slab gels electrophoresis was carried out at room temperature,
150 V (constant voltage) until the tracking dye was approximately 2 cm
from the bottom of the gel. The electrode buffer in the upper reservoir
was changed once, halfway through the electrophoresis, since electrolysis
resulted in a change in pH which might affect the electrophoresis.
The gels were fixed and stained as described in Section 3.2.3.
3.2.1.1 'Activity' gels
These were 5% non denaturing disc or slab gels prepared as described
above. However, before loading the samples, the gels were prerun, at 4°C,
for 1.5 hours at 3 mA/gel (disc gels) or for 3 hours at 150 V (slab gels)
with 0.37M Tris phosphate containing 2 mM EDTA, pH 8.8, as electrode
buffer to remove oxidising agents. The Tris phosphate buffer was
replaced with sodium borate electrode buffer and electrophoresis carried
out as described previously for non denaturing gels but at 4°C rather
than room temperature.
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Figure 3-3 The apparatus used to elute proteins from slices
of polyacrylamide gel. See text, section 3.2.1.2.2. for description
and experimental details.
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3.2.1.2 Elution of proteins from 'activity' gels
3.2.1.2.1 Elution Into standard buffer
Unstained 'activity' disc gels were cut into slices which were 3 nun
thick. Corresponding regions from several gels were pooled, finely
macerated and eluted into 400 p.1 of standard buffer, at 4°C, for 4 hours
or overnight. Samples were taken from the elution buffer and assayed
for GAD activity as described in Section 4.1.2.
3.2.1.2.2 Elution by electrophoresis
The Rp values (Rp = relative mobility of the protein with respect
to the tracking dye bromophenol blue) for proteins in a non denaturing
polyacrylamide slab gel were determined after fixing and then staining
with Coomassie Blue (Section 3.2.3.1). These Rp values were used to
estimate the position of the proteins in equivalent unstained 'activity'
slab gels. The appropriate areas of the gel were excised, equivalent
regions pooled and the proteins eluted using the apparatus shown in
Figure 3.3.
Glass tubes, of the same diameter as those used for disc electrophoresis,
were modified by the addition of a chamber to contain slices of gel.
As many as 4 of these tubes were fitted into a standard, 8 place,
disc gel electrophoresis apparatus so that gel slices taken from 4
different areas could be eluted simultaneously. Visking dialysis
tubing (1 - 8/32") was tightly faste^to the tubes by means of a rubber
grommet.
The whole apparatus was filled with sodium borate electrode buffer
(see Section 3.2.1) and the protein in the gel slices eluted by
electrophoresis at 3 mA/tube (constant current) at 4°C for 4 to 6 hours
or overnight. The eluted protein was assayed for GAD activity as
described in Section 4.1.2.
3.2.2 Denaturing
Whereas non denaturing polyacrylamide gel electrophoresis separates
proteins on the basis of charge, SDS polyacrylamide gel electrophoresis
separates proteins primarily on the basis of their (Shapiro et_ a^ 1967) .
In general, over a wide range of M there is a linear relationship
between log of a protein and its value (Shapiro et_ al^ 1967;
Weber & Osborn 1969). There are some exceptions to this caused by
anomalous binding of SDS, for example to glycoproteins or to proteins
of a very acidic nature.
2>°)
Table 3,2. M^_ standards for denaturing polyacrylamide gel electrophoresis




































Nakashima et_ al_ (1976)
Weber and Osborn (1969)
Lai et_ al_ (1976)
Weber and Osborn (1969)
Weber and Osborn (1969)
Weber and Osborn (1969)
Weber and Osborn (1969)
Weber and Osborn (1969)
Cohen et al (1971)
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This relationship can be used to determine the of proteins of
unknown size by using a number of well characterised marker proteins,
of known , to calibrate each gel.
Table 3.2 lists the proteins which were used as marker proteins to
calibrate 11% and 15% (w/v) polyacrylamide SDS/urea gels.
Semi logarithmic plots of versus log M^_ obtained by using a selection
of those proteins in 11% and 15% polyacrylamide gels are shown in
Figures 3.4 and 3.5 respectively. The line of best fit was calculated
using the nonparametric method of Nimmo and Atkins (1979). Such plots
were used to calculate the of the polypeptides present in the most
purified GAD preparations.
Urea was added to the sample incubation buffer and gel buffer to
prevent reaggeregation of the polypeptides. In addition it has been
shown that if urea is present the range of over which the
semi logarithmic relationship with Rp is linear can be extended to
include proteins of very low Mr (Swank & Munkres 1971) .
Denaturing polyacrylamide slab gel electrophoresis was carried out
using 11% and 15% (w/v) polyacrylamide slab gels, containing SDS and
urea, and a discontinuous buffer system similar to that used by Laemmli
(1970) except that urea was incorporated in both the gel buffer and
the sample incubation buffer.
Polyacrylamide gels (final concentrations) were either 11%
acrylamide (w/v), 0.15% bis acrylamide (w/v) or 15% acrylamide (w/v),
0.2% bis acrylamide (w/v), containing 0.075% Temed (v/v), 2 mM
ammonium persulphate, 0.1% SDS (w/v) and 4M urea buffered with 0.37M
Tris HC1, pH 8.8.
The electrode buffer was 0.02M Tris/0.2M glycine, pH 8.3,
containing 0.1% SDS (w/v).
The sample was mixed 4:1 (v/v) with the sample incubation mixture
(0.12M Tris HC1 containing 4% SDS (w/v), 2% B mercaptoethanol (v/v),
8M urea, pH 6.8).and incubated at about 60°C for 15 to 30 minutes.
After incubation the sample was made 10% (v/v) with respect to glycerol
and, with bromophenol blue as tracking dye, was loaded onto the gel.
Electrophoresis was carried out at 150 V (constant voltage) until the
tracking dye was approximately 2 cm from the bottom of the gel.



















Figure 3.it. A graph of relative mobility (in an 11%
polyacrylamide slab gel containing SDS and urea ) versus
log M for some of the proteins listed in Table 3.2.
Details of the composition of the gel can be found in
section 3.2.2. The best straight line was calculated
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Figure 3-5 A graph of relative mobility (in a *\$%
polyacrylamide slab gel containing SDS and urea ) versus
log M for some of the proteins listed in Table 3-2.
Details of the composition of the gel can be found in
section 3-2.2. The best straight line was calculated
using the method of Nimmo and Atkins (1979).
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3.2.3 Staining of proteins in polyaerylamide gels
3.2.3.1 Coomassie Brilliant Blue
Prior to staining with Coomassie Blue the protein bands were fixed
by soaking the gel for 30 minutes in a mixture 50% methanol/10% acetic
acid (v/v) in water.
Coomassie Blue stain was made by dissolving 1.25 g Coomassie
Brilliant Blue R in a mixture of 454 ml 50% methanol (v/v) in water
and 46 ml glacial acetic acid. After stirring vigorously overnight
the stain was filtered through Whatman number 1 chromatography paper
before use.
The gels were destained by shaking gently at 37°C in an excess
of destain which consisted of 7.5% glacial acetic acid and 5% methanol
(v/v) in water.
3.2.3.2 Silver staining
Silver staining of proteins in polyacrylamide gels was carried out
using the method of Wray et al (1981). The method can be used to detect
proteins at the nanogram level and may be used before or after staining
with Coomassie Blue.
The polyacrylamide gel was soaked overnight in 50% (v/v) methanol
in water. The stain was prepared as follows. Silver nitrate (0.8 g)
was dissolved in 4 ml double distilled water and this was added dropwise,
with constant stirring, to a solution which consisted of 21 ml 0.09M
sodium hydroxide and 1.4 ml 14.8M ammonium hydroxide. The stain was
then made up to 100 ml with water. This solution must be used
immediately. The gel was stained in this solution for 15 minutes
whilst being shaken gently. After it had been washed for 5 minutes
in double distilled water the gel was soaked in freshly made developer
solution until bands started to appear.
The developer solution was a mixture of 2.5 ml 1% (w/v) citric
acid and 0.25 ml 38% (w/v) formaldehyde made up to 500 ml with double
distilled water. Bands should appear after approximately 10 minutes.
The gel was washed in double distilled water and placed in 50% (v/v)
methanol to prevent further development. The gel was stored in 25%
(v/v) methanol/10% (v/v) acetic acid.
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3.3 Concentration of protein
3.3.1 Ultrafiltration
The Amicon ultrafiltration system was used to concentrate samples
containing GAD. The ultrafiltration system, using a stirred cell equipped
with a DIAFLO PM 30 membrane, was assembled and operated according to
the manufacturers'instructions. Samples, in standard buffer, were
concentrated at 4°C under nitrogen. This method was used primarily to
prepare samples for SDS/urea polyacrylamide gel electrophoresis since
ultrafiltration always resulted in large losses of GAD activity.
3.3.2 Using dry Sephadex G25
Solutions of high molecular weight, such as proteins, can be
concentrated by the addition of dry Sephadex G25. Water and small
ions are absorbed into the swelling Sephadex beads whilst the proteins
remain in the external solution. In this way a protein solution can
be concentrated whilst the pH and ionic strength remain the same
(Flodin et^ al_ 1960) .
Sample concentration using dry Sephadex G25 was carried out at
4°C. Dry Sephadex G25 was added, in the proportions 1 g gel per 4 ml
solution, to the sample contained in a small glass column. After
thorough mixing the gel was allowed to swell for 10 minutes before the
proteins were eluted. Blue dextran (0.2%) was added to the first 10% of
the elution buffer as an indicator of the end of the sample. In this
way a 2 to 3 fold concentration was achieved. If the process was repeated
a five fold concentration could be obtained with only a negligible
reduction of total GAD activity, the specific activity remained constant.
Samples containing GAD activity were concentrated in this manner
when subsequent experimental procedures required a high level of GAD
activity e.g. for gel filtration using Sephadex G200 (Sections 5.1 and
5.3) or for non denaturing polyacrylamide gel electrophoresis on
'activity' gels followed by elution of the protein bands (Section 5.2)
and assay for GAD activity (Section 4.1.2).
3.4 Paper electrophoresis
Samples (1 pi to 15 pi) were applied, at 2 cm intervals, to the
midline of a strip of Whatman number 1 chromatography paper, 23 cm long
and up to 10 cm wide. Electrophoresis was carried out at 200 V for
20 to 30 minutes in pyridine-acetic acid buffer, pH 6.5. This buffer
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was prepared by mixing 100 ml pyridine, 4 ml glacial acetic acid and
1900 ml double distilled water.
Amino acids were stained by spraying the dried paper with a solution
of 0.2% (w/v) ninhydrin in acetone and drying in the oven at 70°C to 80°C.
3.5 Scintillation counting
For non-aqueous samples or aqueous samples up to and including 0.5 ml,
toluene-methoxyethanol scintillation fluid was used. This consisted of
6 g PP0 per litre of a 1:1 (v/v) mixture of toluene and methoxyethanol.
For aqueous samples up to and including 5 ml, toluene-Triton
(See a W»rei/i& n«..s)
scintillation fluid was used. This consisted of 6 g PPO^per litre of a
2:1 (v/v) mixture of toluene and Triton X100.
Samples were counted on a Searle MK III liquid scintillation system
which calculates dpm by the sample channels-ratio method or on a
Packard Tri-carb 460C liquid scintillation system which calculates dpm




The method of Lowry et_ al (1951) was used for all determinations of
protein concentration. Bovine serum albumin was used as a standard.
The eluant from chromatography columns was monitored for protein by
measuring the absorbance at 280 nm.
3.6.2 GAD assay
The assay used to measure GAD activity is described in Section 4.1.2.
3.6.3 Phosphate assay
The sample was made up to 1 ml with distilled water and 3 ml of 1M
perchloric acid, 0.5 ml of concentrated perchloric acid and 1 ml of 2.5%
ammonium molybdate were added. The solution was mixed thoroughly.
After heating at 60°C for 5 minutes 1 ml 0.1M ascorbic acid was added,
the solution mixed throughly and heated at 60°C for 15 minutes. The
samples were read against a reagent blank (containing no phosphate)
on a Pye Unicam SP6-500 spectrophotometer at 650 nm. Standards which
contained between 0 and 1 /imol of inorganic phosphate were used to
construct a standard curve.
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3.6.4 GABA-T assay
GABA-T activity in samples was estimated by measuring the amount of
succinic semialdehyde (SSA) produced- by GABA-T during the assay
(Taberner et^ al_ 1972) . SSA was measured using the colorimetric method
described by Taberner et al_ (1972) which involves reacting the SSA with
3-methyl-2-benzothiazotrione hydrazone (MBTH) to form a stable coloured
product.
3.6.4.1 Tissue preparation and GABA-T incubation
A tissue homogenate, 1:10 (w/v), in 0.32M sucrose was either sonicated
or frozen to -40°C and thawed to disrupt the mitochondria. A 100 pi
sample (containing about 1 mg protein) was added to 400 pi of the GABA-T
incubation buffer so that the final incubation concentrations were 50 mM
GABA, 10 mM Z-oxoglutarate, 0.1 mM PLP buffered with 100 mM sodium
phosphate, pH 8.2. After incubation for 1 hour at 37°C the reaction was
stopped by the addition of 15 jul concentrated perchloric acid.
The precipitated protein was removed by centrifugation for 1 minute in a
Beckman microfuge at approximately 10 000 g and 75 pi of the supernatant
assayed for SSA. Controls consisted of an enzyme blank to which perchloric
acid was added before incubation at 37°C.
3.6.4.2 Reaction of SSA with MBTH
The MBTH colour reaction was linear over the range 0.01 to 0.1 pmol
SSA, Taberner et_ al_ (1972) and as shown by the standard curves obtained
in this work (see Figure 3.6). A sample volume of 75 pi was chosen since
it gave values on the linear portion of the SSA standard curve.
The sample to be analysed was added to 0.4 ml of a 1% (w/v) aqueous
solution of MBTH (freshly prepared since the solution is unstable) and
mixed. The solution was allowed to stand for 5 minutes at room temperature,
heated at 100°C for 3 minutes then cooled for 6 minutes before the
addition of 2 ml of a 0.2% (w/v) aqueous ferric chloride solution.
The mixture was shaken then after 5 minutes the volume was made up to
6 ml with acetone. After 40 minutes (when the colour development was
complete) the samples were read at 650 nm versus the controls (samples
taken from enzyme blanks to which perchloric acid had been added before
incubation at 37°C) on a Pye Unicam SP6-500 spectrophotometer.
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Figure 3•6 Standard curve for the MBTH colour reaction
in the GABA-T assay. See section 3.6.1;. Each value is
a mean 3 s.e.m. , nsl;
3.6.5 Measurement of high affinity uptake of [ ~^h] GABA
The high affinity uptake of [ ^h] GABA into chick brain tissue
homogenates was measured using a procedure modified from that described
by Bondy and Purdy (1977) . The standard incubation medium consisted
of Krebs-Ringer buffer which was 121 mM NaCl, 4.0 mM KC1, 1.3 mM CaC^
1.2 mM MgS0..7H 0, 0.015 mM EDTA, 20 raM glucose, 1 mM ascorbic acid,^ ^ (Stefc alob^euuxI'ioAs)
40 mM Tris HC1, pH 7.6, and contained 10 uM A0AA/^(an inhibitor of
GABA-T activity, Wallach 1961) and 0.01 uM [ 2,3-^h] GABA (specific
radioactivity = 740 kBq/nmol). This medium was gassed with 95% -
5% CO2 and 0.9 ml aliquots were dispensed into small stoppered glass
tubes. After preheating at 37°C the incubation was started by the
addition of 0.05 ml of a brain tissue homogenate, 1:100 (w/v) in 0.32M
sucrose. After 5 minutes 0.05 ml ice-cold liver homogenate (1:10 w/v
in 0.32M sucrose), which does not have a high affinity uptake system
for GABA (Goodchild & Neal 1973) was added as carrier protein, quickly
mixed and the incubation mixture emptied on to a Whatman GFC (2.5 cm
diameter) filter disc in a filtration tower. The incubation medium was
drawn through the filter by applying a vacuum and the filter washed
with 3 x 5 ml of ice cold isotonic saline.
Each incubation was carried out in triplicate with a parallel set
of control incubations at 0°C to account for neurotransmitter binding
which was not energy dependent. The amount of radioactivity on the
filter discs was determined by immersing the discs in 5 ml toluene-
methoxyethanol scintillation fluid followed by liquid scintillation
counting as described in Section 3.5. The filter discs were immersed
in scintillation fluid for 90 minutes before scintillation counting
with occasional shaking, to release the radiolabel.
Any loss of homogenate through the filter or loss of [ "^H J GABA
from the tissue caused by the filtration procedure would lead to an
underestimation of the amount of [ "^h] GABA accumulated by the
homogenate. However, control experiments, using centrifugation to
separate the homogenate tissue from the incubation medium, produced
similar results to those obtained using the filtration method
(J. Haywood, unpublished data) .
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SECTION 4: L-GLUTAMATE DECARBOXYLASE (GAD)
4.1 GAD assay
The assay used to measure L-glutamate decarboxylase (GAD EC.4.1.1.15)
activity was a modification of that used by Kanazawa ejt al^ (1976).
GAD activity was determined by measuring the amount of radioactive
GABA produced from L-Ju-^cJ glutamate. The [ ^c] GABA was separated
from the residual [^c] glutamate by ion exchange chromatography.
Commercial L-Ju-^c] glutamate contains radioactive impurities,
some of which would be eluted from the ion exchange column with the
[ ^c] GABA and produce artefactually high blank values. The [ ^c]
glutamate was therefore, partially purified by removing those substances
bearing a similar charge to GABA.
4.1.1 Purification of [ ] glutamate
The [^c] glutamate was purified by ion exchange chromatography
using a Dowex AG 1-X2 (100-200) mesh column (0.6 cm x 3 cm) in the
acetate form. The conversion of Dowex from the chloride to the acetate
form is described in Section 3.1.2.2. A 1 ml (1.85MBq) aliquot of
[ ^c] glutamate was applied to the column which was then washed with
15 ml double distilled water to elute any uncharged or positively
charged impurities. This was followed by 15 ml of 0.1M phosphoric acid
to elute the [ ^c] glutamate. Fractions, 0.5 ml, were collected
throughout. Any radioactive fractions eluted with water were discarded
and only those fractions eluted with phosphoric acid and containing
the highest radioactivity were collected. These fractions were pooled
and evaporated to dryness in a vacuum dessicator.
The [ C J glutamate was resuspended in 1 ml of potassium phosphate
buffer containing unlabelled glutamate so that the final glutamate
concentration was 250 mM. The specific radioactivity ranged from
6.66 k.Bq/pmol to 7.4 kBq/umol depending on the efficiency with which
r 14 i .
the [ CJ glutamate was recovered. The phosphate concentration m the
buffer was calculated, taking into account the phosphate ions already
present due to the elution with phosphoric acid, so that the phosphate
concentration was 500 mM. The pH was adjusted to pH 7.4 using 10M
potassium hydroxide.
So
Paper electrophoresis of the purified ( ^c] glutamate was carried
out to establish that all the radioactivity co-migrated with glutamate
(see Figure 4.1). Small amounts of unpurified and partially purified
glutamate (4 yul, about 400 000 dpm and 2.5 pi, about 200 000 dpm
respectively) were loaded in duplicate with a GABA standard (5 p. 1 of a
10 mM GABA solution) on to the centre of a strip of Whatman no. 1
chromatography paper. Section 3.4.1 describes the buffers and voltage
used.
After electrophoresis the strip was divided, one half was treated
with 0.2% ninhydrin (w/v in acetone) and the other half cut into 1 cm
squares. These were immersed in 5 ml toluene-methoxyethanol scintillation
fluid and left for 90 minutes before liquid scintillation counting
(see Section 3.5).
4.1.2 Measurement of [ ^c] GABA produced by GAD
The purified[ ] glutamate in potassium phosphate, pH 7.4 (see
previous section) was added, in the proportions 1:4 (v/v), to a solution
which was 2.5 mM with respect to both pyridoxal-5-phosphate (PLP) and
dithiothreitol (DTT) . A 5 jil aliquot of this assay mixture was added
to 5 F1 of the enzyme sample to give final concentrations in the assay
as follows: [ ] glutamate, 25 mM (specific radioactivity between
6.66 kBq/|imol and 7.4 kBq/pmol); potassium phosphate, 50 mM; PLP,
1 mM; DTT, 1 mM; pH 7.4.
After a 30 minute incubation at 37°C each assay was terminated by
adding 0.4 ml ice cold double distilled water and the tubes transferred
to ice. Each sample was then applied to a column (0.6 cm x 1.5 cm)
of Dowex acetate. The [ J GABA which had been produced was washed
through the column with 1.5 ml ice cold double distilled water and
collected in scintillation vials. Toluene-Triton scintillation fluid
(12 ml) was added and the radioactivity counted (see Section 3.5).
4.1.3 Paper electrophoresis of the products of the GAD assay
The products of the GAD assay were analysed by paper electrophoresis
(see Section 3.4.1) to ascertain whether the radioactivity in the sample,
after ion exchange chromatography, was due to [ "^C] GABA. Electrophoresis
of the products of the reaction without prior ion exchange chromatography
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Figure I;.1 Comparison between unpurified and, partially purified
L c") glutamate by electropherisisf See section 1|.1 . Track 1 is a
GABA standard to compare relative mobilities of glutamate and GABA
under these conditions. Track 2 is lyil of unpurified [1 ^cjglutamate
(ij.00000 dpfp )• Track 3 is 2.5 pi of partially purified [^CJ glutamate




Incubations were set up as follows:
(a) Four tubes each containing 10 ^ul of a chick brain supernatant
(homogenate 1:10 (w/v) in standard buffer and centrifuged for 1 hour
at 100 000 g , 4°C) and 10 jul GAD assay mixture, incubated forcLV /
1 hour at 37°C.
(b) Two tubes, each containing 5 ^ul chick brain supernatant and 5 pi
GAD assay mixture, incubated for 1 hour at 37°C.
(c) Four blanks, each containing 5 ^al boiled chick brain supernatant
and 5 pi GAD assay mixture, incubated for 1 hour at 37°C.
The two incubations from (b) and two of the blanks from (c) were
processed as described in 4.1.2 and counted to determine the amount
of [ ^c] GABA produced.
Two of the incubations from (a) and one of the blanks from (c)
were passed through ion exchange columns (as described in Section 4.1.2)
and the eluants evaporated to dryness in a vacuum dessicator.
Each sample was resuspended in 20 pi of distilled water and 5 ul of
each was applied, in duplicate, to a strip of Whatman no. 1
chromatography paper with 5 ^ul 10 mM glutamate and 5 pi 10 mM GABA
as standards (see Figure 4.2) .
The remaining two incubations from (a) and a blank were evaporated
to dryness, without prior ion exchange chromatography, then applied to
chromatography paper exactly as described above (see Figure 4.2).
After electrophoresis the two paper strips were cut in half and,
in each case, one half was stained with ninhydrin whilst the other
half was cut into 1 cm squares which were placed in scintillation vials.
Toluene-methoxyethanol scintillation fluid (5 ml) was added and the
radioactivity counted so that the position of the radioactivity could
be determined in relation to the position of the glutamate and GABA.
Although this was not done quantitatively the electrophoresis
showed that ( ] GABA was the only labelled product of the GAD reaction.
Figure 4.2, track 3 shows GABA comigrating with the radioactivity
when the incubation contained active GAD but no GABA (or corresponding
radioactivity) when the incubation contained heat inactivated GAD,
track 4. In addition it was shown that the ion exchange columns
used in the assay completely retained the[ ^CJ glutamate present in
the assay, Figure 4.2B, since the only radioactivity detected was due
to GABA.
S3
Figure 4.2. Electrophoresis of the products of the GAD assay
See Section 4.1.3 for details.
A = before ion exchange chromatography
B = after ion exchange chromatography
In each case track 1 = glutamate standard
track 2 = GABA standard
track 3 = incubation contained active GAD
track 4 = blank i.e., incubation contained heat
inactivated GAD.
Samples (5 yul) were spotted onto strips of Whatman no. 1 chromatography
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4.2 Characteristics of the GAD assay
The following experiments all used chick whole brain supernatants,
prepared by centrifuging an homogenate at 100 000 g , 4°C, for 1 hour,3V
as a source of GAD activity.
4.2.1 Linearity of GABA production versus time
Experiments were carried out in which the GAD assay was terminated
after several different time periods to determine how long the reaction
rate remained linear. The assay was performed as described in
Section 4.1.2 using chick brain cytosol prepared from an homogenate,
1:10 (w/v) in standard buffer (approximately 15-20 ^ig protein/assay),
as a source of enzyme activity. The assay was halted after 0, 10, 20,
30, 45 and 60 minutes and the amount of [ ^c] GABA produced was determined
(Section 4.1.2). The data shown in Figure 4.3 were taken from 5 experiments.
The best straight line was calculated using the nonparametric method
of Nimmo and Atkins (1979). Under the assay conditions used the
production of GABA was linear for 1 hour at 37°C, consequently
30 minutes was chosen as a suitable incubation period for the assay.
4.2.2 The effect of varying protein concentration on the production
of GABA
The total amount of protein in the assay was varied from 1.3 jag/assay
to 45.4 ^ig/assay. This was achieved by serial dilution, in standard
buffer, of chick brain cytosol prepared from an homogenate, 1:3 (w/v)
in standard buffer. Using samples of diluted cytosol as a source of
GAD activity the assay was carried out as described in Section 4.1.2.
Figure 4.4 shows the pooled results from three experiments. The best
straight line, considering all the points, was calculated using the
nonparametric method of Nimmo and Atkins (1979). GAD activity was
proportional to protein concentration, under these assay conditions,
when the protein concentration was varied from 0.26 mg/ml to 9.07 mg/ml.
4.2.3 pH profile
The GAD activity in chick brain cytosol (prepared from an
homogenate 1:10 (w/v) was determined over a range of pH values,
pH 5.5, 6.5, 7.0, 7.5, 8.5 and 9.5. Apart from the alteration
of pH the assay was carried out as described in Section 4.1.2.
A plot of GAD activity versus pH is shown in Figure 4.5. The pH
profile obtained shows that the pH optimum for the assay is near pH 7.
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Figure 4.3. GAD activity as a function of time
Chick brain cytosol was incubated at 37°C under the conditions
described in Section 4.2.1. One unit of enzyme activity is 1 nmol GABA
produced/mg protein. Each value is the mean - S.E.M., n = 5. The best
straight line was calculated using the nonparametric method of Nimmo
and Atkins (1979).
GADactivity(uni s)
Figure 4.4. GAD activity as a function of protein concentration in
the assay
Experimental details are described in Section 4.2.2. The data shown
are the means from three separate experiments, each determination was in
triplicate. The best straight line through all the data was calculated
using the nonparametric method of Nimmo and Atkins (1979). GAD activity
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pH
Figure I;.5 pH profile for GAD in chick brain cytosol,. See
section i|.2.3. One unit of specific enzyme activity = one
nmol. GABA produced / mg protein / hour.
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4.3 K values of chick brain GAD
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4.3.1 Apparent for glutamate
Since chick brain GAD could not be purified to homogeneity (see
Section 5) the apparent for glutamate was determined using chick
brain cytosol (prepared from an homogenate, 1:3 (w/v) in standard
buffer) which had been desalted by gel filtration on Sephadex G25
(see Section 3.1.1.2). The assay conditions were as described in
Section 4.1.2 with the exception of the glutamate concentration which
was varied, whilst the specific radioactivity was kept constant.
Seven different glutamate concentrations were used, ranging from
0.5 mM to 50 mM, whilst the PLP concentration was kept constant at
1 mM (see Figure 4.6).
From the data shown in Figure 4.6, the apparent for glutamate
of chick brain GAD was calculated to be 3.7 - 0.4 mM. The best straight
line was calculated by the nonparametric method of Nimmo and Atkins (1979).
4.3.2 Apparent for PLP
These experiments were carried out in parallel with those described
in 4.3.1. Chick brain cytosol, prepared using standard buffer from
which PLP had been omitted, was desalted by gel filtration on Sephadex G25
(Section 3.1.1.2) to remove exogenous PLP and any PLP which was not
very tightly associated with protein in the supernatant. The assay
conditions were as described in Section 4.1.2 with the exception of
the PLP concentration which was varied from 0.1 |iM to 1 mM. In addition
assays were performed in the absence of any added PLP. The glutamate
concentration was kept constant at 25 mM.
Table 4.1 shows the specific activity (expressed as nmol GABA
produced/mg protein/'hr) of GAD in chick brain supernatant in the absence
of PLP or in the presence of PLP at the concentrations shown.
An analysis of variance showed that there was no significant difference
between the values obtained for specific activity in the absence of
added PLP or when PLP was added to the concentrations shown in the table.
Since GAD activity remained at the same level irrespective of
whether PLP was added to the assay, it can be concLuded that, using
the experimental procedure described here, the enzyme remained saturated
with PLP. Consequently it was not possible to determine an apparent
K for PLP.
m
Figure 4.6. Hanes plot for determination of for glutamate.
See Section 4.3.1 for experimental details.
Intercept on x axis ="Km- [$3 = glutamate concentration (mM) ,
v = initial reaction rate. Units = nmol GABA produced/mg protein/hr.
Each point is the mean - S.E.M., n = 3. The best straight line was
calculated using the nonparametric method of Nimmo and Atkins (1979).
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Table 4.1. The effect of varying PLP concentration on GAD activity













*1 unit specific activity = 1 nmol GABA produced/mg protein/hour.
The specific activity of GAD in chick brain cytosol in the
presence or absence of PLP. The data is taken from 2 experiments
with triplicate determinations for each concentration. An analysis
of variance gave a variance ratio (F) = 0.059 for df 1 = 6 and
df 2 = 6, p 0.05. See Section 4.3.2.
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4.4 Discussion
The assay used in this study to measure GAD activity was a
modification of the radiometric assay described by Kanazawa et al_ (1976)
in which the product of the reaction, GABA, was separated from the
substrate by ion exchange chromatography. Separation of the
radiolabelled product of the reaction was chosen since it was
considered to be the most accurate as well as the simplest and
most reproducible method of measuring GAD activity. It was confirmed
that GABA was the only detectable radiolabelled product when partially
purified L-[u-^c] glutamate was used to assay GAD activity in chick
brain supernatant.
The method which has been most widely used as an alternative for
assaying GAD activity relies on the measurement of carbon dioxide formed
during the reaction, either radiometrically (Albers & Brady 1959;
Roberts & Simonsen 1963) or using a Warburg apparatus (Roberts &
Frankel 1951). However, there have been a number of reports of
discrepancies when values obtained for GAD activity by measuring the
amount of radiolabelled carbon dioxide liberated were compared with
those obtained by measuring the amount of radiolabelled GABA formed
(Wilson et ai 1972; Kanazawa et al 1976). Both authors concluded
that alternative metabolic pathways were contributing to the production
of carbon dioxide. Further experiments by Kanazawa et^ al^ (1976)
indicated that any alternative metabolic pathways which might be
operating did not affect the production of radiolabelled GABA in the assay.
The presence of contaminants in commercial [l-^c] glutamate
which release radiolabelled carbon dioxide during incubation have
been reported (Miller & Martin 1973). The possibility that carbon
dioxide might be released by decarboxylation of pyroglutamic acid,
identified as a contaminant of radiolabelled glutamic acid (Drummond &
Phillips 1974), following acidification was suggested (Gonnard &
Whicker 1974).
Immunochemical studies have indicated that GAD from avian brain
differs greatly from GAD from mouse, rat, human or calf brain (Saito
et al 1974). Since the assay conditions used to determine GAD activity
had been developed using the mammalian enzymes, experiments were carried
out to characterise the GAD assay for avian GAD before it was used on
a routine basis. The extent to which GABA production was linear with
(o2
respect to time and protein concentration were established and the effect
of varying the pH and the glutamate and PLP concentrations of the assay
were investigated.
Human GAD activity is optimal at pH 6.8 (Blindermann et_ al_ 1978(a))
and both mouse and rat GAD activities are optimal at pH 7 (Wu ejt al_ 1973;
Maitre et^ al^ 1978). Chick brain GAD activity is optimal at about pH 7
and therefore does not differ greatly in this respect. This suggests
the possibility that although structurally avian and mammalian GAD may
differ markedly, the environment of the active site may be similar.
There is evidence to suggest that GAD is not highly conserved during
evolution (Saito et_ al_ 1974) . Using immunochemical methods it was
demonstrated that whereas GAD was similar in several mammalian species,
frog, avian and fish GAD were very different.
An apparent for glutamate for chick brain GAD was calculated
to be 3.7 mM. This compares with 0.7 mM, 1.1 mM, 1.28 mM and 1.6 mM
for mouse (Wu ejt al_ 1973) , rat (Maitre et_ al_ 1978) , human (Blindermann
et_ al^ 1978(a)) and bovine (Wu 1982) brain GAD respectively. Although
the value determined for chick brain GAD is slightly higher than
those calculated for the other species, this may just be the result
of generic differences between birds and mammals. The differences in
for glutamate of GAD from the different species may reflect the
structural differences demonstrated immunochemically (Saito ejt al_ 1974).
Preliminary experiments to determine an apparent for PLP
indicated that GAD present in a chick brain supernatant remained
saturated with PLP, even after desalting on Sephadex G25. This implies
that the association between enzyme and cofactor is very tight.
This is consistent with evidence that, in the absence of glutamate,
PLP is very tightly bound to GAD (Miller et_ al^ 19 78) . Further
experiments involving the association of PLP with GAD are described
in Section 7. Difficulties involved in trying to determine a KJ °
m
for PLP for GAD and any evidence for a role for PLP in the control
of enzyme activity will be discussed in Section 7.
A K for glutamate for chick brain GAD will only be determined
m
unequivocably using a pure protein preparation which will ensure
there are no unknown factors modifying enzyme activity and hence
affecting the K^. As a major inhibitory neurotransmitter in the CNS
GABA has an important role in determining the overall level of neuronal
<o2>
excitability. Consequently there must be a mechanism by which GABA
levels in the brain are controlled. At present the mechanism by which
GABA synthesis is regulated has not been elucidated consequently
little is known about factors which may be involved in controlling or
modulating GAD activity. It seems unlikely, in view of the high
concentration of glutamate throughout the brain, that control of enzyme
activity will be effected by substrate availability. There is no
evidence either for or against the presence of an "effector" or
"modulator" molecule which regulates GAD activity.
Any evidence for possible mechanisms regulating GAD activity and,
therefore, GABA synthesis will be discussed further in Section 7.
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SECTION 5: PURIFICATION OF CHICK BRAIN GAD
5.1 Purification protocol
Tissue preparation
The brains from 70 to 1L|.0 broilers, 6-12 months old,"
(Marshalls Ltd, Newbridge, Midlothian) were homogenised 1:10 (w/v) in
standard buffer containing 0.4 mM PMSF as a serine protease inhibitor
(Fahrney & Gold 1963) using an Ystral tissue macerater. The homogenate
was centrifuged for 1 hour at 100 000 g , 4°C, and the resulting
supernatants pooled. The total volume of the pooled supernatant was
between 1100 ml and 2500 ml. A sample of approximately 250 ml was
removed for immediate processing and the remainder was made 20% (v/v)
with respect to glycerol and stored at -20°C until use.
Batches of the supernatant (between 100 and 150 ml) were desalted
and the buffer concentration changed by gel filtration on a column of
Sephadex G25 (5.4 cm x 27 cm) as described in Section 3.1.1.2. This
replaced lengthy dialyses and reduced the amount of time required for
the purification which minimised losses of GAD activity.
Chromatography on DEAE cellulose
After desalting by gel filtration on Sephadex G25 and the addition
of PMSF (final concentration 0.4 mM) up to 300 ml of the supernatant
was applied (100 ml/hour) to a column (2.5 cm x 42.5 cm) of DEAE
cellulose which had previously been equilibrated in standard buffer at 4°C.
After washing with 1 bed volume of standard buffer (100 ml/hour) the
proteins were eluted with a linear gradient of 800 ml potassium phosphate
(50 mM to 750 mM) containing 0.1 mM PLP and 1 mM AET, pH 7.4.
The elution rate was approximately 50 ml/hour. The first 100 ml of the
wash was discarded then 13.6 ml fractions were collected. On a number
of occasions these fractions were assayed for phosphate (using the
method described in Section 3.6.3) to check the gradient. Those
fractions containing the highest GAD activity (assayed as described in
Section 4.1.2) were pooled and desalted by gel filtration on Sephadex G25
into 5 mM potassium phosphate buffer; pH 7.4, containing 0.1 mM PLP
and 1 mM AET. Protein concentration was determined by the method of
Lowry et al (1951). Figure 5.1 shows the elution profile obtained.
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Figure 5.1. Chromatography on DEAE cellulose of chick brain supernatant.
See Section 5.1.
Fraction volume, 13.6 ml. The fractions containing the highest GAD
activity, indicated by arrows, were pooled. One unit of enzyme activity =















































The synthesis of the hydroxyapatite and preparation of the column
are described in Section 3.1.3. PMSF was added (final concentration
0.4 mM) to the desalted peak fractions collected from the DEAE cellulose
column. These were then adsorbed (40 ml/hour) on to a hydroxyapatite
column (2 cm x 8 cm) previously equilibrated with 5 mM potassium phosphate
buffer. Proteins were eluted with a series of steps of increasing
potassium phosphate concentration, pH 7.4, containing 0.1 mM PLP and
1 mM AET, as follows; 25 ml 5 mM potassium phosphate (40 ml/hour)
followed by 25 ml 50 mM potassium phosphate, 25 ml 150 mM potassium
phosphate and 25 ml 300 mM potassium phosphate all at 80 ml/hour.
Figure 5.2 shows the elution profile obtained. Those fractions containing
the highest enzyme activity were retained for chromatography on
Sephadex G200. Protein concentration was determined by the method of
Lowry et_ al_ (1951) .
Chromatography on Sephadex G200
For calibration of the Sephadex G200 column see Section 3.1.1.2.
If the volume of the active fraction obtained from hydroxyapatite
chromatography exceeded 10 ml, the sample was concentrated using dry
Sephadex G25 as described in Section 3.3.2. Samples of less than 10 ml
were applied directly to a column (1.8 cm x 95 cm) of Sephadex G200
previously equilibrated with standard buffer. The proteins were eluted
with standard buffer at a rate of 10 ml/hour. The elution profile is
shown in Figure 5.3. Protein concentration was determined by the method
of Lowry e_t al_ (1951). The peak fractions were pooled and stored in
20% (v/v) glycerol at -20°C.
Table 5.1 shows the degree of purification of chick brain GAD
achieved using this procedure. Compared with the supernatant the
enzyme was purified 25 fold with an activity yield of 3.1%. The protein
concentration was decreased about 800 fold.
At each stage of the procedure samples were removed and analysed
by non denaturing polyacry1amide gel electrophoresis and electrophoresis
on 11% and 15% (acrylamide w/v) denaturing SDS/urea slab gels to
assess the progress of the purification, Figures 5.4a and b, 5.5 and
5.6 respectively. Details of the preparation of the gels, conditions
of electrophoresis and staining of proteins in the gels are described
in Section 3.2.
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Figure 5.2. Chromatography on hydroxyapatite of the pooled peak
fractions from the DEAE cellulose column. See Section 5.1.
Volume of fractions 1-17 inclusive, 9 ml; volume of fraction 18
onwards, 5.6 ml. Those fractions containing the highest GAD activity
(25-27 inclusive) were pooled. One unit of enzyme activity = 1 nmol
GABA produced/hour. (———) indicates the potassium phosphate
concentrations used for elution. CJ-Q , protein concentration;

























Figure 5.3. Chromatography on Sephadex G200 of the pooled fractions from
the hydroxyapatite column. See Section 5.1.
Fraction volume, 1.8 ml. The fractions containing the highest GAD
activity, indicated by arrows, were pooled. One unit of enzyme activity =
1 nmol GABA produced/hour. Q-D , protein concentration;



















Table 5.1. Purification of chick brain GAD
Fraction Total Specific Purification Total Activity
Protein Activity (-fold) Activity Yield
(mg) (units/mg (units) (%)
protein)
Supernatant





(post G25) 273.6 0.480 2.1 131 27
Hydroxy-
apatite
Apeak 1 33.3 1.291 5.6 43 8.8 7
peak 2 28.6 1.119 4.8 32 6.5J
Sephadex
G200 peaks 2.71 5.667 24.5 3.1
1 unit of GAD activity = 1 umol GABA produced/hour.
APeak 1 applied to Sephadex G200.
The purification of chick brain GAD is described in Section 5.1,
15.3
lo
Non denaturing polyacrylamide gel electrophoresis of the peak
fractions from the Sephadex G200 column revealed 3 bands, 1 strong and
2 much weaker (Figures 5.4a and b). When denaturing SDS/urea
polyacrylamide gel electrophoresis was carried out multiple bands
could be distinguished on both the 11% and 15% gels (Figures 5.5 and 5.6).
5.2 Elution of proteins from rion denaturing 'activity' gels
5.2.1 Elution into standard buffer
A chick brain supernatant was prepared by centrifuging an homogenate,
1:10 (w/v) in standard buffer, at 100 000 g , 4°C, for 1 hour. The
av
supernatant was concentrated as described in Section 3.2.2 and 50 ul
samples (containing 500 p.g protein) loaded onto 5% (w/v acrylamide)
"activity" disc gels followed by electrophoresis as described in
Section 3.2.1.2.1.
Figure 5.7 shows the results obtained by pooling gel segments from
7 disc gels with elution periods of either 4 hours or overnight
(approximately 15 hours). An increase in the elution period did not
greatly alter the recovery of the GAD activity which appeared to be
located in a diffuse band over the top 20%-25% of the gel. A total of
2317 units of GAD activity (1 unit is 1 nmol GABA produced/hour) were
loaded on to the 7 gels. After 4 hours 15.7% of the activity was
recovered in the elution buffer and after 15 hours 18.2% was recovered.
Since electrophoresis may cause some loss of enzyme activity, as much
as 50% of the activity of catfish brain GAD was lost due to electrophoresis
(Su et_ al 1979), then recovery by elution may be more efficient than
it appears.
Alternatively, it is possible that these values for recovery of
enzyme activity may have been overestimated. They were obtained by
addition of the results obtained from GAD assays performed on the
eluted proteins from consecutive regions of the gels. The number of
dpm obtained per assay was low, the highest being approximately 500 dpm,
therefore the errors inherent in the calculation of dpm in liquid
scintillation counting will comprise a much larger percentage of the
final value. Addition of the values obtained for the eluted proteins
from more than one region of the gel to give a total value for the
recovery will magnify any errors resulting in an overestimation of
the percentage recovery of activity.
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Figure 5.4.
Noil denaturing polyacrylamide gel electrophoresis, 5% acrylamide
(w/v) . Tracks 1 and 2, supernatant, 125 /.lg and 250 ^ig protein
respectively; Tracks 3 and 4, peak fractions from DEAE cellulose column,
40 pg and 90 yig protein respectively; Tracks 5 and 6, peak fractions
from hydroxyapatite column, 47 and 94 ^ug protein respectively;
Tracks 7 and 8, peak fractions from Sephadex G200 column, 20 pg and
40 pg protein respectively. (a) Gel stained with Coomassie Brilliant
Blue (Section 3.2.3.1). (b) Gel stained using the silver staining
method of Wray et_ al_ (1982) (Section 3.2.3.2). Conditions of
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Figure 5-5 SDS/urea denaturing polyacrylamide gel electrophoresis
(11 %,acrylamide, /v). Tracks 1,7 and 8, marker proteins; Track 2,
supernatant, 1 25 jag protein; Track 3, peak fractions from DEAE
cellulose column, If? Jig protein; Track 1;, peak fractions from
hydroxyapatite column, h7 Jig protein; Tracks 5 and 6, peak
fractions from Sephadex G200 column, 10 pig and 20 jig protein








1 2 3 4 5 6 7
Figure 3*6 SDS/urea denaturing polyacrylamide gel electrophoresis
(13% aerylamide W/v).Tracks 1,2 and 7, marker proteins; Track 3,
supernatant, 123 jug protein; Track Ij., peak fractions from Sephadex G200
column, 20 pg protein; Track 3, peak fractions from DEAE cellulose
column, hS pg protein; Track 6, peak fractions from hydroxyapatite




Figure5«7Adiagrammaticrepresent tionofthproteint rbtai edaf roly- acrylairiidegelelectrophoresisofchickbr insupernatant5%acrylamidp,w/v, 'activity'd scgel.TheGADactivityelut dfromsev nparal elsi expressedad.p.m./ooledg lslic s(6mm)—*)utionfori;h r ,) elutiondv rnight.S esecti£.2foretails
Increasing the volume of the elution buffer would improve the
efficiency of diffusion of the protein out of the gel but the resulting
dilution would make it impossible to detect GAD activity. It was not
possible to increase the amount of protein loaded per gel and, therefore,
the amount of GAD activity per gel since the gels had already been
overloaded and this would result in even more reduced resolution.
When the experiment was repeated using partially purified samples
containing GAD activity, for example the peak fractions obtained from
chromatography on DEAE cellulose or hydroxyapatite it proved impossible
to detect any GAD activity in the eluted proteins.
5.2.2 Elution by electrophoresis
The sample was prepared as described in Section 5.2.1 and a total
volume of 800 ul (between 6 mg and 8 mg of protein) loaded on to a 5%
"activity" slab gel followed by electrophoresis as described in
Section 3.2.1.1. The proteins were eluted from slices of gel as
described in Section 3.2.1.2.2.
Although protein was eluted from the gel segments and concentrated
at the bottom of the dialysis bag, GAD assays which were performed on
the eluted proteins failed to detect any GAD activity.
5.3 Determination of an approximate Mr for chick brain GAD
The approximate for chick brain GAD was determined by gel
filtration on Sephadex G200 as described in Section 3.1.1.1. Using
this method an = 150 000 - 15 000 (n = 4) was calculated.
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5.4 Discussion
GAD from several'vertebrate species has been purified (Wu et al
1973; Hadjian & Stewart 1977; Blindermann et^ al_ 1978(a); Maitre
et^ al^ 1978; Su et^ al_ 1979; Wu 1982) using chromatographic techniques
similar to those used for chick brain GAD. Ammonium sulphate fractionation
was included in the purification of mouse, catfish and bovine brain GAD
(Wu et_ al 1973; Su et_ al^ 1979; Wu 1982) to precipitate much unwanted
protein. However, ammonium sulphate fractionation of chick brain
supernatant resulted in substantial losses of GAD activity. This could
be due to the presence of trace contaminants in the ammonium sulphate
which were sufficient to affect the enzyme activity. However, ammonium
sulphate fractionation caused large losses of rat and human brain GAD
activity (Blindermann et_ ad 1978(b)) indicating that ammonium sulphate
fractionation may be responsible for the activity loss. Since 75%
saturation with ammonium sulphate results in a concentration of 4M
ammonium sulphate, it is possible that the high ionic concentration may
cause denaturation. Alternatively, interaction between sulphate ions
and positively charged amino acids on the surface of the protein may
cause charge shifts sufficient to result in denaturation. Since there
is evidence to suggest that the active site of GAD may be positively
charged (Wu & Roberts 1974; Wu 1976), sulphate ions may interact with
positively charged amino acids at the active site resulting in
inactivation. It is interesting that sodium sulphate fractionation
has also been reported to cause loss of mouse brain GAD activity
(Susz et_ al_ 1966) .
The protocol finally adopted to try to isolate chick brain GAD
resulted in a 25 fold purification with respect to the supernatant,
see Table 5.1. This was accompanied by an 800 fold reduction in protein
concentration and was represented by 3 bands on a non denaturing
polyacrylamide gel (Figure 5.4). These facts suggest that GAD protein
may have been enriched more than the data indicate and that the value
for "-fold purification" has been artefactually lowered due to
denaturation and loss of enzyme activity. Further column chromatography
after Sephadex G200 proved impossible since enzyme activity was reduced
to undetectable levels. Storage of fractions from Sephadex G200
columns in 20% (v/v) glycerol at -20°C so that the products of large
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amounts of material could be pooled for future processing also proved
to be of limited value since, despite the protective effect of glycerol
(Blindermann e£ al_ 1978(b)) and careful concentration of protein,
enzyme activity was lost.
It is interesting to note that a minor low molecular weight peak
of GAD activity was detected after gel filtration on Sephadex G200.
There has been a report of a minor high molecular weight peak of GAD
activity which was excluded from the gel during chromatography with
Sephadex G200 (Wu e_t al_ 1976) . This proved to be immunologically and
kinetically the same as the major peak. However, other groups have not
detected the high molecular weight species (Blindermann £t al_ 1978(a)).
There have been no reports of a minor low molecular weight species.
The lower molecular weight species observed here may be artefactual,
for example, the product of partial proteolysis. Alternatively it may
represent a low molecular weight form of the enzyme which constitutes
a small percentage of the total enzyme activity. It is possible that
for full activation GAD may have to associate with another, as yet
unidentified, molecule converting it to the major higher molecular form.
Protease activity probably contributed to the loss of enzyme
activity during the early stages of the purification although PMSF
was added at several stages to try to prevent the action of serine
proteases, the most active at the pH of the buffers used (Barrett 1977).
However, chick brain GAD appears to be an unstable enzyme, despite the
presence of PLP and AET in all the buffers, particularly when the
protein concentration is reduced. The addition of PLP (Roberts &
Simonsen 1963; Susz et_ al_ 1966) and AET (Susz e_t al_ 1966) has been
shown to stabilise GAD activity. AET will maintain any sulphydryl
groups in a reduced state. There is evidence that there may be at
least one sensitive sulphydryl group, at or near the active site,
which is required for activity (Wu & Roberts 1974).
Greater success has been achieved in the purification of GAD from
other species. Human brain GAD has been purified 8 000 fold (Blindermann
et_ al^ 1978(a)) and rat brain GAD about 3 000 fold (Maitre £t_ al_ 1978)
over the original homogenate. In each case the enzyme was judged
to be pure by a number of criteria including the fact that the protein
was homogeneous with respect to mobility on both denaturing and
non denaturing polyacrylamide gels and, in the latter case, all the
ns
enzyme activity was associated with the one band. Since the molecular
weight obtained for pure human and rat brain GAD under denaturing
conditions was approximately half that calculated for the undenatured
enzyme, and only one N-terminal amino acid was detected, it was concluded
that the enzyme was a dimer with two identical subunits (Blindermann
et al 1978(a) ; Maitre e_t al^ 1978) .
Mouse brain GAD has been purified 700 fold over the supernatant.
Non denaturing polyacrylamide gel electrophoresis revealed one major
protein band with which all the enzyme activity was associated and one
other faint band (Wu et^ al_ 1973) . However, when this preparation was
analysed by polyacrylamide gel electrophoresis under denaturing conditions
multiple bands were revealed with M^_ s ranging from 15 000 to 129 000.
Four major bands had M^s ranging from 60 000 to 120 000 (Matsuda
et al 1973). This was interpreted as being due to dissociation and
association, 15 000 being the smallest dissociable subunit, and that
six of these small polypeptides might be associated together to form
two larger identical subunits. Since comparison of immunochemical
data (Saito et al_ 1974; Maitre et_ al_ 1978) suggests that there is no
significant difference between mouse, rat and human brain GAD, these
discrepancies in electrophoretic pattern have been explained as due to
differences in methodology (Sze 1978) or the presence of contaminants
(Blindermann e_t aL_ 1978(b)) .
An alternative explanation could be that the low molecular weight
bands were the result of proteolysis by a protease which had copurified
with mouse brain GAD but, due to the different protocols employed,
was absent in the rat and human preparations. Incubation at 37°C or
60°C with SDS will permit the retention of proteolytic activity
(Gordon 1975). The high molecular weight bands could be due to
incomplete denaturation of the protein since, unless the protein is
incubated at a temperature and for a period of time which would normally
cause denaturation, the addition of SDS will not necessarily result in
complete denaturation (Gordon 1975) . Alternatively there may have been
some reaggregation of the polypeptides. The addition of urea eliminates
this problem (Swank and Munkres 1971)-, however, dialysis of the samples
prior to electrophoresis to remove the urea may also cause the
dissociation of a small amount of SDS from the protein (Shapiro &
Maizel 1969), sufficient to allow limited reaggregation.
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There is evidence of proteolytic activity from the multiple bands
obtained on the SDS/urea polyacrylamide gels shown in Figures 5.5 and 5.6.
Since the sample contained more than one protein, multiple bands under
denaturing conditions would be expected but there are at least 10
polypeptides, for which the molecular weight has been estimated, plus a
few very faint bands which can barely be distinguished. Although the
samples were heated rapidly to greater than 60°C there could still have
been opportunity for limited proteolysis. It is unlikely that
reaggregation occurred since urea was present in both the samples and
polyacrylamide gel. Any proteolytic fragments generated during the
purification of GAD would have been removed by chromatography on
Sephadex G200 unless the protein had contained disulphide bonds and
hence retained structural integrity until SDS polyacrylamide gel
electrophoresis. There is evidence that mammalian GAD does not contain
disulphide bonds (Maitre et al 1978) however, care must be employed
when relating properties shown for mammalian GAD to avian GAD since
the two enzymes have been shown, immunologically, to be very different
(Saito e_t al_ 1974) .
It was hoped that preparative polyacrylamide gel electrophoresis of
partially purified GAD which had retained a reasonably high level of
enzyme activity would solve the problem of enzyme instability and yield
pure GAD. Preparative gel electrophoresis had been used with some
success in the purification of bovine brain GAD (Hadjian & Stewart 1977;
Wu 1982) and catfish brain GAD (Su et^ al_ 1979) . However, the pilot
experiments indicated that enzyme instability might again cause problems,
mainly that of loading sufficient enzyme activity to be detectable after
electrophoresis and elution. The application of very concentrated samples
of a supernatant resulted in the elution of a small proportion of the
activity loaded (Figure 5.7). This was however, located at the top of
the gels and did not coincide with any of the three bands present in
the most purified sample (Figure 5.4). As can be seen from the gels in
Figure 5.4, in each track a large proportion of the protein loaded has
remained at the top of the gel. It is possible that most of the GAD
in the protein sample applied remained at the top of the gel so that the
GAD which was separated by electrophoresis was not present in sufficient
amounts to be detected after elution: GAD activity could not be
detected after electrophoresis of partially purified GAD probably due
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to a combination of being unable to load sufficnt GAD in relation to
the total protein concentration and the enzyme's instability to the
conditions of electrophoresis.
Samples of concentrated supernatant were electrophoresed on slab
gels since as much as 8 mg protein could be applied. However, although
protein could be successfully eluted by electrophoresis, GAD activity
could not be. This may be attributed to the increased length of time
GAD was exposed to the electrophoretic conditions which caused increased
loss of activity. Since it was not possible to identify which of the
three proteins separated by non denaturing polyaery1amide gel
electrophoresis corresponded to GAD, molecular weight analysis using
SDS polyacrylamide gel electrophoresis could not be carried out.
A tentative of 150 000 - 15 000 was assigned to chick brain
GAD by gel filtration on Sephadex G200. This compares with M = 140 000
for human and rat brain GAD (Blindermann ej: al_ 1978(a) ; Maitre et_ a1_
1978) and = 90 000 for mouse and catfish brain GAD (Wu et_ al^ 1973;
Su et_ al_ 1979) . The calculated for chick brain GAD is an approximate
value. Any determined by gel filtration, without confirmation
using other techniques can only be regarded as tentative since the
calculation relies on assuming that the protein is completely spherical.
In addition, the possibility of interaction between the protein and
the gel matrix or of aggregation cannot be discounted.
It did not prove possible to purify chick brain GAD to homogeneity
using conventional techniques. Successful purification would necessitate
that the partially purified extracts from very large quantities of
tissue could be pooled for future processing. Unfortunately chick brain
GAD lost activity so rapidly that it was not possible to detect
activity in the peak fractions from the Sephadex G200 column after
storage at -20°C.
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SECTION 6: AFFINITY CHROMATOGRAPHY
6.1 Methods
6.1.1 Preparation of the gel for the PMP-Sepharose 4B column
The PMP-Sepharose 4B affinity gel was synthesised as described by
March et^ al_ (19 74)
Cyanogen bromide activation of Sepharose 4B
One volume (25 ml) washed Sepharose 4B slurry (equal volumes of
gel and double distilled water) was added to 1 volume 2M sodium carbonate
and stirred slowly. The rate of stirring was increased and 0.05
volumes of acetonitrile containing cyanogen bromide, 2 g cyanogen
bromide/1 ml acetonitrite was added. After vigorous stirring for
1-2 minutes the slurry was washed, as rapidly as possible, on a
coarse scintered glass funnel, with between 5 and 10 volumes ice cold
0.1M NaHCO^, pH 9.5. This was followed with between 5 and 10 volumes
of double distilled water and finally 0.1M NaHCO^, pH 9.5 which was
the buffer used in the coupling reaction. After the final wash the
slurry was filtered under vacuum to produce a moist cake.
Coupling reaction
The moist cake of activated Sepharose 4B was placed in a plastic
bottle containing 1 volume (25 ml) 0.1M NaHCO^, pH 9.3 and 6 g
diaminohexane. This was mixed then left for 18-20 hours at 4°C on an
end-over-end shaker for the coupling reaction to occur.
Addition of PLP
After 18-20 hours the gel was washed, on a coarse sintered glass
funnel, under vacuum with 1.5 1 double distilled water. The moist cake
of gel was added to 1 volume (25 ml) double distilled water and 0.1 g
PLP added. The slurry was stirred gently for 30 minutes. The beaker
containing the slurry was transferred to ice and 40 mg sodium
borohydride was added slowly with gentle stirring throughout. The slurry
was left to stir until no more hydrogen was evolved and then washed with
1 1 ice cold double distilled water. The PLP coupling step was
repeated twice more. After the final wash with distilled water the
slurry was washed with 2M KC1. The aminohexyl pyridoxamine phosphate
Sepharose 4B (PMP-Sepharose 4B) was stored in 1M KC1 at 4°C until use.
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Figure 6.1. Schematic diagram showing the steps involved in coupling PLP


















































6.1.2 Preparation of aminohexyl pyridoxamine phosphate
Melted diaminohexane (28 y.1) was added to 50 ml 0.1M NaHCO^, pH 9.5,
containing 25 mg PL? and left to stir at room temperature for 20 minutes.
The solution was then cooled on ice (to below 10°C) and 40 mg sodium
borohydride added slowly, stirring throughout. After the addition of
sodium borohydride was complete the solution was stirred for a further
10 minutes and then at room temperature until no more hydrogen was
evolved. Samples of this solution were diluted in 0.1 M NaOH for
examination of the absorbance spectrum and of the excitation and
emission spectra.
6.1.3 Spectrofluorimetrlc arid spectrophotometry analysis of the
PMP-Sepharose 4B gel
6.1.3.1 Spectrofluorimetric analysis
Between 10 ml and 15 ml of the PMP-Sepharose 4B gel was washed with
0.1M KC1 followed by distilled water. A dilute suspension of this gel
was placed in a quartz cuvette and mixed thoroughly to ensure even
distribution of the beads. The PMP-Sepharose 4B proved to be fluorescent
when irradiated with light of the correct wavelength. The excitation and
emission spectra of the gel, using a blank of untreated gel, were
compared with the excitation and emission spectra of an aminohexyl
pyridoxamine phosphate solution, using a blank of diaminohexane, on a
Perkin-Elmer fluorescence spectrophotometer.
6.1.3.2 Spectrophotometry analysis
The washed PMP—Sepharose 4B was resuspended in 0.1M NaOH. A dilute
suspension of the gel was placed in a quartz cuvette and mixed
thoroughly to ensure even distribution of the beads. The absorbance
spectrum of the gel, measured versus a blank of untreated gel in 0.1M
NaOH on a Pye Unicam SP 1800 double beam spectrophotometer, was compared
with that of aminohexyl pyridoxamine phosphate read versus a blank of
diaminohexane diluted with 0.1M NaOH.
6.1.4 Chromatography on PMP-Sepharose 4B
A number of small scale pilot experiments were performed to test
the efficiency of the PMP-Sepharose 4B affinity gel at binding chick
brain GAD.
Two 3 week old chicks were decapitated and their brains homogenised,
1:5 (w/v), in ice cold double distilled water containing 0.1% Triton X100(w*(/)
and 1 mM PMSF. The homogenate was centrifuged at 100 000 g for 1 hourclV
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and the supernatant put into the correct buffer by gel filtration on a
column of Sephadex G25 which had been equilibrated with 20 mM imidazole
acetate, pH 6.5, containing 1 mM AET. After a 15 minute preincubation
at 37°C with 100 mM glutamate (see Section 7) the supernatant was passed
through a second Sephadex G25 column which had been thoroughly washed
with distilled water. The resulting sample was loaded (15 ml/hour) onto
a small (5 ml packed bed volume) PMP-Sepharose 4B column, in distilled
water. The column was washed with 3 ml distilled water followed by
approximately 5 bed volumes 10 mM potassium phosphate, pH 7.2 then
100 mM potassium phosphate pH 7.2. Fractions (2 ml) were collected,
made 500 uM with respect to PLP then, after a 10 minute interval in ice,
assayed for GAD activity as described in Section 4.1.2. Protein
concentration was determined by the method of Lowry £t_ al (1951).
Alternatively, after the second gel filtration step, the sample was
added to 5 ml (packed volume) of washed PMP-Sepharose 4B. This was left
for 30 minutes at 4°C, stirring just quickly enough to keep the gel
dispersed throughout the sample so that the protein could bind to the gel.
The slurry was then poured into a glass column and protein eluted as
previously described. Fractions (2 ml) were collected.
85
6.2 Results and Discussion
6.2.1 Spectrofluorimetric and spectrophotometric analysis of the
PMP-Sepharose 4B gel
6.2.1.1 Spectrofluorimetric analysis
The PMP-Sepharose 4B gel and aminohexyl pyridoxamine phosphate solution
had identical excitation and emission spectra, with the excitation maximum
at 310 nm and the emission maximum at 365 nm. This suggests that PLP has
been linked to the Sepharose 4B.
The amount of PLP covalently bound to the Sepharose 4B was estimated
by comparing the height of the peaks obtained using a known amount of gel
with the height of the peaks obtained using known dilutions of
pyridoxamine phosphate. The height of the peaks caused by the aminohexyl
pyridoxamine phosphate solution will be proportional to the amount of
aminohexyl pyridoxamine phosphate in the solution. There is unlikely to
be any free PLP in the aminohexyl pyridoxamine phosphate solution used
for comparison since diaminohexane was added in excess. An approximate
pyridoxamine phosphate concentration of 2 ^imol/ml settled gel was
estimated in this manner.
6.2.1.2 Spectrophotometric analysis
The absorbance spectrum of the PMP-Sepharose 4B gel and that of the
aminohexyl pyridoxamine phosphate were identical with maximum absorbance
at 245 nm and 308 nm. This confirmed that the ligand had been attached
to the gel. The excitation maximum (310 nm) does not quite coincide with
the wavelength (308 nm) at which maximum absorbance occurred but the
difference is small, 2 nm, and is probably due to machine variability.
Pyridoxamine phosphate in 0.1M NaOH has absorbance maxima at 244 nm
and 312 nm. The experimental values differ slightly from these however,
the difference could be due to a slight error in machine adjustment.
Alternatively, the difference, particularly in the second of the two
values which represents absorbance by the substituted pyridine ring,
might be attributed to slight changes in charge distribution caused by
the covalent bond with the diaminohexane spacer. Pyridoxamine HC1 shows
maximum absorbance at 245 nm and 308 nm however, the reaction conditions
were such that pyridoxamine phosphate was the only pyridoxal derivative
which could be formed. An approximate value for the amount of ligand
bound to the gel of 2.29 ^imol/ml settled gel was calculated from the
extinction coefficient for pyridoxamine phosphate.
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6.2.2 Chromatography on PMP-Sepharose 4B gel
The elution profile shown in figure 6.1. is representative of those
obtained using the procedure described in 6.1.4. GAD activity was
eluted just after the water/10 mM potassium phosphate interface.
This indicated that GAD had not bound to the column, although it was
retarded by the column since greater than two bed volumes of 10 mM
potassium phosphate buffer were required to elute the activity completely.
This interaction between the column and GAD was presumablynon specific
and ionic in nature. Approximately 70% of the total protein and 50%
of the GAD activity was eluted in this first peak.
A second, much smaller, peak of GAD activity was eluted with 100 mM
potassium phosphate. This contained 30% of the total protein and 13%
of the GAD activity. Again the column probably acted as an ion exchange
rather than an affinity column. This supposition is based on the fact
that increased ionic strength, although only to 100 mM potassium phosphate,
was sufficient for elution and also evidence presented in Section 7 that
the interaction between pyridoxal phosphate and GAD, even when the
pyridoxal phosphate has formed a Schiff's base with glutamate, is extremely
strong in the presence of 50 mM potassium phosphate. Consequently it
would be expected that the elution conditions required to overcome such
a strong interaction would need to be more rigorous and probably also
more specific.
Almost 100% of the protein was recovered however, 37% of the GAD
activity was unaccounted for. Since GAD has proved to be particularly
labile this could represent enzyme inactivation. Alternatively GAD
might have bound tightly to the column and therefore not have been eluted
with 100 mM potassium phosphate.
Although the ligand was attached to the gel through the aldehyde
group which would probably interact with a lysine residue at the active
site of GAD to form a Schiff's base, the protein should still be able
to bind specifically to the ligand. It has been shown that although
the aldehyde group is essential for the catalytic activity of PLP
dependent enzymes with amino acid substrates, it is not essential for
binding (Snell, 1970). In addition there are two reports describing
chromatography of mouse brain GAD using affinity resins with a similar
structure to that used here (Possani et jil, 1977; Perez de la Mora













































Figure 6.2 Elution profile of FMP-Sepharose IfB affinity column.
Chick brain supernatant, after pretreatment with 1OOmM glutamate
(see section 6.1 .1;.), was applied to a PMP-Sepharose ijJB column.
(---) indicates the potassium phosphate concentrations used for
elution. Fraction size, 2ml. One unit of enzyme activity is one
nmol. GABA produced /ml /hour, (o-a), protein concentration;
(■—•), GAD activity.
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However, there is evidence for a very tight association between GAD
and PLP. It seems unlikely therefore that PLP bound to a gel matrix
could displace PLP at the active site. Incubation with glutamate in
imidazole acetate buffer was used to try to deplete the PLP content but,
as shown in Section 7, this was not a particularly successful method.
Only a small amount of any activity lost could be restored by the addition
of PLP. Consequently only a small percentage could be expected to bind
specifically to the column.
The GAD activity which was not accounted for might have bound to
the column, although this implies that the pretreatment step had been
more successful than had ever been demonstrated. Alternatively, it might
represent a combination of binding and denaturation.
Despite the possibility that some GAD activity might have bound to
the column it was decided not to develop affinity chromatography further.
Since it had not proved to be sufficiently reproducible and the amount
of GAD specifically bound to the column could only have been a very small
percent of the activity present in the original supernatant. Although
37% of the activity loaded on the column was unaccounted for, this
was only 12.5% of the activity in the starting material. This is
probably due to enzyme inactivation caused by incubation in imidazole
acetate and small losses of protein (and hence of GAD) when the fractions
were collected from the Sephadex G25 columns.
This particular resin did not fulfil the criteria upon which affinity
chromatography was chosen, namely, a one step method of obtaining a
concentrated, much purified GAD solution from a large volume of
supernatant containing a low concentration of enzyme activity. It seemed
unlikely in the absence of a reliable and reversible method of removing
PLP from GAD (see Section 7) that large scale preparative affinity
chromatography using PLP as a ligand would be effective.
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SECTION 7: FACTORS AFFECTING THE INTERACTION OF PLP WITH GAD
7.1 Tissue preparation
Chicks were killed by decapitation and rats were killed by cervical
dislocation. Whole chick brain or whole rat brain was homogenised 1:10
(w/v) or 1:30 (w/v) in ice cold double distilled water containing 0.1%
(w/v) Triton X100 and 1 mM PMSF.
The homogenates were centrifuged at 100 000 g^ for 1 hour and the
supernatants dialysed for 24 hours, at 4°C, against 10 to 15 volumes of
one of the following buffers.
(a) Phosphate buffer, which is 25 iriM potassium phosphate containing
1 mM AET, pH 7.2.
(b) Imidazole acetate buffer which is 100 mM imidazole acetate containing
1 mM AET, pH 6.5.
In each case the dialysis buffer was changed twice.
7.2 Experimental conditions
The experimental conditions used in this section were modified
from those described by Miller e_t A1 (1978) .
7.2.1 Dialysed chick brain supernatant (from an homogenate, 1:10 (w/v))
in phosphate buffer was preincubated at 37°C, in the presence or absence
of 10 mM glutamate, for 30 minutes. The glutamate-treated supernatant
was desalted by gel filtration on a column (2 cm x 15 cm) of Sephadex G25
(equilibrated in phosphate buffer) to remove the glutamate and any PLP
which may have become dissociated from the enzyme.
The supernatant which had been preincubated with glutamate and that
which had been preincubated without glutamate were both assayed for GAD
activity in the presence or absence of PLP. The GAD assay was performed
as described in Section 4.1.2 except PLP was omitted from some of the
incubations. The total incubation period for the GAD assays was 60 minutes.
Samples were withdrawn at intervals (10, 20, 30, 45 and 60 minutes) so
that any effect on the rate of the reaction caused by the omission of
PLP could be examined.
7.2.2 The experiments described in 7.2.1 were repeated using rat brain
supernatant. The total incubation period for the GAD assays was 30 minutes.
Samples were withdrawn at intervals (5, 10, 20 and 30 minutes) so that
any effect on the rate of the reaction caused by the omission of PLP
could be examined.
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7.2.3 Dialysed rat brain supernatant (from an homogenate, 1:30 (w/v))
in imidazole acetate buffer was treated exactly as described in 7.2.1,
except that imidazole acetate buffer replaced phosphate buffer, until
the GAD assay. The supernatant which had been preincubated with
glutamate and the supernatant which had been preincubated without
glutamate were both assayed in the presence or absence of PLP. Those
samples which were to be assayed in the presence of PLP were preequilibrated
for 5 minutes at room temperature with 1 mM PLP. The PLP concentration
in the GAD assay mixture added to those samples assayed in the presence
of PLP was adjusted so that the final assay concentration was 1 mM.
The GAD assay incubation period was 15 minutes.
7.2.4 The experiments described in 7.2.3 were repeated using chick
brain supernatant. The procedure was exactly the same except for the
conditions used for preincubating the supernatant with glutamate.
In these experiments the supernatant was preincubated at 37°C for
15 minutes in the presence of 10 mM, 100 mM or 250 mM glutamate or in
the absence of glutamate.




7.3.1 These results were obtained using the experimental conditions
described in 7.2.1. When a dialysed chick brain supernatant was
preincubated at 37°C in the absence of added glutamate then assayed for
GAD activity in the presence of 1 mM PLP the reaction was linear for
1 hour (Figure 7.1a). The rate of the reaction when the same supernatant
was assayed without added PLP remained linear for 30 minutes before
conditions became limiting (Figure 7.1a). The rate of the reaction
over the linear region of the graph was about 15% lower when assayed
in the absence of added PLP than it was when assayed in the presence
of added PLP.
The linearity of the reaction (up to 30 minutes) in the absence of
added PLP and the fact that the reaction rate over this period was only
15% lower than that obtained when GAD was assayed in the presence of a
large excess of PLP suggests that most of the enzyme was still saturated
with PLP. Since the tissue was prepared in buffer which did not contain
PLP, the supernatant underwent a long period of dialysis versus PLP free
buffer and the enzyme was not inactivated by gel filtration using
Sephadex G25, it can be concluded that PLP must be very tightly bound
to the enzyme. This agrees with the findings of Miller e_t j^l (1977)
who reported that the bond between PLP and rat brain GAD was stable to
both dialysis and gel filtration.
When a dialysed chick brain supernatant was preincubated with 10 mM
glutamate followed by gel filtration on Sephadex G25 (see 7.2.1) and
then assayed for GAD activity with 1 mM PLP or without added PLP the
results obtained (Figure 7.1b) were similar to those described for a
supernatant which had not been preincubated with glutamate. However,
the omission of PLP had a much greater effect on the rate of the GAD
reaction using glutamate-treated supernatant than it did using non
glutamate-treated supernatant. Over the linear region of the plot there
was a 29% reduction in the rate of the reaction using a glutamate-treated
supernatant (Figure 7.1b) compared with a 15% reduction using an
non glutamate-treated supernatant (Figure 7.1a) when PLP was omitted.
There was a lower level of GAD activity in the glutamate-treated
supernatant than in the non glutamate-treated supernatant, under the same
conditions, implying that the glutamate-treated enzyme might be less
saturated with PLP and therefore, that glutamate had had an effect on
the PLP bound to the enzyme.
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Figure 7.1. Comparison between the GAD activity in untreated, dialysed
chick brain supernatant with that in dialysed chick brain supernatant
after preincubation with 10 mM glutamate.
Samples assayed with (•-§) and without (0-0) the addition of 1 mM
PLP. Dialysis was for 24 hours at 4°C against 25 mM potassium phosphate
containing 1 mM AET, pH 7.2.
(a) GAD activity in dialysed chick brain supernatant which had been
prewarmed at 37°C for 30 minutes before assay.
(b) GAD activity in dialysed chick brain supernatant which had been
preincubated with 10 mM glutamate at 37°C for 30 minutes before assay.
Experimental details are contained in Section 7.2.1. 1 unit enzyme
activity = 1 nmol GABA produced/mg protein. Data are the means from
2 sets of experiments with triplicate determinations.
p
GADactivity(uni s)
However, the effect of 10 mM glutamate on the PLP bound to chick
brain GAD was small under these conditions since the enzyme still appeared
to be greater than 70% saturated with PLP. The dialysed but non glutamate-
treated supernatant appeared to be 85% saturated. Per cent saturation
is used to express the activity which remains after the various treatments
and was defined by Miller et al(1978) as the activity obtained in the
absence of added PLP expressed as a percentage of the activity obtained
with a (presumed) saturating concentration of PLP.
7.3.2 These results were obtained using the experimental conditions
described in 7.2.2. The previous experiment was repeated using rat
brain supernatant and produced very similar results (Figure 7.2) to
those obtained with chick brain supernatant (Figure 7.1). The rate
of reaction over the first 30 minutes, when PLP was omitted, was 16%
lower using a non glutamate-treated supernatant and 30% lower using
a glutamate-treated supernatant. Preincubation with 10 mM glutamate
in phosphate buffer at 37°C caused a small reduction in GAD activity
when the enzyme was assayed without PLP. The effect on chick and rat
brain GAD appeared similar.
7.3.3 Miller ejt (1978) described substrate-promoted dissociation
of PLP from rat brain GAD in 100 mM imidazole acetate, pH 6.5, rather
than in phosphate buffer. Therefore, the previous experiments were
repeated using rat brain supernatant and the experimental conditions
described in 7.2.3. Preincubation with 10 mM glutamate resulted in a
considerable reduction in GAD activity when the supernatant was assayed
in the absence of added PLP (Figure 7.3). The GAD activity in the
glutamate-treated supernatant assayed without added PLP was 54% lower
than that in the non glutamate-treated supernatant assayed under the
same conditions and 79% lower than that in the non glutamate-treated
supernatant assayed with PLP. The addition of PLP to the glutamate-
treated supernatant caused a 19% increase in GAD activity to 40% of
that in the non glutamate-treated supernatant assayed with PLP.
If the GAD in the untreated supernatant assayed in the presence of
PLP is regarded as fully saturated then preincubation with 10 mM
glutamate caused an apparent 79% decrease in saturation. However,
a 19% increase in enzyme activity to only 40% of the original GAD
activity was obtained by the addition of PLP rather than the expected
Figure 7.2. Comparison between the GAD activity in untreated, dialysed rat
brain supernatant with that in dialysed rat brain supernatant after
preincubation with 10 mM glutamate
Samples assayed with (•-•) and without (0-0) the addition of 1 mM PLP.
Dialysis was for 24 hours at 4°C against 25 mM potassium phosphate
containing 1 mM AET, pH 7.2.
(a) GAD activity in rat brain supernatant which had been prewarmed at
37°C for 30 minutes before assay.
(b) GAD activity in rat brain supernatant which had been preincubated
with 10 mM glutamate at 37°C for 30 minutes before assay.
Experimental details are contained in Section 7.2.2. 1 unit enzyme
activity = 1 nmol GABA produced/mg protein. Data are the means from
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Figure 7.3 Comparison between the GAD activity in untreated,
dialysed rat brain supernatant (SN) with that in dialysed rat
brain supernatant after preincubation with 10 mM glutamate
(Glu 10). Samples assayed with (SN+PLP, Glu 10+PLP) and
without (SN-FLP, Glu 10-PLP) 1mM PLP. Dialysis was for 2h hours
at U°C against 100 mM imidazole acetate containing 1mM AET,
pH 6.5. Experimental details are contained in section 7-2.3.
The data are the means from 2 sets of experiments expressed as
percentages of the GAD activity (nmol. GABA produced / mg
protein) in untreated rat brain supernatant assayed with 1mM
PLP (SN+PLP). Each determination was made in triplicate.
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complete recovery. This indicated that the procedure caused a large
amount of irreversible inactivation of the enzyme. In addition it is
interesting to note that the GAD activity in the non glutamate-treated
supernatant assayed without PLP is 75% of the control value (Figure 7.3)
compared with 85% using phosphate buffer (Figure 7.2). If these effects
on activity are due to substrate-promoted dissociation of the cofactor,
it would appear that a large percentage of the dissociation was
irreversible since, in these experiments, addition of PLP did not
regenerate much GAD activity.
7.3.4 Dialysed chick brain supernatant, in imidazole acetate buffer,
was preincubated with 10 mM, 100 mM and 250 mM glutamate before it was
assayed for GAD activity with and without added PLP (see Figure 7.4).
Experimental details are described in Section 7.2.4. Data was compared
using the Students t test.
Preincubation with 10 mM, 100 mM and 250 mM glutamate caused a
decrease in GAD activity in supernatant assayed without added PLP of
28%, 42% and 26% respectively when compared with the activity in a
non glutamate-treated supernatant assayed with PLP (see Figure 7.4).
This difference was statistically significant. However, under these
experimental conditions the GAD activity in a non glutamate-treated
supernatant assayed without added PLP was reduced by 30%, again
statistically different from the control value. When this value was
compared with those for GAD activity in glutamate treated supernatants
assayed without PLP the difference was not statistically significant.
Addition of PLP to the glutamate-treated supernatants failed to
restore GAD activity to the value of the non glutamate-treated
supernatant assayed with added PLP. In the cases of the supernatants
treated with 10 mM and 100 mM glutamate the GAD activity assayed with
added PLP was not significantly different from that assayed without
PLP. Addition of PLP to the supernatant treated with 250 mM glutamate
did cause a significant increase in activity however, this was still
significantly lower than the GAD activity in the non glutamate-treated
supernatant assayed with PLP.
From these results it would appear that preincubation with glutamate
in imidazole acetate buffer may have caused a small amount of mostly
irreversible inactivation of GAD. Since there was only 70% of the
control GAD activity present in the non glutamate-treated supernatant
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Figure 7-h Comparison bet-ween the GAD activity in untreated,
dialysed chick brain supernatant (SN) with that in dialysed chick
brain supernatant after preincubation 'with 10 mM (Glu IQ), TOO mM
(Glu 100) or 250 mM (Glu 250) glutamate. Samples assayed with (+PLP)
and without (-PLP) 1 mM PLP after preincubating or prewarming for
15 minutes at 37°C. Dialysis was for 2h hours at U°C against 100 ;mM
imidazole acetate buffer containing 1 mM AET, pH 6.5• Experimental
details are in section 7*2.I*. Results are expressed as percentages
of the GAD activity ( nmol. GABA produced /mg protein ) in untreated
chick brain supernatant assayed with PLP. Each value is the mean of 3
experiments I_.s .e .m.Each experiment used 2 birds with triplicate
determinations. The data were compared using the Student's t test.
* indicates that the value was not significantly different from
(SN+PLP) p 0.005, d.f.= li. indicates that the values are
significantly different from each other p 0.005 d.f .= I4..
assayed without PLP compared with 85% when the experiment was performed
using phosphate buffer -it can be inferred that either phosphate buffer
is protective or that imidazole acetate buffer causes some denaturation.
Preincubation with 10 mM glutamate followed by assay for GAD activity
without added PLP resulted in the same level of GAD activity as in the
untreated supernatant, assayed under the same conditions, implying that
much of the effect was promoted by the buffer conditions. The effect
was not readily reversible, addition of PLP increased GAD activity by 3%
(Figure 7.4). This result is interesting since preincubation with 10 mM
glutamate in imidazole acetate buffer resulted in a marked decrease in
activity for rat brain GAD (Figure 7.3).
Preincubation with 250 mM glutamate caused a decrease in GAD activity
of 26% compared with the control value (Figure 7.4). The addition of
PLP resulted in the recovery of 15% of the enzyme activity. The most
marked effects were obtained by preincubating the supernatant with
100 mM glutamate. GAD activity was reduced by 42% by preincubation
with 100 mM glutamate followed by assay without added PLP. Addition
of PLP caused a recovery of activity of 24%.
Of the glutamate concentrations used to try to promote dissociation
of PLP from chick brain GAD, only 100 mM glutamate in imidazole acetate
reduced the enzyme activity, in the absence of PLP, to less than the
non glutamate treated control under the same conditions. In addition
the effect was to some extent reversible. There did not appear to
be substrate-promoted dissociation of PLP from either chick or rat brain
GAD using phosphate buffer.
7.4 Discussion
The effects on GAD activity observed when chick and rat brain
supernatants were incubated with glutamate in imidazole acetate buffer
are somewhat difficult to interpret. The fact that pretreatment with
10 mM glutamate at 37°C in imidazole acetate buffer had a much greater
effect on rat brain GAD (Figure 7.3) than pretreatment with the same,
or higher concentrations of glutamate, had on chick brain GAD
(Figure 7.4) under the same conditions may be consistent with the idea
that chick and rat brain GAD are structurally different (Saito £t al_
1974). The results obtained strongly suggest that the buffer played
an important role in causing the effects observed after pretreatment
with glutamate.
Imidazole has a ring structure comprised of carbon atoms and
two nitrogen atoms and at pH 6.5 would exist both in the protonated
form and as the non ionised free base. The charge distribution of
the protonated imidazole ion may be similar enough to that of the
pyridoxal ring to dislodge the cofactor under certain conditions,
for example, when it is no longer bound via a Schiff's base to the
protein but has formed a Schiff's base with glutamate. Differences
in the amino acid sequence in the vicinity of the active site between
rat and chick brain GAD may result in PLP being held more strongly
in the latter case and therefore being more difficult to dislodge.
There is evidence that imidazole, in the protonated state,
can affect the conformation of a protein. Shaltiel e_t al^ (1966 & 1969)
used imidazole citrate at pH 6 and pH 7 as a "deforming" buffer in the
removal of PLP from phosphorylase Id. The data suggested that the
imidazole ion, rather than the free base, caused localised denaturation
of the protein exposing the PLP which could then be removed by a
carboxyl reagent although at higher concentrations of imidazole a
carbonyl reagent was unnecessary. The denaturation was reversed by
the removal of the imidazole.
A similar, although not completely analogous, situation might
arise with GAD. Since PLP is a cofactor participating in the
decarboxylation of glutamate it must be accessible to glutamate and
therefore it is unlikely to be inaccessible to other small molecules
such as hydrazides which will also react with the aldehyde group in
contrast with phosphorylase b. Consequently, although the imidazole
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ion may not interact with the active site itself, the environment of
the active site may be influenced by interactions with other regions
of the molecule. Since it is probable that the amino acid sequence
of chick and rat brain GAD differ (Saito et al 1974) the imidazole
acetate buffer might distort one enzyme more than the other. Rat brain
GAD might therefore be more susceptible than chick brain GAD.
It would be necessary to assay for the presence of PLP to be
certain that the alterations in GAD activity were due only to the
removal of PLP. If the GAD activity was reduced due to reversible
substrate-promoted dissociation as has been suggested (Miller e_t al_
1978) it should have been possible to regenerate almost 100% activity
by the addition of PLP. However, that did not prove to be the case in
these experiments. It has been shown (Shaltiel et al 1966) that if
too high a concentration of imidazole is used (for phosphorylase b^,
at this pH, between 0.6M and 0.8M) the protein may become denatured
rather than "deformed". It is possible that in these experiments the
concentration of imidazole was approaching that critical concentration
for GAD and therefore that a significant amount of PLP was lost
irreversibly.
The experiments described in this section were designed to exploit
the phenomenon of substrate-promoted dissociation, reported by Miller
et al (1978), to deplete chick brain GAD of PLP, prior to affinity
chromatography. There has been controversy as to the strength of the
association between GAD and PLP. In vivo evidence is contradictory
and has suggested that PLP may be loosely bound to the active site
(Baxter 1969) so that GAD might be regulated by cofactor availability,
but also that PLP may be tightly bound to GAD since enzyme activity is
unaffected by changes in PLP concentration in vivo (Gey & Georgi 1974).
It has been postulated, from in vitro studies, that neuronal GAD may
have two types of binding site, one which binds the cofactor tightly,
the other weakly (Tapia & Sandoval 1971; Bayon et_ al 1977(a) & (b))
whereas Miller ££ al (1978) described very tight association between
GAD and PLP in the absence of glutamate, with dissociation from the
active site in the presence of glutamate.
The evidence presented in this section is in agreement with the
proposal that the enzyme and cofactor are tightly associated. However,
the data regarding the possibility of substrate-promoted dissociation
IOI
conflict with the previous report (Miller e£ al 1978). There is no good
evidence for substrate-promoted dissociation of PLP from GAD in phosphate
buffer (Figures 7.1 & 7.2). In imidazole acetate buffer the evidence
is against rather than for substrate-promoted dissociation of PLP from
chick brain GAD (Figure 7.4). In the case of rat brain GAD, although
enzyme activity was reduced by the treatment described (Figure 7.3)
to similar levels as previously reported (Miller e£ al_ 1978) , in contrast
only a small percentage could be regenerated by the addition of PLP.
Although many of these observations have been attributed to buffer
effects, this does not preclude any facilitation of the removal of PLP
by the formation of a Schiff's base with glutamate but suggested that under
these unphysiological conditions this may be a secondary effect.
A Km for PLP for chick brain GAD
Data obtained from these experiments highlight the difficulties
involved in the estimation of a K for PLP, described in Section 5.
m '
It did not prove possible to determine an apparent for PLP for GAD
using chick brain cytosol since the enzyme had apparently remained
saturated with its cofactor. This is corroborated by the evidence for
a very strong association between PLP and chick brain GAD in phosphate
buffer presented in this section (See 7.3.1).
Values for a for PLP have been reported for mouse, rat and
human brain GAD of 0.05 pM (Wu ej: al^ 1973), 0.5 pM (Maitre ej: al^ 1978)
and 0.1 pM (Blindermann e_t al^ 1978(a)) respectively using the purified
protein. Blindermann .al (1978(a)) described a method of preparing
the apoenzyme which was similar in principle to that described in
this section but substituted GABA, which acted as a weak competitive
inhibitor, for the substrate glutamate. Although there was no
"deforming" agent present it is possible that the rigours of the
purification schedule may have slightly altered the conformation of
the protein so that the cofactor was not held so tightly in place.
In addition the ionic interactions between PLP and the protein would
probably not be as strong at the pH used (pH 5) to prepare the apoenzyme
consequently the addition of a high concentration of a competitive
inhibitor might be sufficient to promote binding and allow the removal
of the cofactor. Wu et^ al. (1973) make no mention of the necessity of
preparing the apoenzyme however, the purification protocol used
contained several ammonium sulphate precipitations. Evidence from
other enzymes (Snell 1970) showed that ammonium sulphate precipitation
resulted in the loss of PLP.
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Although attempts were made to establish an apparent K for PLP for
m
chick brain GAD, a stable, pure enzyme preparation is necessary for an •
accurate value to be determined. Using a crude system such as chick
brain cytosol it is not possible to control all the factors which might
affect the K^. Assuming that the system could be completely depleted
of PLP there would be competition for the cofactor by other PLP
requiring enzymes for a total PLP concentration which might be as low
as 0.01 uM. Another factor which would significantly affect the level
of available PLP at such a low concentration is that PLP will readily
and non-specifically bind to protein (Snell 1970), albeit with low
affinity.
Finally, steady state kinetic theory assumes that the rate of
association and dissociation of cofactor or substrate is not slow in
comparison with the overall rate. However, evidence suggests that
dissociation of PLP is at least slow and there is no definitive evidence
that, in vivo, dissociation does occur. Consequently values for a K
for PLP may not be meaningful and may depend on other, as yet
unidentified, factors.
Regulation of enzyme activity
Enzyme activity can be regulated not only by substrate or cofactor
availability or by binding with effector molecules which alter enzyme
activity but also by a variety of cellular mechanisms which affect
transcription or translation of proteins. The manner in which GABA
synthesis is controlled and GAD activity regulated has not been
elucidated. In view of the high glutamate concentration throughout
the brain (approximately 3 jimol/g wet weight, Levi & Morisi 1970)
it is doubtful that the levels would fluctuate sufficiently for
substrate availability to control GABA synthesis. Preliminary
experiments have been carried out by several workers in an attempt
to uncover a control mechanism for GAD.
Miller et_ al_ (1978) suggested that association and dissociation
of PLP might play a role in regulating GABA synthesis. They postulated
that the high concentration of glutamate in brain prevented saturation
of the enzyme by causing substrate promoted dissociation of the PLP and
necessitating a constant supply of PLP to maintain activity. This was modifiec
to include the effects of adenine nucleotides on GAD activity by Seligman
et al (1978) who followed up earlier reports (Tursky et^ al_ 1970)
)o2>
that ATP inhibited GAD non-competitively with respect to both substrate
and cofactor in a manner which was dependent on PLP concentration.
On the basis of data showing that ATP, ADP and the magnesium complexes
of ATP and ADP were potent inhibitors of GAD in dialysed preparations
of rat brain cytosol it was proposed that, in the absence of ATP,
available PLP reactivated enzyme which had been inactivated by substrate
promoted dissociation. This reactivation could however, be blocked
by ATP (at physiological concentrations) which bound to the protein
causing a conformational change so that the active site was blocked.
In the presence of high concentrations of PLP, 100 juM, which is several
fold higher than physiological concentrations (physiological PLP
concentrations, approximately 15 juM, Bilodeau 1965) this ATP inhibition
was lifted since reactivation occurred as rapidly as the apoenzyme
was formed (Seligmann et al 1978), see Figure 7.5. The observation
that, in vivo, GAD is only partially saturated with PLP despite a
concentration which appeared high enough for full activation (15 juM)
and that a post-mortem activation of GAD was accompanied by a decrease
in ATP concentration (Miller £t al_ 1977) was presented as corrobative
evidence.
However, more recently Martin et al_ (1980) carried out similar
experiments to those previously described (Miller e£ al_ 1978) replacing
rat brain cytosol with partially purified hog brain GAD. The results
obtained were similar to those previously reported however, inhibition
of GAD by ATP was apparently PLP-independent, in contrast with previous
observations (Seligmann ejt a1_ 1979) .
Kinetic experiments using mouse brain cytosol produced data which
were interpreted as being consistent with two types of PLP binding site,
one which bound PLP tightly and was therefore unaffected by exogenous
PLP levels and the other which was only weakly associated with PLP
and therefore dependent on the exogenous PLP concentration (Tapia &
Sandoval 1971; Bayon e_t al 1977(a) & (b)). This would result in a
constant basal level of GABA synthesis with increased synthesis in the
presence of increased levels of PLP. On the basis of this the kinetic
model shown in Figure 7.6 was suggested.
The model for the control of GAD activity proposed by Miller e_t aT
(1978) and modified by Seligmann et al (1978) relies on the ready
dissociation of PLP in the presence of high, but still physiological
\Ofy
Figure 7.5. A mechanism proposed for the^-decarboxylation of glutamate
by GAD (from Seligmann et_ a_l 1978)
PLP = pyridoxal phosphate, G = glutamate, E = apoenzyme. Normally
decarboxylation occurs to produce GABA however, a small fraction of the
time the E-PLP-G complex may dissociate resulting in progressive
Of- PCP
inactivation in the absence of PLP. In the presence^the reaction rate
remains constant. ATP competes with PLP for the enzyme although this
competition is overcome by high PLP concentrations. See text, Section 7
for discussion.
Figure 7.6. A kinetic model proposed for the-decarboxylation of
glutamate by GAD (from Bayon e£ al 1977(b))
It is postulated that GAD possesses a free PLP dependent and free PLP
independent catalytic activity. In the latter case PLP is very tightly
bound to the catalytic site. See text, Section 7. for discussion.
SA = glutamate-PLP Schiff's base, A = free PLP, S = free glutamate,
P = reaction products, E = apoenzyme, Ea = enzyme with free PLP
independent catalytic activity
Figure 7.7. A hypothetical kinetic model for the °<-decarboxylation of
glutamate by GAD
Normally decarboxylation occurs to produce GABA however, a small
fraction of the time a "mistake" may occur resulting in the inactive
E-PMP complex. Exogenous PLP, possibly by transamination could cause
regeneration of PLP at the active site. See text, Section 7.
for discussion. PLP = pyridoxal phosphate; PMP = pyridoxamine
phosphate; G = glutamate.
E-FLP + G N E—FLP—G—> E-PEP ,+ GAP A + COg
PEP
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concentrations of glutamate. However, evidence presented in this section
suggests that PLP may not readily dissociate from GAD under physiological
conditions. An alternative mechanism which would fit the observations
made here and be compatible with those made by other groups (Miller e_t a_l
1978; Seligmann et al 1978; Martin e£ al^ 1980) is outlined in
Figure 7.7. Briefly, the PLP would remain tightly bound to the enzyme
throughout the reaction by virtue of strong interactions involving the
phosphate group, and the methyl group (Snell 1970) irrespective of the
glutamate concentration. This raises the question of why, if PLP
never dissociates from the enzyme, exogenous PLP is necessary to maintain
activity.
Figures 7.1 and 7.2 show that even in the absence of PLP the
inactivation of the enzyme is relatively slow. If the inactivation
were due to the loss of cofactor at each turnover of the enzyme,
it would be expected that enzyme inactivation would be much more rapid.
The data is more indicative of the cofactor slowly but progressively
becoming unavailable.
One possible explanation is as follows. Figure 7.8 shows a schematic
diagram of ^.-decarboxylation of an amino acid. GAD catalyses the
^-decarboxylation of glutamate to produce GABA, in this diagram pathway 1.
However, as the diagram indicates, after decarboxylation the proton
could be added to the pyridoxal carbon atom which would result, after
hydrolysis, in the production of succinic semialdehyde and pyridoxamine,
pathway 2. Presumably pathway 2 must be in some way unfavourable
otherwise GABA and succinic semialdehyde would be produced in equivalent
amounts. However, if for some reason occasionally a "mistake" was made
this would result in the formation of pyridoxamine phosphate which would
be tightly bound to the enzyme by virtue of its phosphate and methyl
groups and would result in slow, progressive inactivation in the absence
of added cofactor since the pyridoxamine phosphate at the active site
would preclude further decarboxylation.
Transamination with exogenous PLP might be a means of regenerating
PLP at the active site without dissociation of the cofactor. Such a
transamination might be catalysed enzymatically however, non-enzymatic
transamination will occur readily at neutral pH (Snell 1958) which















Figure 7«8 Schematic diagram showing otdecarboxylation of an
amino acid. See section 7 .h- for discussion.
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Inhibition of GAD by ATP can readily be incorporated into this model.
It could prevent regeneration of PLP either by inhibiting an enzyme
catalysed transamination or by binding to GAD and either blocking the
active site or causing a conformational change so that the active site
becomes inaccessible.
Although this suggested mechanism is speculative it does fit the
observations, made during these and other experiments (Miller et al
1978; Seligmann et_ aJ 1978) and can be modified to include the
influence of other factors such as ATP. It does not take into account
however, the observations of Bayon et_ ^1 (1977(b)) who proposed two
binding sites with differing affinities for PLP.
Although a number of possible mechanisms for the control of GABA
synthesis have been described, these would appear to be responsible
for control of a basal level of GABA synthesis in response to the general
metabolic state of the cell. It might be thought, since there is no
evidence for specific intracellular storage sites for GABA, that during
periods of increased neuronal activity there might be a specific
mechanism responsible for causing a rapid increase in the rate of GABA
synthesis. Preliminary experiments using mouse brain cytosol suggested
that phosphorylating conditions increased GAD activity (Sze 1978).
These results apparently contradict other observations (Tursky 1970;
Seligmann e_t al 1978; Martin ert al^ 1980) however pretreatment with
2+ ...
5 mM Ca before incubation under phosphorylating conditions suggests
2+
that the activation was Ca -dependent.
Analogy was drawn with tryptophan hydroxylase (tryptophan-5-
monooxygenase EC.1.14.16.4) for which there was evidence of activation
through the action of a cyclic nucleotide-dependent protein kinase.
2+
Subsequently activation of tyrosine hydroxylase by a Ca -dependent,
2+
calmodulin-dependent protein kinase in the presence of Mg /ATP
has been demonstrated (Yamauchi al 1981). There is no further
evidence for such a mechanism for activation of GAD although Miller
2+
et al (1980) have reported a Ca -dependent increase in GAD activity
associated with synaptosomal depolarisation.
2+
A Ca -dependent mechanism of activation of GAD, possibly through
phosphorylation, presents an interesting model for the regulation of
GAD activity enabling a rapid response of increased GABA synthesis on
IOB
stimulation of the neurons. Such a mechanism would link the regulation
2+
of GAD activity, neuronal activity and Ca -dependent release of GABA
(De Belleroche & Bradford 1972; Levy e£ al^ 1973; Redburn et al 1976).
It has also been proposed that coupled synthesis-secretion of GABA
occurs (Tapia &t_ al 1975). This has been linked with the observation
that GAD binds to synaptic membranes and liposomes in the presence of
2+ 2+
Ca (Fonnum 1968; Covarrubias 1978 & 1980). Consequently Ca -
dependent activation of GAD may be involved with coupled synthesis-
secretion rather than depolarisation-secretion of GABA, or both.
It should be possible to reconcile conflicting data to a limited
extent. It is possible that interactions between GAD, glutamate, PLP
and ATP provide a means of controlling the basal level of GABA synthesis
which could maintain ionic inhibition by leakage into the synaptic
cleft (or by coupled synthesis-secretion coupling) and also be involved
in general metabolism through the GABA shunt (see 1.6). In addition
2+
some other factor, for example Ca -dependent phosphorylation, might
be responsible for changes in GAD activity in response to physiological
changes.
The mechanism by which GABA is released into the synaptic cleft
is not known. It is possible that tonic inhibition is maintained
by non-specific leakage of GABA and that coupled synthesis-secretion
represents the mechanism of release in response to depolarisation
2+
with the influx of Ca causing increased association of GAD with the
synaptic membrane resulting in increased synthesis and release.
Much of this discussion has been speculative based on a limited
amount of evidence. However, strongly illustrated is the lack of any
strong, unequivocal evidence in favour of a particular control mechanism
for GAD. The in_ vivo evidence is contradictory (undoubtedly due to
the complexity of the tissue and difficulties associated with the
compartmentalisation of GABA metabolism) and most of the in. vitro
evidence has been obtained using crude, often unphysiological conditions,
where any interactions or factors affecting enzyme activity cannot
be adequately predicted, monitored or controlled. A consequence of
this is ambiguous or contradictory results which may simply be the
result of differing tissue preparation or buffer conditions. In addition
the use of unphysiological buffers and concentrations can make it




8.1.1 Double immunodiffusion (Ouchterlony Technique)
Noble agar, 2% (w/v) in water, was mixed 1:1 (v/v) with 0.1M sodium
barbitone buffer which was adjusted to pH 8.4 with 1M HC1 and contained
a
0.1% (w/v) sodium azide as^bacteriostat (Dawson et_ al^ 1979). This was
stored at 4°C until use. The agar was melted in a boiling water bath
and applied to clean glass slides (or plates), which were on a levelling
table to ensure an even depth of agar throughout. The agar was applied
using a warm pipette, 2 ml per slide (2.6 cm x 7.6 cm) and 14 ml per
glass plate (8.2 cm x 8.2 cm). Seepage of kolten agar under the slide
or plate was prevented by placing them on small washers (1 mm deep).
The pattern was cut in the agar using a template. The samples and
appropriate antisera were applied to the wells, 2.5 jil per well when
using the small glass slides, 5 ^jul per well when using the glass plates,
and the slides or plates placed in a sealed moist chamber and left for
24 hours at room temperature for the precipitin arcs to develop.
8.1.2 Washing and staining immunodiffusion plates
Unprecipitated protein was removed by washing the plates in 0.9%
(w/v) sodium chloride (containing 0.1% sodium azide) for 48 hours at
room temperature. The sodium chloride was changed after 24 hours.
Salt was removed from the agar by washing in distilled water (containing
0.1% sodium azide) for 48 hours, at room temperature, with 1 change
after 24 hours. The agar was dried down by laying a piece of wet
Whatman number 1 chromatography paper over the agar and leaving at
room temperature overnight or placing in an oven at 37°C. When the
process was complete the paper was dampened with distilled water and
peeled off. Any paper still adhering to the agar was removed using
a wet, soft bristled brush.
The plate was soaked in 2% (v/v) acetic acid for 10 minutes and
the precipitated protein stained by immersing the plate for 10 minutes
in 0.5% (w/v) amido black in methanol-glacial acetic acid (<3:1 v/v).
To destain the plate was washed in methanol-glacial acetic acid
(9:1 v/v) until the background was clear then dried in an oven at 37°C.
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8.1.3 Preparation of solid phase antibody
Oxidation of the gel
Sephacryl S300 (Superfine), 15 ml settled volume, was washed in
50 ml 0.1M sodium acetate containing 5 mM sodium periodate, pH 5,
in a glass, stoppered tube. Following end-over-end mixing for 1 hour
at room temperature 5 ml 10% (v/v) glycerol was added to utilise the
excess periodate and the slurry washed for a further 1 hour. The gel
was then washed with 2 1 0.1M sodium bicarbonate pH 9.
Coupling reaction with sheep anti-mouse-immunoglobulin immunoglobulin G (IgG)
Oxidised Sephacryl S300, 15 ml settled volume, was resuspended
in 20 ml of a protein solution (18% sodium sulphate IgG fraction from
sheep serum), protein concentration between 5 and 8 mg/ml. The suspension
was left, end-over-end mixing, at room temperature for between 16 and
18 hours. The uncoupled protein was removed by filtration.
Reduction with sodium borohydride
The coupled solid phase antibody was resuspended in 50 mM phosphate
buffered saline, pH 7.5, allowed to settle for 30 minutes and the
supernatant removed. The solid phase antibody was then resuspended in
phosphate buffered saline to a final volume of 100 ml and 500 mg
sodium borohydride added, with stirring. The slurry was left, with
intermittent stirring, for 30 minutes at room temperature.
Following reduction the solid phase antibody was washed twice with
phosphate buffered saline then 5 times with 0.25M Tris HC1, pH 8.5,
containing 1% Tween 20 and 2% horse serum. The settled gel, 15 ml,
was resuspended in 20 ml 0.25M Tris HC1, pH 8.5, containing 1% Tween 20,
2% horse serum and 0.01% sodium azide and stored at 4°C until use.
8.1.4 Assay for anti-GAD activity
A two step assay method to detect anti-GAD antibodies was developed.
The GAD activity in cytosol obtained from whole chick brain was removed
by double antibody precipitation using solid phase anti-mouse antibody.
Any residual GAD activity was detected using a radiometric GAD assay
essentially as described in Section 4.1.2.
Preparation of chick brain cytosol
One three week old chick was decapitated, the brain rapidly removed
and homogenised, 1:3 (w/v) in ice cold 100 mM potassium phosphate buffer
containing 1 mM AET and 0.1 mM PLP, pH 7.2. The homogenate was
centrifuged at 100 000 g , 4°C for 1 hour and the resulting cytosol
cLV
used as a source of GAD activity.
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Figure 8.1 Schematic diagram showing the manner in -which sheep
antj-mouse-rimiimndglobiilin G was coupled to Sephacryl S3QQ. See text
section 8.1 .3« for details.
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Double antibody precipitation
Equal volumes (20 ^il) of cytosol and the sample to be tested (mouse
antiserum, medium taken from wells or flasks containing hybrid cells,
ascites fluid) were mixed in an Eppendorf pot containing 5 p.1 foetal
calf serum. After 30 or 45 minutes at room temperature 20 pi of well
mixed, solid phase anti-mouse antibody was added (see Section 8.1.3).
The samples were left at room temperature for a further 30 or 45 minutes
with gentle intermittent shaking. (Care must be taken to ensure that,
whilst shaking is not vigorous or prolonged enough to cause "frothing"
which inactivates the enzyme, the beads are kept evenly dispersed in
the protein solution.) The samples were then centrifuged for 10 seconds
using a Beckman microfuge and 5 pi samples withdrawn from the supernatant
for assay (in triplicate) for GAD activity.
The controls used for the assay differed slightly depending on the
source of the sample assayed and will be noted in the experimental
procedure for the individual experiments.
In early experiments problems were encountered due to protease
activity in the chick brain cytosol during incubation at room temperature
which led to highly variable results. The most effective method of
counteracting this activity was to add a small amount of foetal calf
serum which contains several protease inhibitors (see Discussion).
8.1.5 Production of monoclonal antibodies to GAD
8.1.5.1 Tumour cell line
The parent tumour cell line used was a Balb/c tumour cell line
X6 3NS-1. This cell line lacks the enzyme hypoxanthine (guanine)
phosphoribosyl transferase (H(G)PRTase EC.2.4.2.8) and therefore
cannot survive in HAT (hypoxanthine, aminopterin, thymidine) selective
medium (Littlefield 1964).
8.1.5.2 Media
The parental cell line was maintained in stationary suspension
5 6
cultures (cell concentration between 10 and 10 /ml) in NS-1 medium
which is RPM1-1640 medium containing 2 mM L-glutamine, 1 mM sodium
pyruvate (sodium pyruvate MEM) , 10% foetal calf serum and antibiotics,
500 units streptomycin and 500 units penicillin per 500 ml medium.
The fusion of spleen cells with X6 3NS-1 cells was carried out
in serum free NS-1 medium.
U3>
HAT medium is NS-1 medium containing 2% (v/v) of a HAT stock
solution. HAT stock solution consists of 100 ml of a solution containing
38.8 mg thymidine and 136.1 mg hypoxanthine and 10 ml of a solution
containing 1.76 mg aminopterin made up to 2oo ml with double distilled
water.
HT medium is NS-1 medium containing 2% (v/v) of a HT stock solution.
The HT stock solution is HAT stock solution with aminopterin omitted.
All media were sterilised by membrane filtration.
The 35% (w/v) polyethylene glycol solution, approximately 1500
(PEG 1500) was made up fresh each time by adding 0.7 g PEG (sterilised
by autoclaving for 10 minutes at 15 lb/sq. in) to 1.3 ml serum free NS-1
medium containing 10 ul sterile 2M Tris base.
8.1.5.3 Immunisation of mice
Balb/c mice were injected intraperitoneally with 200 pi of a mixture
of partially purified GAD (see Section 5.1) and Freund's complete
adjuvant, 1:1 (v/v). Prior to mixing with adjuvant the GAD solution
was concentrated (see Section 3.3.2) so that the animals each received
approximately 100 pg protein. This primary injection was followed,
3 weeks later, by a second intraperitoneal injection with 100 pi
(approximately 100 pg) partially purified GAD. The mice were then
divided into 2 groups A and B.
Group A
Three weeks after the last injection each mouse was injected
(subcutaneously into several sites) with 300 pi partially purified GAD
(approximately 300 pg protein) and 50 pi Freund's complete adjuvant.
After another interval of 3 weeks each mouse was injected intravenously
with 100 pi partially purified GAD and on the 4th day after injection
the spleen was removed from 1 mouse for fusion, Fusion 1.
Group B
Four weeks after the last injection each mouse was injected
(subcutaneously into several sites) with 250 pi (approximately 250 pig
protein) partially purified GAD and 50 ul Freund's complete adjuvant.
This was followed, at intervals of 3 weeks, by 2 more injections of
100 pi of partially purified GAD, subcutaneously into several sites.
After a further 3 weeks the mice were injected intravenously with
200 pi partially purified GAD and on the 4th day after injection the
spleen was removed from 1 mouse for the fusion, Fusion 2.
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8.1.5.4 Fusion of spleen cells with X63NS-1 cells
This was carried out by an adaptation of the method used by Kennet
et_al (1978).
The spleen was removed aseptically and homogenised gently to give
a cell suspension which was washed twice in serum free NS-1 medium.
After the second wash the supernatant was removed and 5 ml of ice cold
sterile ammonium chloride (0.17M) was added to lyse red blood cells.
Ten minutes later serum free NS-1 was added to a final volume of 25 ml
and the cells pelleted by centrifugation (1000 rpm for 5 minutes).
After a further wash with serum free NS-1 the cells were counted and
the appropriate number of X63NS-1 cells (which had also been washed
twice in serum free NS-1 medium) added. Approximately 10^ X63NS-1
cells were added to between 5and 10 x 10^ spleen cells. The volume was
made up to 25 ml with serum free NS-1 and the cells pelleted by
centrifugation (1200 rpm for 5 minutes).
All the supernatant was removed, the pellet tapped loose and
0.5 ml 35% (w/v) PEG 1500 added and the cells resuspended by swirling
gently. The cell suspension was centrifuged at 700 rpm for between 3
and 5 minutes then 8 minutes after the addition of the PEG 5 ml serum
free NS-1 medium was added, over a period of approximately 2 minutes
without disturbing the pellet. The cells were resuspended, over a
period of between 3 and 4 minutes, by swirling gently so as not to
dislodge the whole pellet at once. After centrifugation at 1200 rpm
for 5 minutes the supernatant was removed and 5 ml HAT medium added
slowly so that the pellet was not disturbed. After 5 to 7 minutes the
pellet was resuspended gently, the volume made up so that there were
2 x 10^ cells/ml and 100 pi aliquots added to each well of 4 Sterilin
(96 well) flat bottom tissue culture plates, onto a macrophage feeder
layer. The feeder cells were freshly harvested peritoneal macrophages
from Balb/c mice which had been plated at 10^ cells/well in HAT medium
the previous day.
The cells were maintained in HAT medium for 14 days and then this
was replaced with HT medium. After the clones had appeared macroscopically
samples of the medium were removed for assay for antibodies to GAD
(see Section 8.1.4). Since the medium had been changed at least twice
before samples were taken no residual antibody, secreted by unfused
spleen cells, remained to give falsdy positive results. After a change
of medium a minimum of 4 days elapsed before medium was removed for assay.
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Any hybrids that secreted antibodies which affected GAD activity
were expanded into 24 well flat bottom tissue culture plates and
subsequently into small, flat bottomed tissue culture flasks holding
approximately 5 ml medium. Cells from one of the hybrids produced
from Fusion 2 (approximately 10^ cells in a volume of 0.5 ml) were
injected intraperitoneally into 7 Balb/c mice 7 days after a primary
injection of pristane. The ascites fluid which was produced was
screened for anti-GAD activity as described in Section 8.1.4.
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8.2 Experimental
8.2.1 Demonstration of anti-GAD activity in mouse serum
8.2.1.1 Inhibition of GAD activity by serum from mice immunised against GAD
Three Balb/c mice were injected intraperitoneally with 250 pi of a
total- '
mixture of partially purified GAD, approximately 125 pgj^protein, and
Freund's complete adjuvant. Eight days later each mouse received 50 pi
partially purified GAD intravenously. Nine days later blood samples were
taken from blood vessels near the eye, the blood allowed to clot and the
serum removed after centrifugation for 5 minutes in a Beckman microfuge.
Equal volumes (15 pi) of chick brain cytosol, prepared as described
in Section 8.1.4, and each of the mouse sera were mixed then left on
ice overnight (approximately 16 hours). The samples were centrifuged
for 5 minutes in a Beckman microfuge, and 5 jil samples of the supernatants
removed for assay for GAD activity as described in Section 4.1.2.
Each GAD assay was performed in triplicate. Controls consisted of
replacing serum taken from mice which had been immunised against
partially purified GAD, ie "immune" serum, with serum from mice which
had not been immunised against GAD, ie "non immune" serum, or with
100 mM potassium phosphate buffer, pH 7.2, containing 1 mM AET and
0.1 mM PLP.
8.2.1.2 Precipitation of GAD activity by a double antibody method
The three mice sera used were the same as those described in the
previous experiment. Chick brain cytosol was prepared as described in
Section 8.1.4.
Four slightly different sets of experimental conditions were used:
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Controls consisted of replacing "immune" serum with "non immune"
serum or potassium phosphate buffer for each set of experimental
conditions. The sheep antiserum to mouse immunoglobulins was added to
precipitate any mouse immunoglobulins in the mouse serum.
After centrifugation 5 pi samples of the supernatants were removed
for assay for GAD activity as described in Section 4.1.2. In addition
the pellets from A and B were resuspended in standard buffer and assayed
for GAD activity. Each assay was performed in triplicate.
8.2.1.3 Precipitation of GAD activity by a double antibody method
using solid phase anti-mouse antibody
Blood samples were taken from a mouse in group A (see Section 8.1.5.3)
10 days after the last intravenous injection. Anti-GAD activity in the
serum was detected as described in Section 8.1.4 however, the incubation
conditions were varied slightly. Incubation A was exactly as described
in Section 8.1.4. Incubation B, 20 pi of a 1/100 dilution of mouse
serum in phosphate buffer was added to the incubation. Incubation C,
20 pi of a 1/4 dilution of solid phase antibody was added to the
incubation. Controls consisted of replacing "immune" serum with
"non immune" serum or phosphate buffer.
8.2.2 Screening for production of monoclonal antibodies against GAD
Samples of medium were taken from wells or flasks containing hybrid
cells and assayed for anti-GAD activity as described in Section 8.1.4.
When very large numbers of samples were involved, equal volumes of
medium, taken from several wells, were combined and a sample of the
mixture assayed. If anti-GAD activity was detected in any of these
"pools", the individual samples were assayed. Controls included
samples of medium from wells which contained hybrids from an unrelated
fusion. Any positive wells were retested several times, usually as
blind tests, included amongst other new samples or media samples taken
from unrelated fusions.
Double immunodiffusion was carried out as described in Section 8.1.1,
with samples from those wells containing hybrids and sheep anti-mouse-
immunoglobulin antiserum to detect immunoglobulins.
Ascites fluid samples taken from mice which had been injected with
hybridoma cells from a positive well were assayed for anti-GAD activity
as described in Section 8.1.4. Controls included ascites fluid from
mice injected with hybridoma cells from an unrelated fusion.
8.3 Results
8.3.1 Demonstration of anti-GAD activity in mouse serum
8.3.1.1 Inhibition of GAD activity by serum from mice immunised against GAD
Table 8.1 shows the effects on GAD activity when chick brain cytosol
was mixed with serum taken from mice immunised against GAD. Section 8.2.1.1
contains experimental details.
The results shown in Block A indicated that serum from mice 1 and 2
contained anti-GAD antibodies whereas serum from mouse 3 contained
little or no anti-GAD activity. However, when the experiment was
repeated exactly, Block B, only the serum from mouse 2 showed any
anti-GAD activity.
The variability in results which occurred when the experiment was
performed in this manner could be attributed to the presence of soluble
antigen-antibody complexes which had retained enzyme activity. Although
the mouse serum contained anti-GAD activity the mice were not highly
immune since a 10 fold dilution of the serum was sufficient to reduce
anti-GAD activity to an undetectable level. Consequently it is possible
that these incubations were approaching antigen excess so that there
was incomplete lattice formation and therefore a different proportion
of the GAD activity was precipitated when the experiment was repeated.
The results might be interpreted as follows. The serum from mouse 1
and 2 contained anti-GAD antibodies, although the serum from mouse 2
may have had a higher titre since the effect proved to be reproducible
whereas mouse 1 may have had a lower titre and in the second experiment
no antigen-antibody complexes precipitated due to antigen excess.
This could have been caused by using chick brain cytosol which had a
slightly higher protein concentration. Serum from mouse 3 seemed to
contain little or no anti-GAD activity.
Double immunodiffusion of samples of serum from the three mice
versus partially purified GAD did not result in the formation of precipitin
bands. However, it is possible that this might be the result of using
an unconcentrated sample of antigen (partially purified GAD from G200
peak fractions). Consequently the amount of protein in the antigen
wells, 1 p.g or less, would be insufficient for GAD to be detected by
this technique.
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Table 8.1. Inhibition of GAD activity by serum taken from mice
immunised against GAD
A B
GAD activity % buffer % non immune % buffer % non immune
control serum control control serum control
Mouse 1 58 62 86 96
Mouse 2 51 54 53 59
Mouse 3 85 90 91 100
The table shows the GAD activity which remained after chick
brain cytosol was mixed with serum taken from 3 mice. Experimental
conditions are described in Section 8.2.1.1. Block A and Block B
represent identical experiments. GAD activity is expressed as a
percent of that in the buffer control and as a percent of the GAD
activity in the non immune serum control.
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8.3.1.2 Precipitation of GAD activity by a double antibody method
Table 8.2 shows the GAD activity which remained in chick brain
cytosol after double antibody precipitation using serum from mice
immunised against GAD and sheep anti-mouse-immunoglobulin antibody.
The GAD activity in the pellets, which were resuspended in standard
buffer, was also determined. A, B, C and D represent four slightly
different experimental conditions with regard to temperature and the
length of time allowed for antigen-antibody complexes to form and
to precipitate. Experimental details are contained in Section 8.2.1.2.
There was no marked difference in the percentage activity remaining
in the supernatant whether the GAD-anti GAD complex was allowed to
form at 25°C for 1 hour or on ice for 3 hours, columns A and B,
Table 8.2. Similarly, there was no marked difference in the results
whether the anti-GAD-anti-mouse-immunoglobulin complex was left to
form for 2 hours or overnight, columns C and D.
The results again indicate that serum from mouse 2 contains the
highest anti-GAD activity. However, in this experiment the sera from
mice 1 and 3 seem to contain similar amounts of anti-GAD activity
whereas in the previous experiment serum from mouse 3 did not appear
to contain any anti-GAD activity.
A possible reason, as suggested for the previous experiment, might
be antigen excess which prevented lattice formation and hence precipitation
in the absence of a second antibody. The antigen: antibody ratio could
have been greater when serum from mouse 3 was used than when serum from
mouse 1 was used. Consequently there was no indication of any anti-GAD
activity. In the presence of a large excess of the second antibody
any mouse immunoglobulin would be precipitated so that the effects of
only a small concentration of the first antibody would be detected.
Whereas, for mouse 2 when the percent GAD activity which remained
in the supernatant was added to the percent GAD activity in the pellet,
the value was approximately 100%, this did not prove to be the case for
mice 1 and 3. A possible reason might be different antibody specificities,
both of the first and second antibody. Data from this and the previous
experiment suggest that although there are anti-GAD antibodies in the
serum from mice 1 and 3, interaction with GAD does not prevent enzyme
activity. Different combinations of antibody specificity however, might
result in the blocking of enzyme activity upon addition of the second
antibody (sheep anti-mouse-immunoglobulin antibody) in the case of serum
from mice 1 and 3 but not with serum from mouse 2.
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Table 8.2. Precipitation of GAD by a double antibody method
% GAD activity
A B C D
Mouse 1 28 36 32 33
(33) (13)
Mouse 2 18 19 ND ND
(81) (88)
Mouse 3 43 36 25 33
(17) (5)
The table shows GAD activity which was not precipitated from
chick brain cytosol. Experimental conditions are described in
Section 8.2.1.2. GAD activity is expressed as a percent of that
in the buffer and non immune serum controls. Figures in brackets
represent the GAD activity in the pellets expressed as a percentage
of the controls. ND = not determined.
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The results described in these two experiments, in addition to the
fact that it only proved possible to demonstrate anti-GAD activity
using undiluted serum, suggested that although injection of partially
purified GAD had provoked an immune response, the titre of anti-GAD
antibodies was very low indeed.
8.3.1.3 Precipitation of GAD activity by a double antibody method using
solid phase anti-mouse antibody
Table 8.3 shows the effects of reducing the concentration of mouse
serum and the solid phase anti-mouse antibody. When the mouse serum was
diluted 100 fold, the amount of GAD precipitated was reduced as shown by
a 29% increase in the enzyme activity which remained in the supernatant.
This demonstrated that the amount of solid phase antibody added was
adequate to precipitate all the mouse immunoglobulin present in this
sample of antiserum. If the amount of solid phase antibody added had
been inadequate, a dilution of mouse serum would have resulted in
increased precipitation of GAD since all, rather than a percentage,
of the mouse immunoglobulins would be precipitated. Similarly, the
four fold dilution of solid phase antibody would have resulted in a
much higher percentage of unprecipitated GAD. However, anti-GAD activity
was still demonstrable using a 100 fold dilution of mouse serum which
indicates that the antibody concentration was higher than previously.
8.3.2 Screening for production of monoclonal antibodies against GAD
8.3.2.1 Pusion 1
From this fusion, using the spleen from a mouse in group A, 3% of
the wells seeded contained hybrids. Samples of medium taken from these
wells were tested for anti-GAD activity. In addition double immunodiffusion
versus sheep anti-mouse-immunoglobulin antibody was carried out to
determine the presence of immunoglobulins in the medium (see Section 8.2.2).
The results are shown in Table 8.4. The hybrids were screened again
for anti-GAD activity 5 days after the medium had been changed with
very similar results.
The medium from well 12 apparently contained quite a high concentration
of anti-GAD activity since a 100 fold dilution of the medium more than
doubled the amount of precipitation. In addition there was a very
strong precipitin band produced by double immunodiffusion indicating a
high immunoglobulin concentration. The cultures were expanded into 24
well flat bottom tissue culture plates however, during this procedure
the cultures became contaminated (either bacterial or fungal contamination)
and the cells were lost.
I 23>
Table 8.3. Precipitation of GAD by a double antibody method using
solid phase anti-mouse antibody
Undiluted serum and
undiluted solid phase









The table shows the effect on the precipitation of GAD when
the concentration of mouse serum or solid phase anti-mouse antibody
was varied. The experimental conditions are described in Section 8.2.1.3,
GAD activity is expressed as a percentage of the activity in the controls,
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Table 8.4. Screening of hybrids from fusion 1 for anti-GAD activity
% GAD activity „ ...
——— Prpnnifin prr
Well no. Undiluted 1/100 dilution after immunodiffusion
1 78 95 Tr
2 91 73 -
3 100 70 -
4 71 91 Tr
5 69 76 -
6 90 71 -
7 80 67 ++
8 100 87 -
9 80 84 -
10 76 84 ++
11 61 81 -
12 64 30 +++
Samples of media taken from each well containing hybrids was
assayed for anti-GAD activity as described in Section 8.1.4. Double
immunodiffusion was carried out by the Ouchterlony method as described
in Section 8.1.1. GAD activity is expressed as a percentage of the




From this fusion, using the spleen from a mouse in group B, 20% of
the wells seeded contained hybrids. Samples of medium taken from these
wells were tested for anti-GAD activity. Table 8.5 shows the results
of the initial tests. Since, in the first instance, a large number of
samples were involved several were combined together for assay as
described in Section 8.2.2.. When samples of medium from the positive
"pools" (those where enzyme activity was reduced to 70% or less)
of wells 1 to 58 were assayed individually the medium from well 54
contained the most anti-GAD activity, reducing enzyme activity to 52%,
followed by well 45 at 59% and well 42 at 69%.
At this stage the cultures were expanded into 24 well tissue
culture plates during which contamination occurred resulting in the
loss of many of the hybrids including number 54. Hybrids 59 to 77
were lost before they could be retested. Of those positives which
had been tested individually only 42 and 45 remained. Since there
was no opportunity to test the majority of the positive hybrids by
diluting the medium before determining anti-GAD activity it is not
known whether hybrid 54 had secreted the most anti-GAD activity or
whether one of the apparently less positive hybrids would prove to
have secreted more anti-GAD antibody.
Table 8.6 shows the results when double immunodiffusion was
carried out with samples of medium from each well and sheep anti-mouse-
immunoglobulin antibody. Control wells contained mouse serum taken
from a mouse which was hyperimmune to an unrelated antigen. It is
interesting that with expansion into larger wells hybrids 42 and 45
secreted higher concentrations of immunoglobulin than previously.
This coincides with an increase in anti-GAD activity (see Figure 8.2) .
Figure 8.2 shows the effects on the amount of anti-GAD activity
present in the medium as hybrids 42 and 45 were expanded from 96 well
to 24 well tissue culture plates and finally to small, flat bottomed
tissue culture flasks which hold approximately 5 ml medium. Although
the results are not shown test number 3 and any subsequent tests were
also carried out using a 100 fold dilution of medium. The reduction
in GAD activity obtained was not markedly different from that obtained
using undiluted medium.
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Table 8.5. Screening of hybrids from fusion 2 for anti-GAD activity
Well numbers % GAD activity
1+ 2+ 3 90
4+ 5+ 6 77






























Equal volumes of medium from each well was combined as shown in
the table and assayed for anti-GAD activity as described in Section 8.1.4.
GAD activity is expressed as a percentage of the control values.
Each assay was performed in triplicate.
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Table 8.6. Double immunodiffusion of media samples from wells
containing hybrids versus sheep anti-mouse antibody














Mouse serum +++ ++
1/10 mouse
serum ++ +++
Double immunodiffusion of samples of media from wells containing
hybrids versus sheep anti-mouse-immunoglobulin antibody and versus a
1/10 dilution of sheep anti-mouse-immunoglobulin antibody. Samples
from all the wells were assayed but only those where precipitation
occurred have been included. * indicates samples taken at a later
stage of the procedure after the cultures had been expanded to 24
well plates.
MS
1 2 3 h 5 123
Test number Test numher
Hybrid b5Hybrid 1±2
Figure 8.2 The effects on anti-GAD activity as cultures were
expanded from 96 well tissue culture plates to 5 nil tissue
culture flasks. Tests 1 to 3 were carried out in chronological
order. Test medium from 96 well tissue culture plates; Test 2,
medium from 2b well tissue culture plate; test 3, medium from 2l±
well tissue culture platcjTests li and 5, successive tests on
medium from 3 ml flask.
See section 8.2.2. for experimental details. GAD activity is expressed
as a percentage of the control values.
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Mouse1




1/105/10 79 73 73 8263 68 69 97
58
Mouse3
Undil.1/105 69 7471 65 100
65 60 62
Mouse45 Undil, 67 69 59
Undil. 72 100 72 64 89 73 55
Thetables owsGADctivityremain ngft rpre ipitationbydou lntib dm hodwi hs i s
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There was an initial increase in anti-GAD activity immediately
after the transfer to the 24 well tissue culture plate however, as the
hybrids grew, anti-GAD activity declined. Whereas hybrid 42 was expanded
into flasks, the cells of hybrid 45 stopped dividing before there was
a sufficient number to transfer to flasks. From Figure 8.2 it would
appear that both hybrids were losing their ability to secrete anti-GAD
antibody. However, once antibody forming hybrids have been identified
it is not unusual for them to lose the ability to secrete antibody as
they are grown up (Yeldon et £l_ 1978) . This could be due to chromosome
loss at cell division (Margulies et_ al^ 1976; Milstein et_ al_ 1976;
Kohler 1980) which might also provide an explanation for the loss of
the ability to divide of the cells of hybrid 45. An alternative
possibility is that if the hybrid producing anti-GAD antibody is one
of a number of hybrids in a given well it may be overgrown by the others.
Cells from hybrid 42 were injected intraperitoneally into 7 mice
and samples of ascites fluid taken over an 8 day period. Two of the
mice died after only two samples had been taken from each. When these
undiluted samples were tested for anti-GAD activity enzyme activity was
reduced by 26% and 24%, 0% and 22%. Table 8.7 shows the results when
ascites fluid samples from the other 5 mice, taken on the days shown,
were assayed for anti-GAD activity. A number of the samples were
assayed at more than one dilution and ideally all the samples should
have been assayed over a range of dilutions to ensure the optimum
conditions for complete precipitation. However, this proved to be
impractical. In those cases where more than one dilution of the ascites
fluid was assayed, the dilution did not result in a marked increase in
the precipitation of GAD activity.
The results indicate that the ascites fluid from some of the mice
contained anti-GAD antibodies (mice 5, 4 and 3 seemed to have the best




Initially it had been intended to raise antibodies to pure chick
brain GAD in the conventional manner by immunising rabbits and using
the serum as a source of-anti-GAD antibodies. Monoclonal antibodies
however, eliminate the necessity of using a pure protein as immunogen
since cell lines synthesising monoclonal antibodies may be derived
using an immunogen which is not pure. The multiple components of the
heterogeneous cell population which will be produced by the fusion
between the spleen and myeloma cells can be resolved by cloning.
A major problem proved to be producing immunity in the mice.
Although repeated injections with partially purified GAD did result
in anti-GAD activity in the serum, the antibody titre was obviously
quite low (see Table 8.3). This suggests that GAD which is a soluble
protein located mainly in the cytosol is not particularly immunogenic.
Under certain conditions GAD does bind to membranes (see Introduction)
but the purification procedure used selected for soluble rather than
membrane bound GAD. The mice which had demonstrated the highest
degree of immunity, on the basis of the assay for anti-GAD activity,
were selected for each fusion.
Antibodies to mouse, rat, catfish and bovine brain GAD (Saito
et_ al_ 1974; Maitre et_ al_ 1978(b); Su et_ al_ 1979; Wu 1982) have been
raised by immunising rabbits with the purified protein. There were
no reports of any difficulties in causing hyperimmunity in rabbits
which may perhaps be attributed to differences in immune responsiveness
between rabbits and mice.
During the initial stages of the development of an assay for
anti-GAD activity the assays were left overnight on ice for the
immune complexes to form (Saito et_ al^ 1974) however, as can be seen
from Table 8.2 this proved to be unnecessary.
Since the primary antigen-antibody complex is established within
seconds (Tengerdy &: .Small 1966) and, at room temperature, the final
polymerised antigen-antibody complex forms within about 30 minutes
(Hughes-Jones et_ al^ 1963) the incubation conditions were revised
(see Section 8.1.4). However, the increase in temperature resulted
in marked, unspecific losses in enzyme activity which were attributed
to protease activity. When the whole procedure had been carried out
on ice any protease activity had been minimal and as a consequence
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overlooked. The addition of a small amount of foetal calf serum prevented
this unspecific loss of enzyme activity. Serum contains a number of
protease inhibitors many of which act on serine proteases which are
the most active proteases at the pH and under the buffer conditions
used in this study (Barret 1977). Although a number of the protease
inhibitors in serum are quite specific in their action, several have
quite a wide range of action and one in particular oC-2 macroglobulin
will inhibit the majority of proteases (Starkey & Barret 1977).
Although the first fusion (Table 8.4) was not particularly successful
as regards numbers of hybrids, one of those produced did appear to
secrete quite a high concentration of anti-GAD antibody. When undiluted
medium from the well was tested the GAD activity in chick brain cytosol
was reduced to 64%. When the medium was diluted 100 fold, GAD activity
was reduced to 30%. When undiluted medium was used the second antibody
was not sufficient to precipitate all the immunoglobulin secreted by
the cells. When the medium was diluted a higher percentage of the
antibody present was precipitated.
Double immunodiffusion experiments confirmed that there was a high
concentration of immunoglobulins present. This is not a particularly
sensitive method of determining the presence of immunoglobulin since lack
of precipitation does not necessarily mean that the cells are not
secreting immunoglobulin, just that the level is too low for precipitation
to occur or to be detectable. However, more sensitive methods such as
radioimmunoassay or enzyme linked immunoassay require pure antigen or
pure antibody.
Fusion 2 (see Table 8.5) resulted in a much higher percentage of
hybrids than Fusion 1, a number of which seemed to contain anti-GAD
activity. Unfortunately, due to contamination a large number of the
hybrids were lost and only two of those which appeared to secrete anti-GAD
activity remained. As these two hybrids were expanded the rate of cell
division of hybrid 45 showed down and eventually cell division ceased.
This was accompanied by a decrease in the ability to produce antibodies.
It was suggested that the loss of the ability to divide might have been
caused by chromosome loss at cell division.
There are a number of factors which might contribute to the loss of
the ability to secrete antibodies by hybrids apart from those already
mentioned, namely chromosome loss or overgrowth by other more rapidly
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dividing cells. It is possible that as the cells divide the hybridomas
might generate variants whose affinity might have changed and which might
overgrow the original hybrids (Cook & Scharff 1977) .
Even if the hybrid has been cloned there may be sudden, gradual
loss of the ability to produce antibody presumably due to chromosome loss
(Yeldon e_t al 1978) . In addition subclones of apparently stable hybrid
cell lines were isolated which produced only 50% of the antibody and
overgrew the other cells which eventually died.
It is interesting that there was a considerable increase in the
concentration of immunoglobulins in the medium after hybrids 42 and 45
had been expanded into 24 well tissue culture plates. This coincided,
particularly in the case of hybrid 42, with an increase in anti-GAD
activity. However, anti-GAD activity subsequently started to decline
in both well 42 and 45. At this stage hybrid 45 ceased to grow and
hybrid 42 was expanded into flasks where the gradual decrease in anti-GAD
activity in the medium continued, although the immunoglobulin
concentration remained high. This might indeed be indicative of
overgrowth of the hybrid secreting anti-GAD activity by other
immunoglobulin secreting cells. In retrospect greater success might
have been achieved if the cultures had not been expanded to the same
extent but had been cloned at an early stage.
Cells from hybrid 42 were injected into mice in an attempt to "boost"
the anti-GAD activity. Any ascites tumours formed from hybrid cells
secreting anti-GAD antibody would in turn secrete large amounts of the
homogeneous antibody. Although this would be contaminated by
immunoglobulins from ascites tumours formed from other antibody
secreting cells and to a certain extent by the immunoglobulin repertoire
of the recipient mouse, in the event of a good response in terms of
anti-GAD activity, the antibody, although not homogeneous might have
proved useful. For example in the preparation of an immunoadsorption
column for purification of GAD or in an attempt to identify which of
the protein bands in a polyacrylamide gel represented GAD.
SECTION 9: REGIONAL VARIATION IN GABA METABOLISM IN CHICK BRAIN
9.1 Methods
9.1.1 Histological techniques
9.1.1.1 Preparation of frozen sections
Whole chick brains were placed on microtome chucks, covered with
embedding medium (Tissue Tek II O.C.T. compound) and quenched in liquid
nitrogen. The chucks were kept, usually overnight, at -20°C before the
tissue was sectioned to allow temperature equilibration. Transverse
frozen sections (20 ^urn) were cut in a Pearse-Slee cryostat at -20°C,
thawed onto glass slides and allowed to dry, at 4°C if the sections
were to be used for histochemistry, otherwise under a stream of warm air.
9.1.1.2 Staining sections
Tissue sections were stained with cresyl violet for examination
of tissue morphology. Cresyl violet binds to RNA and stains the cell
bodies of neurons (nucleus and cytoplasm which is rich in RNA-containing
Nissl granules) and to a lesser extent glial cells (nuclei only).
Cresyl violet (0.1 g) was dissolved in 10 ml absolute ethanol,
made up to 75 ml with double distilled water and stirred for 24 hours.
A 9 ml aliquot of this stock solution was added to 100 ml 0.1M acetic
acid which had been corrected to pH 4.5 with NaOH.
The slides were immersed in stain for 30 minutes, washed quickly
in distilled water and the sections dehydrated in alcohol by immersing
for 10 seconds in 75%, 95% and absolute ethanol. After clearing in
xylene the sections were mounted in DEPEX mounting medium. The sections
were examined using a Vickers M17 fluorescence microscope fitted with
a 35 mm camera and automatic exposure meter. Photographs were taken
using Ilford Pan F ASA 50 black and white film.
9.1.1.3 Histochemical localisation of GABA-T
The histochemical technique used to demonstrate GABA-T activity
was that described by Hyde and Robinson (1976).
9.1.1.3.1 Perfusion fixation of chick brain
Chick brain tissue was fixed by vascular perfusion with a mixture
of 2% formaldehyde and 2% glutaraldehyde, 1:1 (v/v), in Tris HC1,
pH 7.5, at 4°C.
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Anaesthetised chicks (usually 14 days post hatch) were perfused by
intracardial injection into the ventricle followed by cannulation of the
ascending aortae. During perfusion the descending aorta was clamped.
Perfusion pressure was obtained using a gravity feed system with the
reservoir containing the fixative maintained at 150 cm. The tubing
was primed with ice cold saline before it was attached to the reservoir.
After perfusion the brains were excised, placed on microtome chucks
and frozen rapidly using liquid nitrogen. The tissue was sectioned as
described in Section 9.1.1.1.
9.1.1.3.2 Histochemical GABA-T assay
GABA-T was localised by coupling the oxidation of succinic
semialdehyde (SSA), a product of the GABA-T reaction, by succinic
semialdehyde dehydrogenase (SSADH) with the reduction of nitroblue
tetrazotium (Nitro-BT) to form an insoluble blue formazan (Nitro-BTI^)
at the site of the reduction. The reaction which takes place is,
PARA—T
o<-oxoglutarate + GABA glutamate + SSA
N
SSA + NAD+ + H„0 SSADH succinate + NADH + H+z
NADH + H+ + PMS , ... ^PMS, + NAD+(oxid) (red)
PMS. + Nitro-BT >Nitro-BTH„ + PMS.
(red) 2 (oxid)
(PMS = phenazine methosulphate).
The sections were incubated in the following medium for 30 minutes
at 37°Cj Tris maleate (0.1M), pH 7.6 containing 50 mM GABA, 25 mM
2.-oxoglutarate (disodium salt), 1.5 mM NAD+, 1.2 mM Nitro-BT, 0.16 mM
PMS, 20 mM sodium malonate, 1 mM sodium cyanide, 124 mM sodium chloride
and 5 mM magnesium chloride.
Malonate is present in the medium to prevent succinate dehydrogenase
activity and sodium cyanide as a respiratory inhibitor. Control sections
were incubated in medium containing A0AA (5 mg/ml), a GABA-T inhibitor
(Wallach 1961). After incubation the slides were washed briefly in ice
cold double distilled water,dehydrated in alcohol, cleared in xylene
and mounted in DEPEX as described in 9.1.1.2. Sections were examined
and photographed as noted in 9.1.1.2.
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Rubenstein and Roberts (1967) demonstrated that the formazan
precipitation is specific and, except at very high enzyme activity,
proportional to GABA-T activity in brain sections.
Alternate sections were stained with cresyl violet as described
in Section 9.1.1.2 for examination of the tissue morphology and
identification of the regions containing GABA-T activity.
9.1.2 Biochemical experiments
Chicks were taken at intervals from the first to the fourteenth
day post hatch and killed by decapitation. Their brains were rapidly
removed and dissected immediately, on ice, into the following regions;
hyperstriatum (HS), ectostriatum (ES) , archistriatum (AS), midbrain (M)
and optic lobes which were divided into the outer tectum (OT) and
inner tectal nuclei (OTN).
The cerebellum and optic lobes were separated from the brain.
The optic lobes were divided, in the transverse plane, using a razor
blade moistened with 0.32M sucrose and the tecta were separated from
the central white matter (see Figure 9.1). The telencephalon (forebrain)
was separatedfrom the diencephalon (midbrain). The telencephalon was
divided into four equal transverse slices using a razor blade moistened
with 0.32M sucrose then further dissected, using a fine scalpel blade,
into hyperstriatum, ectostriatum and archistriatum (see Figure 9.2).
The tissue samples were weighed and each homogenised 1:10 (w/v) in
ice cold 0.32M sucrose.
Samples were taken from each of the homogenates and diluted 1:10
(v/v) with ice cold Krebs-Ringer buffer (see Section 3.6.5) to give a
final homogenate concentration of 1:100 (w/v). These homogenates were
immediately assayed for high affinity uptake of ["^h] GABA as described
in Section 3.6.5.
Half of each of the remaining homogenates, 1:10 (w/v) in sucrose
were kept on ice and the other halves frozen to -20°C whilst the uptake
assays were being carried out. The homogenates which had been kept on
ice, for 45 minutes maximum, were assayed for GAD activity as described
in Section 4.1.2. The frozen homogenates were then rapidly thawed and
assayed for GABA-T activity as described in Section 3.6.4. Protein
concentration was determined by the method of Lowry et_ al_ (1951).
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Figure9.1Schematicdiagramoflater lvi wfchickbr n
Figure 9.2. Schematic diagram of a transverse section through chick brain
to show the relative positions of the forebrain regions analysed.
(See text, Section 9.1.1 )
Posterior plane positions according to Youngren and Phillips (1978).
Abbreviations
AA Nucleus archistriatalis anterior
Ad Archistriatum pars dorsalis












The results obtained when high affinity uptake of [ "^h] GABA and GAD
and GABA-T specific activities were measured in six brain regions,
namely OT, OTN, M, HS, AS and ES (see Section 9.1.2) were combined
together into two histograms, Figures 9.3 and 9.4.
High affinity uptake of [ ~^h] GABA
High affinity uptake of [ ^h] GABA was generally greater in the
optic lobes and midbrain than in the three forebrain regions examined
and declined with age in all regions. This decrease was most noticeable
in OT but there was also a marked decrease in OTN and HS. Although GABA
uptake remained high in M there was still a gradual decrease over
fourteen days. Similarly in AS although high affinity uptake of [^h]
GABA decreased with time this decrease was only slight.
GAD specific activity
GAD specific activity was considerably greater in OT, OTN and M
than in the forebrain regions examined. In OT and OTN GAD specific
activity was approximately 2.5 fold greater. There was a general
decrease in specific activity in OT, OTN and M over fourteen days showing
a similar trend to that obtained for high affinity uptake of [ "^hJ GABA.
However, there was a marked decrease in GAD specific activity on day 3
in these regions. By day 7 specific activity was again at a level
slightly lower than that seen on day 1 and continued decreasing with
age. In HS and AS GAD specific activity did not change greatly with
age remaining at a much lower level than in OT and OTN although the
decrease in specific activity at day 3 was still noticeable. In ES,
after an initial decrease to day 3, GAD specific activity increased
reaching a level, at day 14, similar to that found in the midbrain
and optic lobes on that day.
GABA-T specific activity
GABA-T specific activity was slightly higher in optic tectum than
in the other regions examined although the difference in activity was
not as marked as for GAD. In all regions, except ES, there was a
large peak in GABA-T specific activity at day 3. This had decreased
by day 7 to a level slightly greater than that found at day 1 and
remained constant except in OT where the specific activity increased.
In ES there was no very marked fluctuation in GABA-T specific activity,
although this was higher on days 3 and 7 than on days 1 and 14.
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Figure 9.3. Levels of high affinity uptake of £"^h) GABA and GAD and
GABA-T specific activities in optic tectum (OT) , the tectal nuclei
(OTN) and midbrain (M). See Section 9.2.1.
Experimental details are contained in Section 9.1.2. Enzyme specific
activity (GAD and GABA-T), 1 unit = 1 nmol product/mg protein/hour.






















Figure 9.4. Levels of high affinity uptake of GABA and GAD and
GABA-T specific activities in hyperstriatum (HS), archistriatum (AS)
and ectostriatum (ES). See Section 9.2.1.
Experimental details are contained in Section 9.1.2. Enzyme
specific activity (GAD and GABA-T), 1 unit = 1 nmol product/mg






























































Table 9.1. High affinity uptake of [ 3h] GABA, and GAD and GABA-T
specific activities in the visual system of 14 day old chicks
L3h] GABA uptake GAD GABA-T
Optic tectum 175-47 136 -7 274-6
Tectal nuclei 155-10 132-11 243-10
Midbrain 191-19 126-15 242-26
Hyperstriatum 146-3 77-2 176-36
Archistriatum 188-26 61-5 239-28
Ectostriatum 117-14 144^6 211-25
Values are the means — S .E.M. of 4 determinations. Each
determination was carried out in triplicate. Enzyme specific
activities are expressed as nmol product/mg protein/hr. High
affinity uptake of [ hJ GABA is expressed as pmol GABA/mg
protein/hr. See Section 9.2.1.
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In general high affinity uptake of [ "^h] GABA paralleled GAD specific
activity, i.e. it was higher in those regions, namely OT, OTN and M,
where GAD specific activity was higher and tended to decrease with age
GABA-T specific activity did not follow this pattern since, with the
exception of OT where levels were slightly higher, GABA-T specific
activity was similar in all the regions examined. In all these regions
GABA-T specific activity was very much higher than GAD specific activity.
This difference was particularly noticeable in the two forebrain regions
HS and AS.
Table 9.1 lists the values obtained for high affinity uptake of [ "^h]
GABA and GAD and GABA-T specific activities using the brains from
14 day old chicks.
9.2.2 Histological
Comparison of the sections stained for GABA-T with the corresponding
sections stained with cresyl violet made it possible to identify the
regions with high GABA-T activity. The nomenclature used throughout is
that of Karten and Hodos (1967) . Structures were identified using the
chicken brain atlases of van Tienhoven and Juhasz (1962) and Youngren
and Phillips (1978). Extracts from the atlas of van Tienhoven and
Juhasz (1962) have been included in Appendix 1. It should be noted that
in this study sections were taken in a slightly different plane from
that used by van Tienhoven and Juhasz (see Appendix 1).
The forebrain was diffusely and fairly evenly stained for GABA-T.
It was difficult to distinguish any particular region by the presence
of high GABA-T activity, although a number of discrete, deeply stained
cells were apparent in paleostriatum just where the lateral forebrain
bundle terminates. Comparison between Figures 9.5a and 9.5b shows the
extent to which high GABA-T activity is localised in this region.
In midbrain a number of nuclei could be clearly distinguished by
high GABA-T activity. These were identified as nucleus rotundus,
nucleus ovoidalis (Figures 9.6a and b); nucleus subpraetectalis,
nucleus spiriformis lateralis, nucleus isthmo opticus (Figures 9.7a
and b); nucleus nervi occulomotorii (Figures 9.8a and b).
Whereas nucleus ovoidalis was uniformly and very deeply stained
for GABA-T throughout, nucleus rotundus stained more deeply ventrally.
Discrete deeply stained stained cells can be seen throughout both the
deeply and less deeply stained areas. Nucleus subpraetectalis is
characterised by a cluster of small deeply staining cells whereas the
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Figure 9.5. Transverse sections through chick forebrain at the level
of paleostriatum (pa)
(a) Section stained with cresyl violet for examination of tissue morphology.
(b) GABA-T activity in palestriatum.
See Section 9.1.1 for details of the histological techniques and
Appendix 1 for extracts from a chick brain atlas. Scale bar represents
300 jim. Sections were taken consecutively and were 20 jim thick.
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Figure 9.6. Transverse sections through chick midbrain at the level of
nucleus rotundus (rt) and nucleus ovoidalis (ov)
(a) Section stained with cresyl violet for examination of tissue morphology.
(b) GABA-T activity in nucleus rotundus and nucleus ovoidalis.
See Section 9.1.1 for details of histological techniques and Appendix 1
for extracts from a chick brain atlas. Scale bar represents 300 jum.
Sections were taken consecutively and were 20 p.m thick.
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Figure 9.7. Transverse sections through chick midbrain at the level of
nucleus subpraetectalis (sp) , nucleus isthmo opticus (io) and nucleus
spiriformis lateralis
(a) Section stained with cresyl violet for examination of tissue morphology.
(b) GABA-T activity in nucleus subpraetectalis, nucleus isthmo opticus
and nucleus spiriformis lateralis.
See Section 9.1.1 for details of histological techniques and Appendix 1
for extracts from a chick brain atlas. Scale bar represents 300 jum.
Sections were 20 yum thick.
 
Figure 9.8. Transverse sections through chick midbrain at the level of
nucleus nervi occulomotorii
(a) Section stained with cresyl violet for examination of tissue morphology.
(b) GABA-T activity in nucleus nervi occulomotorii. See Section 9.1.1
for details of histological techniques and Appendix 1 for extracts from a
chick brain atlas. Scale bar represents 300 jxm. Sections were taken
consecutively and were 20 yum thick.
14-8
Figure 9.9 Transverse sections through chick brain at the level of
nucleus isthmi pars magnocellularis (Imc) and Nucleus isthmi pars
parvocellularis, (Ipc).
(a) Section stained with cresyl violet for examination of tissue
morphology.
(b) GABA-T activity in nucleus isthmi pars magnocellularis and
nucleus isthmi pars parvocellularis. See Section 9.1.1. for details of
histological techniques and Appendix 1 for extracts from a chick brain
atlas. Scale bar represents 300 jim. Sections were taken consecutively




Figure 9.10 Transverse section (20 pm thick) through chick optic
lobe. The optic tectum (ot) is deeply stained indicating high GABA-T
activity. v= ventricle. Scale bar represents 15>0 um.
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Figure 9.11 Transverse section through chick optic lobe.The optic
tectum (6t) is deeply stained throughout indicating high GABA-T
activity. In layers I and II, stain is deposited uniformly. In
layer III individual cell bodies can be seen. Sections are 20^um
thick. Scale bar represents 60 |im.
I5I
part of nucleus spiriformis lateralis which is visible is more diffusely
stained. Nucleus isthmo opticus is much less obvious and apparently
composed of larger and generally less deeply staining cells.
Nucleus isthmi pars magnocellularis and nucleus isthmi pars
parvocellularis also stained very deeply. It is interesting to note
that whereas in nucleus isthmi pars parvocellularis the staining is
uniform throughout, in nucleus isthmi pars magnocellularis, discrete
more deeply staining cells can be seen (Figures 9.9a and b).
In the optic lobe the optic tectum generally stained very deeply
indicating very high GABA-T activity, Figure 9.10. In layers I and II
the stain was deposited uniformly whereas in deeper layer III individual
cell bodies, which were deeply, stained could be seen (Figure 9.11).
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9.3 Discussion
The aim of this study was to localise GABAergic neurons in chick
brain with particular reference to the visual system (see Section 1.13)
using two approaches. Firstly to determine biochemically the regional
distribution of GABA metabolism by looking at regional variations in
high affinity uptake of GABA, a mechanism by which GABA can be removed
from the synaptic cleft, (Iversen 1968 & 1971; Iversen & Johnston
1971; Balcar & Johnston 1973; Iversen & Kelly 1975) and of the
enzymes of GABA metabolism, GAD which is the enzyme of synthesis
and GABA-T the degradative enzyme (see Section 1.6). Secondly it
had been intended to use immunocytochemical methods to determine
more precisely the localisation of GABAergic neurons using FITC
labelled antibody to GAD and thin (20 urn) sections of brain.
This was to be compared with the distribution of GABA-T activity
detected histochemically by the method of Hyde and Robinson
(1976) .
In studies concerning regional distribution it is not the absolute
values for the parameters measured, in this case high affinity uptake
of GABA and GAD and GABA-T specific activities, which are significant
but the relative values when comparisons are made with other regions.
This is particularly important in the current study since it has been
shown that there is considerable variation in the specific activities
of a number of neurotransmitter enzymes, including GAD, when chicks
or embryos from different hatches are used (Haywood et_ al_ 1975;
Haywood 1978). Suggested reasons included possible variations in
incubation conditions and different parental hens.
The regional distribution of GAD specific activity (Table 9.1)
obtained using brains from 14 day old chicks was very similar to that
obtained by Vischer et al (1982) using brains from adult pigeons.
By 14 days post hatch it was considered that any variations due to
development would be minimal or absent. Sisken et_ al_ (1961) showed
that GAD and GABA-T specific activity and the concentration of GABA
had reached a constant value by day 10 post hatch.
Vischer e_t al_ (1982) found GAD specific activity to be highest in
paleostriatum, a region of the brain not involved in the visual system.
Of those regions involved in the visual process which were studied GAD
specific activity was reported to be highest and similar in optic tectum,
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nucleus rotundus and dorsolateral thalamus, the latter two being midbrain
regions. In the Wulst (hyperstriatal region) and ectostriatum GAD
specific activity was much lower, less than 50% of the values found in
the other regions.
In this study GAD specific activity in optic tectum, the inner
tectal nuclei and midbrain were similar and approximately twice the
value found in hyperstriatum (Wulst) or archistriatum (see Table 9.1
and Figures 9.3 and 9.4). The results obtained for ectostriatum showed
GAD specific activity to be similar to that in optic tectum whereas
Vischer et^ al_ (1982) found the level more similar to that in hyperstriatum.
A possible explanation for this anomaly may be found in the close
proximity of ectostriatum and paleostriatum (see Figure 9.2).
fc
Contamination of the ec^pstriatal tissue with a small amount of tissue
from paleostriatum, shown to contain high GAD specific activity
(Vischer et_ al_ 1982) during dissection cannot be totally dismissed.
Haywood (1978) showed that during the last six days of incubation
GAD specific activity in five brain regions (optic lobes, anterior and
posterior forebrain roofs, forebrain base and thalamus) gradually
increased. The most significant increase was during the last day of
incubation and first day post hatch when enzyme activity reached a
maximum value. In an earlier study (Sisken et_ al^ 1961) GAD and GABA-T
specific activities and concentration of GABA in optic lobes were studied
from day 7 of incubation to day 17 post hatch. Each parameter was
shown to increase with time, the maximum value for GAD specific activity
being found several days post hatch. At hatching GAD specific activity
was half the maximum value. These results contrast with those shown
in Figures 9.3 and 9.4 which show that GAD specific activity is highest
on day 1 and tends to decrease post hatch, particularly in optic lobes.
The exception to this was ectostriatum where by day 14 GAD specific
activity was very slightly higher than on day 1, though by only 9%.
Different assay systems were used in the two studies which may be
a contributary factor in the conflicting results. The assay used in
this study relied on the measurement of [ ^c] GABA produced from
uniformly labelled [ ] glutamate compared with measurement of
r 14 i
radioactive carbon dioxide released, again using uniformly labelled L CJ
glutamate. Electrophoresis of the reaction products (Section 4.1.3)
showed that GABA was the only remaining radiolabelled product.
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No such check was carried out in the study of Sisken et al (1961)
therefore the production of carbon dioxide, if only in trace amounts,
from other metabolic processes cannot be ruled out. Wilson et al
(1972) found that the ratio of [ ^c] GABAi^^CO^ produced from uniformly
labelled GABA was rarely 1:1, with the production of GABA, on occasions,
10% of the carbon dioxide production.
A problem with using high affinity uptake in neurotransmitter
studies is the location of the active uptake process since glial cells
can also accumulate GABA by a sodium and energy dependent high affinity
mechanism (Henn & Hamberger 1971; Schou & Kelly 1974; Shon & Iversen
1974; Iversen and Kelly 1975). Glial cells should account for little
of the [ ~^h] GABA accumulation in the uptake assay since homogenisation
disrupts glial cells. Although the formation of "gliasomes" during
homogenisation with the capacity to accumulate GABA has been postulated,
the rate of uptake would probably be similar to that of intact glial cells
and therefore relatively slow (Schon & Kelly 1974). By using a short
incubation such as five minutes, in effect only neuronal uptake would
be measured (Schon & Kelly 1975). Experiments carried out in this
laboratory involving subcellular fractionation and also L-2,4-
diaminobutyric acid, an inhibitor of synaptosomal uptake of GABA,
(Schon & Kelly 1974; Iversen & Kelly 1975) suggested that the uptake
measured by this method was indeed predominantly synaptosomal and any
accumulation by glial elements minimal (S. Wilson, personal communication).
High affinity uptake of [^h] GABA declined with age in all the
regions examined. This correlates with the findings of Bondy and Purdy
(1977) who noted that although high affinity uptake of GABA in chick
brain increased during development the peak in activity was at hatching
and subsequently activity declined to a level slightly higher than that
found just before hatching.
There are similarities in the pattern of distribution of high
affinity uptake of GABA and high GAD specific activity. GAD specific
activity is higher in those regions where GABA uptake is greater and
the changes during development generally more pronounced, namely optic
lobe tissue and midbrain. The value for high affinity uptake of GABA
recorded for AS on day 14 (Table 9.1) would therefore appear anomalous.
However, although at a high level, and comparable with 0T, OTN and M
for day 14 values, there was little change in high affinity uptake of
GABA during development (Figure 9.4). A high value for ES was obtained
on day 14.
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In contrast to the similar patterns of distribution of GAD and GABA
uptake there was no such association found between GABA uptake and GABA-T
specific activity which was high in all the regions examined. It was
expected that the distribution of high GABA-T specific activity would
have some similarity to that of high affinity uptake of GABA since
reuptake by inhibitory neurons (Iversen 1968 & 1971; Iversen & Johnston
1971; Balcar & Johnston 1973; Iversen & Kelly 1975) in conjunction
with uptake by glial cells (Iversen & Kelly 1975; Schousboe eit al_ 1977)
seems the most likely mechanism for removing GABA from the synaptic
cleft. In addition high GABA-T specific activity has been shown
histochemically to be present in both neurons and glia (Robinson & Wells
1973). Any regional variation in GABA-T activity could not clearly be
demonstrated biochemically although the levels of activity were perhaps
slightly lower in HS.
Regional variations in GABA-T activity were demonstrated more
successfully using histochemical methods. It would appear that there
is a general "background" level of GABA-T activity throughout chick
brain, although less intense in the forebrain, and that the specific
activity is markedly higher in certain specific cells or structures.
This is consistent with the observation that glial cells contain low
but measureable levels of GABA-T activity accompanied by the ability
to accumulate GABA even in tissue that lacks GABA inhibitory neurons
(Schon et_ al_ 1975) . This could explain why no marked regional variation
in GABA-T activity could be detected biochemically. GABA-T activity
was consistently slightly higher in OT, OTN and M than in the forebrain
regions. Since OT stained deeply for GABA-T (Figures 9.10 and 9.11)
and both OTN and midbrain contained deeply staining nuclei (Figures 9.6
to 9.9 inclusive) this would be expected.
The fact that GAD specific activity and high affinity uptake of
GABA is higher in OT, OTN and M than in the forebrain regions suggests
that there is a greater density of GABAergic synapses in those regions.
There is evidence suggesting the importance of GABA as a neurotransmitter
in avian optic tectum (see 1.13) and the results from this study are
in agreement.
It is interesting that GABA-T staining is not uniform throughout
optic tectum. In layers I and II which contain intrinsic GABAergic
neurons (interneurons) as well as the terminals of GABAergic neurons
1 5(y
which form an inhibitory input from nucleus isthmi pars parvocellularis
(Hunt & Kunzle 1976(b); Hunt et_ al_ 1977) the staining is more diffuse
than in layertXI where discrete cell bodies can be seen (Figure 9.11).
The deep staining in layers I and II may reflect the greater nunber of
cell bodies and synaptic connections present in those layers whereas
in layer III which does not contain such a network of neurons, only
discrete cell bodies are stained.
The midbrain contains a number of structures involved in the
transmission of visual information including nucleus rotundus and
dorsolateral thalamus (Figures 9.6 and 9.7). Although the biochemical
evidence pointing to a high level of GABAergic activity in chick
midbrain cannot give any indication as to whether this is involved
with the visual system, the histochemical GABA-T analysis produced
very localised results. Nucleus rotundus was very easily distinguishable
(Figure 9.6). Staining was not uniform throughout, the ventral area
of the nucleus being much more deeply stained. Individual cell bodies
could also be distinguished throughout. This indicates that GABA
may have an important role at least in the ventral part of nucleus
rotundus.
A detailed analysis of the tectofugal pathway (Benowitz & Kartell
1976) suggested that it might consist of five "channels" with cells
at various depths within the optic tectum projecting upon distinct
subdivisions of nucleus rotundus, in particular a ventral subdivision
of nucleus rotundus was found to receive its primary input from two
pretectal nuclei; one of which, nucleus subpraetectalis, receives
direct retinal input (Karten & Hevzin 1966). An indirect inhibitory
pathway from the tectum via nucleus subpraetectalis to the ventral
subdivision of nucleus rotundus was proposed (Benowitz & Karten 1976)
on the basis of their results and those of Granda and Yazulla (1972)
who demonstrated that cells in ventral nucleus rotundus showed an
inhibitory response to light. Both ventral nucleus rotundus and
nucleus subpraetectalis stain deeply for GABA-T, it is possible
therefore that GABA may be an inhibitory neurotransmitter involved
in this particular inhibitory pathway.
Nucleus subpraetectalis can clearly be seen as a cluster of discrete,
deeply stained small cells and nucleus spiriformis lateralis as a
cluster of more diffusely stained larger cells. Nucleus isthmo opticus
i sn
is just visible at this level as a small cluster of very diffusely
stained^cells (Figure 9.7). The tectal input from nucleus spiriformis
lateralis has been tentatively identified as GABAergic and GABAergic
projections have been identified between optic tectum and the pretectum
(Hunt & Kunzle 1976(b)). Nucleus isthmo opticus receives an input
from the tectum and then sends efferent fibres to the retina.
A number of other nuclei in midbrain, for example nucleus ovoidalis
and nucleus nervi acculomotorii (Figures 9.6 and 9.8), obviously
contained high levels of GABA-T activity. Since these structures
are not involved in the visual pathways any implications which might
be drawn from this will not be discussed.
The dissection used in this study resulted in nucleus isthmi pars
magnocellularis and nucleus isthmi pars parvocellularis (Figure 9.9)
being in the region designated OTN. The high GAD specific activity
and GABA uptake found for this region were complemented by very deep
staining for GABA-T, particularly in nucleus isthmi pars parvocellularis.
In nucleus isthmi pars magnocellularis discrete, very deeply staining
cells bodies could also be distinguished whereas in nucleus isthmi pars
parvocellularis staining throughout was so pronounced that individual
cell bodies could not be seen. A GABAergic input to the optic tectum
from nucleus isthmi pars parvocellularis has been postulated (Hunt &
Kunzle 1976(b)) and also a GABAergic connection between the rostral
and caudal regions of nucleus isthmi para parvocellularis (Hunt et_ al_
1977). The high level of GABA-T activity in this nucleus is demonstrated
by the intensity of staining may reflect high level of GABAergic activity.
In the forebrain it was not possible to distinguish any particular
region by the histochemical GABA-T stain. The biochemical data suggested
that GABAergic activity in the forebrain regions examined was not as
great as in the midbrain or optic lobes. From this study it is not
possible to speculate as to the extent of the involvement of GABAergic
neurons in the visual pathways in chick forebrain.
The biochemical and histochemical data obtained for midbrain and
optic lobe correlated with proposed GABAergic pathways in chick visual
system after retrograde transport of [ ^h] GABA (Hunt & Kunzle 1976(b);
Hunt et_ al_ 1977). High GABA-T activity has been shown to be specifically
localised in regions postulated to receive a GABAergic input, for example
nucleus subpraetectalis and optic tectum suggesting that, at least at
the microscopic level, analysis of distribution of high GABA-T activity
could be a useful tool in the preliminary identification of regions
containing GABAergic synapses.
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More precise biochemical information as to regional distribution of
GABA metabolism in chick brain requires dissection and analysis of the
individual nuclei. Definitive evidence as to the extent to which
GABAergic neurons are involved in the avian visual system might be
obtained by immunocytochemistry using specific (FITC labelled)




Diagram of the skull of a chick in side view, a, shows the transverse
plane in which sections were taken in this study ; b, shows the
transverse plane in which sections were taken by van Tienhoven and
Juhasz (1962).
I (9 O
Extracts from a stereotaxic atlas of chicken brain, van Tienhoven and
Juhasz 1962.
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, „ . .. /lateral nucleusAS, Area septalis <^medial nucleus
AV, Area ventralis (Kuhlenbeck, '38) = tuber-
culum olfactorium (Jones and Levi-Montal-
cini)
B, Bed nucleus brachium conjunctivum (cere¬
bellar decussation)
BC, Brachium conjunctivum (Papez) = Superior
Cerebellar Decussation (Jungherr)
BP, Brachium pontis (Papez)
BPC, Bed nucleus of pallial commissure
BS, nu. basalis
BT, Bulbo thalamicus (Black)
C, Cortical area or corticoid area
CA, Central acoustic tract (Papez)
CER, Cerebellum
CHI, Optic chiasma
CIO, Capsula interna occipitalis (Schroeder) =
(tractus thalamo-frontalis pars caudalis)
CP, Choroid plexus
DA, tr. dorso-archistriaticus (Schroeder)
DI, Decuss. tr. infindibularis
DL, nu. dorsolaterals
DM, nu. dorsomedialis
DMP, nu. dorsomedialis posterior
DMS, nu. dorsolaterals superficialis (Kuhlen¬
beck, '37) = nu. superficialis parvo cellu-
laris (Jungherr)
DSO, Decussatio supraoptica dorsalis and ven¬
tralis
DV, nu. decussationis supraopticae ventralis
E, nu. magnocellularis strati gTisei (Edinger,
Wallenberg and Holmes)
EB, Eminentia basalis (Haefelfinger) = nu. ac-
cumbens + primordial hippocampus (Huber




ES, nu. entopeduncularis ventralis superior (Hu¬
ber and Crosby) = nu. reticularis ventralis
of Kuhlenbeck ('37).
FA, tr. fronto-archistriaticus
FLM, Fasciculus longitudinalis medialis
GD, Corpus geniculatus laterodorsalis (Kuhlen¬
beck, '37)
GLOML, Glomerular layer
GV, Corpus geniculatus lateralis ventralis
HA, Hyperstriatum accessorium
HAM, nu. hypothalamicus anterior medialis
HD, Hyperstriatum dorsale
HI, nu. intercalatus hyperstriaticus
HIP, Hippocampus
HL, nu. habenularis lateralis
HM, nu. habenularis medialis
HP, tr. habenularis peduncularis (Schifferli)
HPM, nu. hypothalamicus posterior medialis
HYP, Hyperstriatum
HYPV, Hyperstriatum ventrale
I, Intercalated part of the posterior commissure
IC, nu. intercalatus (thalami)
IF, tr. infundibularis
IGRL, Inner granular layer
IH, nu. hypotbalmic inferior (Kuhlenbeck, '37;
Wingstrand)
IM, nu. isthmi pars principalis magnocellularis
IO, tr. isthmo-opticus = tr. tecto isthmicus
(Groebbels; Schifferli)
IP, nu. isthmi pars principalis parvocellularis
IS, nu. internus superior (Rendahl) = nu. para-
ventricularis dorsalis (Kuhlenbeck)
LA, nu. lateralis anterior
LD, nu. lemniscus dorsalis
LFB, Lateral forebrain bundle
LFS, Lamina frontalis superior
LFSm, Lamina frontalis suprema
LH, Lamina hyperstriaticus — tr. fronto occipitalis
LHT, nu. hypothalamicus lateralis (Kuhlenbeck,
'37; Wingstrand)
LL, Lemniscus lateralis
LM, nu. subhabenularis medialis
LMD, Lamina medullaris dorsalis
LP, Lateral pontal nucleus
LV, Lateral ventricle
LS, nu. subhabenularis lateralis
M, Medullary part of the posterior commissure
MITL, Mitral layer
ML, nu. mammilaris lateralis
MLD, nu. mesencephalicus lateralis pars dorsalis
MM, nu. mammilaris medialis (Kuhlenbeck, '37;
Wingstrand) = nu. mammilaris medialis pars
dorsalis (Huber and Crosby)
MP, nu. mesencephalicus profundus
MPL, nu. mesencephalicus profundus pars lat¬
eralis
MPt, nu. pontis medialis
MPV, nu. mesencephalicus profundus pars
ventralis (Jungherr)
MT, Mesencephalic root of V
nA, nu. annularis of FLM
NB, nu. diagonal band of Broca






nL, nu. linea caudalis
NOC, Nervus oculomotorius
nSM, nu. tr. septomesencephalicus
nT, nu. tuberis (Kuhlenbeck, '37; Wingstrand)
OA, nu. oculomotorius accessorius
OD, nu. oculomotorius dorso medialis
OGRL, Outer granular layer




OV, nu. oculomotorius ventralis (Ariens
Kappers) = nu. oculomotorius ventro me¬
dialis (Jungherr)
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OVD, nu. ovoidalis
P, Pretectal part of the posterior commissure
PAL, Paleostriatum; p — primitivum, a —
augmentatum
PC, Posterior commissure
PD, nu. praeopticus dorsolaterals (Kuhlenbeck,
'37) = partly area ventralis
PG, Periventricular gray
PI, nu. paramedianus intermedius (Kuhlenbeck
'37) = nu. internus inferior posterior




PO, nu. parageniculatus tecti optici
(Kuhlenbeck, '37)
POM, nu. praeopticus medialis
PP, nu. principalis praecommisuralis
(Kuhlenbeck, '37)
PPM, nu. praeopticus paraventricularis
magnocellularis (Kuhlenbeck, '37)
(a) dorsalis, (b) medialis, (c) ventralis




PVM, nu. paraventricularis magnocellularis
QF, Quinto-frontalis
R, Raphe
RD, nu. reticularis dorsalis (Kuhlenbeck, '37)
= nu. decussationis supraopticae dorsalis
(Huber and Crosby)
RET, nu. reticularis superior
ROT, nu. rotundus
RS, Rubrospinal tract (Papez)
RU, nu. ruber
SCT, tr. striotegmentalis et striocerebellaris
(Schifferli)
SE, Strat. cellulare externum
SG, Stilus corpus geniculatus (Edinger,
Wallenberg and Holmes)
different from that used by Ralph and
Fraps, ('59) because the transverse zero
plane in our case is 5 mm posterior to
their transverse zero plane.
MATERIALS AND METHODS
Single Comb White Leghorn hens weigh¬
ing between 2 and 2.5 kg were used. The
following measurements were taken and
the ranges indicated in parentheses indi¬
cate the ranges of these measurements for
birds used in the present studies. All birds
in which the parietal bones curved so that
the level could not be placed flat on the
parietal and frontal bones were discarded.
Measurements; (1) Bregma to external
occipital crest (Chamberlain, '43) mea¬
sured along the midsagittal plane (1.20 —
1.60 cm).
(2) Midline to lateral crest (Chamber¬
lain, '43) measured from the middle of




SOE, nu. supraopticus externus (Legait) = nu.
interstitialis magnocellulaxis lateralis
(Huber and Crosby)
SOV, nu. supraopticus ventralis (Legait) = nu.
supraopticus (Kuhlenbeck, '37)
SP, tr. striopeduncularis (Papez) = tr. occipito-
mesencephalicus (Huber and Crosby)
SpL, nu. spiriformis lateralis




STH, tr. striothalamicus (Schroeder)
STM, tr. strio medullaris (Huber and Crosby)
T, nu. trochlearis
TC, tr. tectocerebellaris (Groebbels)
TD, nu. tegmentalis dorsalis
TE, tr. tectothalamicus nu. ectomammilaris
TEC, Optic tectum
TFM, tr. thalamo-frontalis medialis
TL, nu, tegmentalis laterodorsalis
TM, tr. thalamomammilaris (Schroeder)
Tn, nu. taenia
TO, tr. nu. ovoidalis
TOM, tr. opticus marginalis
TR, nu. triangularis (nu. tr. habenulo-
peduncularis)
TRO, Nervus trochlearis




VL, nu. lemmiscus lateroventralis
VLT, nu. ventrolateralis (Kuhlenbeck, '37)
VM, tr. vestibulo-mesencephalicus (Papez)
the line bregma to external occipital crest
(1.15 - 1.40 cm).
(3) Distance between the earplugs
when fully inserted into the head (1.1 —
1.3 cm).
Brains were perfused through the ca¬
rotid arteries with 1% saline and subse¬
quently with 10% buffered formalin. The
brains were then fixed in 10% for¬
malin. After fixation for 2—3 days the
brains were placed in the stereotaxic in¬
strument and cut in slices of about 1 cm
thick along the transverse plane. The
cutting was done by using the controls of
the stereotaxic instrument (Krieg, '46)
after a knife was placed in the electrode
holder. Three brains to be used for frozen
sections were fixed for two days in buffered
10% formalin and then embedded in gela¬
tin. Frozen sections, 50 u thick, were made.
All sections were saved, mounted on mi-
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Succinic semialdehyde dehydrogenase (EC.1.2.1.24)
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